Professor David Goldstein

Conjoint Professor

MBBS, FRACP, PRCP (UK)

Medicine & Health
School of Clinical Medicine

Prof Goldstein is a Conjoint Clinical Professor. He has been involved in a variety of clinical research projects ranging from laboratory basic science to novel therapeutics trials to psychosocial aspects of Cancer care. He has been PI of a number of NHMRC and Cancer Australia funded therapeutic trials including both investigator initiated and as Australian PI for multinational studies. He has also been involved with psychosocial and cross cultural/CALD research for many years. His clinical interests are treatment of GI malignancies including pancreas cancer, colorectal cancer, anal carcinoma, hepatobilary and upper GI malignancy and renal cell carcinoma and lymphoma.

Prof Goldstein has been a Chief or Principal Investigator on $39,000,000 peer reviewed funded grants. He was the Director of the UNSW Translational Cancer Research Network, a $6,000,000 5 year CINSW funded program now completed. He was the adult program leader of the UNSW National Cancer Survivors Centre and is involved with a research program associated with survivorship issues. As part of this activity, he was the Chief Investigator of a 5 year Cancer Institute NSW translational program grant of $3,100,000 to study the impact of chemotherapy induced peripheral neuropathy, now completed.

He also actively participates in two laboratory research programs dealing with stromal biology, pancreas drug resistance and modelling optimal targeted therapies.

Prof Goldstein has 370 co-authored peer reviewed publications, since 2017 citations 17460, overall 33917, H index 80, since 2017 56 [Google Scholar]. He has presented at numerous national and international meetings: ESMO- ESMO Asia, ESMO GI, USA – ASCO, Japan - Japan Pancreas Society, Gastro week and medical oncology group, New Zealand, S. Korea, Singapore, COSA ASM.

National and international collaborations with researchers at University of Sydney, MRC (UK), University of Liverpool, GERCOR, NCIC. Invited reviewer for leading scientific journals, and grant applications (NHMRC, ARC).

 

 

 

Phone
22577
Location
lowy cancer centre
  • Book Chapters | 2013
    Butow P; Tattersall MHN; Clayton J; Goldstein D, 2013, 'Breaking bad news and truth disclosure in Australia', in New Challenges in Communication with Cancer Patients, pp. 377 - 387, http://dx.doi.org/10.1007/978-1-4614-3369-9_31
    Book Chapters | 2010
    Goldstein D; Jones R; Smalley RV; Borden EC, 2010, 'Interferon Therapy and Cancer', in Oldham RK (ed.), Cancer Biotherapy: Principles and Practice, Springer, New York, pp. 277 - 302
    Book Chapters | 2009
    Goldstein DP; John Kim J; Gullane PJ; Montgomery PQ, 2009, 'Tumors of the hypopharynx', in Principles and Practice of Head and Neck Surgery and Oncology, Second Edition, pp. 233 - 256
    Book Chapters | 2009
    Shrime MG; Goldstein DP; Irish JC; Gullane PJ, 2009, 'Complications of Lip Surgery', in Complications in Head and Neck Surgery with CD Image Bank, pp. 251 - 256, http://dx.doi.org/10.1016/B978-141604220-4.50026-2
    Book Chapters | 2000
    Yip D; Karapetis C; Strickland A; Steer C; Goldstein D; Harper P, 2000, 'Chemotherapy and radiotherapy for pancreatic cancer', in Yip D (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd002093
    Book Chapters | 1998
    Smalley RV; Goldstein D; Borden EC, 1998, 'Interferons: Therapy in Cancer', in Principles of Cancer Biotherapy, Springer Netherlands, pp. 266 - 283, http://dx.doi.org/10.1007/978-94-009-0029-5_11
  • Journal articles | 2024
    Best MC; Butow P; Savard J; Newson AJ; Campbell R; Vatter S; Napier CE; Bartley N; Tucker K; Ballinger ML; Thomas DM; PiGeOn Project , 2024, 'From ownership to custodianship of tumor biopsy tissue in genomic testing: a mixed methods study of patient views.', Oncologist, http://dx.doi.org/10.1093/oncolo/oyae074
    Journal articles | 2024
    De Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J, 2024, 'Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial', JAMA Otolaryngology - Head and Neck Surgery, http://dx.doi.org/10.1001/jamaoto.2024.0423
    Journal articles | 2024
    Gete M; Huang SH; Ringash J; Irish J; Su J; Ballal Y; Waldron JN; Witterick I; de Almeida J; Hosni A; Hope AJ; Monteiro E; Cho J; O'Sullivan B; Kim J; Bratman S; Goldstein DP; McPartlin A; Tsai J; Tong L; Xu W; Hahn E, 2024, 'Causes and impact of delays during the COVID-19 pandemic on head and neck cancer diagnosis', Head and Neck, http://dx.doi.org/10.1002/hed.27784
    Journal articles | 2024
    Heinrich MC; Jones RL; George S; Gelderblom H; Schöffski P; von Mehren M; Zalcberg JR; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Siontis BL; Goldstein D; Boye K; Sanchez C; Steeghs N; Rutkowski P; Druta M; Serrano C; Somaiah N; Chi P; Reichmann W; Sprott K; Achour H; Sherman ML; Ruiz-Soto R; Blay JY; Bauer S, 2024, 'Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial', Nature Medicine, 30, pp. 498 - 506, http://dx.doi.org/10.1038/s41591-023-02734-5
    Journal articles | 2024
    Li T; Timmins HC; Mahfouz FM; Mizrahi D; Horvath L; Harrison ML; Grimison PS; Friedlander M; Marx GM; Boyle FM; Wyld D; Henderson R; King T; Baron-Hay SE; Kiernan MC; Rutherford C; Goldstein D; Park SB, 2024, 'Identifying optimized assessment of nerve damage during chemotherapy.', Journal of Clinical Oncology, 42, pp. 12016 - 12016, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.12016
    Journal articles | 2024
    Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB, 2024, 'Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-024-08484-5
    Journal articles | 2024
    Mahfouz FM; Li T; Joda M; Harrison M; Horvath LG; Grimison P; King T; Marx G; Goldstein D; Park SB, 2024, 'Sleep dysfunction associated with worse chemotherapy-induced peripheral neurotoxicity functional outcomes', Supportive Care in Cancer, 32, http://dx.doi.org/10.1007/s00520-023-08245-w
    Journal articles | 2024
    Mahfouz FM; Li T; Joda M; Harrison M; Kumar S; Horvath LG; Grimison P; King T; Goldstein D; Park SB, 2024, 'Upper-limb dysfunction in cancer survivors with chemotherapy-induced peripheral neurotoxicity', Journal of the Neurological Sciences, 457, http://dx.doi.org/10.1016/j.jns.2023.122862
    Journal articles | 2024
    Mahfouz FM; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; Marx G; Goldstein D; Park SB, 2024, 'Impact of Pain on Symptom Burden in Chemotherapy-Induced Peripheral Neurotoxicity', JNCCN Journal of the National Comprehensive Cancer Network, 22, pp. 108 - 116, http://dx.doi.org/10.6004/jnccn.2023.7083
    Journal articles | 2024
    Namavarian A; Gabinet-Equihua A; Deng Y; Khalid S; Ziai H; Deutsch K; Huang J; Gilbert RW; Goldstein DP; Yao CMKL; Irish JC; Enepekides DJ; Higgins KM; Rudzicz F; Eskander A; Xu W; de Almeida JR, 2024, 'Length of Stay Prediction Models for Oral Cancer Surgery: Machine Learning, Statistical and ACS-NSQIP', Laryngoscope, http://dx.doi.org/10.1002/lary.31443
    Journal articles | 2024
    Netto KG; Chiang S; Kokkinos J; Haghighi KS; Raina A; Pitiyarachchi O; Youkhana J; Truong Q; Wenholz D; Li X; Laczka O; Kumar N; Wilkinson J; Goldstein D; Sharbeen G; Phillips PA, 2024, 'Abstract B062: CRO67 has therapeutic potential against pancreatic tumor cells and cancer associated fibroblasts', Cancer Research, 84, pp. B062 - B062, http://dx.doi.org/10.1158/1538-7445.panca2023-b062
    Journal articles | 2024
    Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Monteiro E; Chung J; Zahedi A; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP, 2024, 'Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study', Thyroid, http://dx.doi.org/10.1089/thy.2023.0634
    Journal articles | 2024
    Tzelnick S; de Almeida JR; Yao CMKL; Kibel S; Kuehne N; Grewal R; Butler MO; Saibil S; Spreafico A; Easson A; Goldstein DP, 2024, 'Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure', Laryngoscope, http://dx.doi.org/10.1002/lary.31515
    Journal articles | 2024
    Watson EE; Hueniken K; Lee J; Huang SH; El Maghrabi A; Xu W; Moreno AC; Tsai CJ; Hahn E; McPartlin AJ; Yao CMKL; Goldstein DP; De Almeida JR; Waldon JN; Fuller CD; Hope AJ; Ruggiero SL; Glogauer M; Hosni AA, 2024, 'Development and Standardization of an Osteoradionecrosis Classification System in Head and Neck Cancer: Implementation of a Risk-Based Model', Journal of Clinical Oncology, 42, pp. 1922 - 1933, http://dx.doi.org/10.1200/JCO.23.01951
    Journal articles | 2024
    Yeung N; Li T; Lin H-M; Timmins HC; Goldstein D; Harrison M; Friedlander M; Mahon KL; Giles C; Meikle PJ; Park SB; Horvath LG, 2024, 'Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.', JCO Precis Oncol, 8, pp. e2300690, http://dx.doi.org/10.1200/PO.23.00690
    Journal articles | 2024
    de Almeida JR; Su JS; Kolarski MM; Truong T; Weinreb I; Perez-Ordonez B; Smith SM; Hosni A; Patel S; Valero C; Xu B; Ghossein R; Katabi N; Clark J; Low TH; Gupta R; Graboyes EM; Davies J; Richardson M; Pasham V; Jester R; Goldstein DP; Huang SH; Xu W; O’Sullivan B, 2024, 'Development and validation of a novel TNM staging N-classification of oral cavity squamous cell carcinoma', Cancer, 130, pp. 410 - 420, http://dx.doi.org/10.1002/cncr.35020
    Journal articles | 2023
    Abdelmogod A; Papadopoulos L; Riordan S; Wong M; Weltman M; Lim R; McEvoy C; Fellowes A; Fox S; Bedő J; Penington J; Pham K; Hofmann O; Vissers JHA; Grimmond S; Ratnayake G; Christie M; Mitchell C; Murray WK; McClymont K; Luk P; Papenfuss AT; Kee D; Scott CL; Goldstein D; Barker HE, 2023, 'A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review', Cancers, 15, http://dx.doi.org/10.3390/cancers15174378
    Journal articles | 2023
    Ballal Y; Gete M; Su J; O'Sullivan B; Waldron JN; Irish J; Ringash J; Kim J; Bratman S; Cho J; Hope AJ; Hosni A; de Almeida J; Goldstein DP; Witterick I; Monteiro E; Tong L; Xu W; Hui Huang S; Hahn E, 2023, 'The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis', Oral Oncology, 138, http://dx.doi.org/10.1016/j.oraloncology.2023.106332
    Journal articles | 2023
    Bekaii-Saab T; Okusaka T; Goldstein D; Oh DY; Ueno M; Ioka T; Fang W; Anderson EC; Noel MS; Reni M; Choi HJ; Goldberg JS; Oh SC; Li CP; Tabernero J; Li J; Foos E; Oh C; Van Cutsem E, 2023, 'Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial', eClinicalMedicine, 58, http://dx.doi.org/10.1016/j.eclinm.2023.101897
    Journal articles | 2023
    Berania I; Tzelnick S; de Almeida JR; McKinnon G; Goldstein DP, 2023, 'Practice patterns for positive sentinel lymph node in head and neck melanoma', Head and Neck, 45, pp. 555 - 560, http://dx.doi.org/10.1002/hed.27262
    Journal articles | 2023
    Bonazzi VF; Aoude LG; Brosda S; Bradford JJ; Lonie JM; Loffler KA; Gartside MG; Patel K; Mukhopadhyay P; Keane C; Gebski V; Kench JG; Goldstein D; Waddell N; Barbour AP, 2023, 'C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients', Asia-Pacific Journal of Clinical Oncology, http://dx.doi.org/10.1111/ajco.13993
    Journal articles | 2023
    Chen T; Chan HHL; de Almeida J; Goldstein DP; Gilbert RW; Yao CMKL; Irish JC; Davies JC, 2023, 'A 3D Analysis of Plating Strategies in Mandibular Reconstruction: A Randomized Control Pilot Study', Laryngoscope, http://dx.doi.org/10.1002/lary.31171
    Journal articles | 2023
    Chepeha DB; Esemezie AO; Philteos J; Brown DH; de Almeida JR; Gilbert RW; Goldstein DP; Gullane PJ; Irish JC; Yao CM; Barbon CEA, 2023, 'Glossectomy for the treatment of oral cavity carcinoma: Quantitative, functional and patient-reported quality of life outcomes differ by four glossectomy defects', Oral Oncology, 142, http://dx.doi.org/10.1016/j.oraloncology.2023.106431
    Journal articles | 2023
    Chibly AM; Patel VN; Aure MH; Pasquale MC; Morell RJ; Izquierdo DM; Boger E; Martin GE; Ghannam M; Andrade J; Denegre NG; Simpson C; Goldstein DP; Liu FF; Lombaert IMA; Hoffman MP, 2023, 'Neurotrophin signaling is a central mechanism of salivary dysfunction after irradiation that disrupts myoepithelial cells', npj Regenerative Medicine, 8, http://dx.doi.org/10.1038/s41536-023-00290-7
    Journal articles | 2023
    Clifford BK; Amorim N; Kaakoush N; Boysen L; Tedla N; Goldstein D; Hardeman E; Simar D, 2023, 'Irradiation-Induced Dysbiosis: The Compounding Effect ofHigh-Fat Diet on Metabolic and Immune Functions in Mice', International Journal of Molecular Sciences, 24, pp. 5631 - 5631, http://dx.doi.org/10.3390/ijms24065631
    Journal articles | 2023
    Clifford BK; Kaakoush NO; Tedla N; Goldstein D; Simar D, 2023, 'The effect of exercise intensity on the inflammatory profile of cancer survivors: A randomised crossover study', European Journal of Clinical Investigation, 53, pp. e13984, http://dx.doi.org/10.1111/eci.13984
    Journal articles | 2023
    Desai V; Lamba W; de Almeida J; Goldstein D, 2023, 'Approach and Management of Alcohol Withdrawal Syndrome in Operative Head and Neck Cancer Patients', Otolaryngology - Head and Neck Surgery (United States), 168, pp. 1258 - 1260, http://dx.doi.org/10.1002/ohn.164
    Journal articles | 2023
    Gelderblom H; Jones RL; Blay JY; George S; von Mehren M; Zalcberg JR; Kang YK; Razak AA; Trent J; Attia S; Le Cesne A; Siontis BL; Goldstein D; Boye K; Sanchez C; Steeghs N; Rutkowski P; Druta M; Serrano C; Somaiah N; Chi P; Harrow B; Becker C; Reichmann W; Sherman ML; Ruiz-Soto R; Heinrich MC; Bauer S, 2023, 'Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study', European Journal of Cancer, 192, http://dx.doi.org/10.1016/j.ejca.2023.113245
    Journal articles | 2023
    Id Said B; Alfaraj FA; Marta GN; Kowalski LP; Kohler HF; Huang SH; Su J; Xu W; Eng L; De Moraes FY; Hahn E; Kim JJ; O'Sullivan B; Ringash J; Waldron J; Matos LL; Prisman E; Irish JC; Yao CMKL; De Almeida JR; Goldstein DP; Hope A; Hosni A, 2023, 'Individualized risk assessment of distant metastases in oral cavity carcinoma: A validated predictive-score model', Journal of the National Cancer Institute, 115, pp. 1555 - 1562, http://dx.doi.org/10.1093/jnci/djad144
    Journal articles | 2023
    Lam LL; Pavlakis N; Shitara K; Sjoquist KM; Martin AJ; Yip S; Kang YK; Bang YJ; Chen LT; Moehler M; Bekaii-Saab T; Alcindor T; O’Callaghan CJ; Tebbutt NC; Hague W; Chan H; Rha SY; Lee KW; Gebski V; Jaworski A; Zalcberg J; Price T; Simes J; Goldstein D, 2023, 'INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)', BMC Cancer, 23, http://dx.doi.org/10.1186/s12885-023-10642-7
    Journal articles | 2023
    Lee JJW; Kunaratnam V; Kim CJH; Pienkowski M; Hueniken K; Sahovaler A; Lam ACL; Davies JC; Brown CM; De Almeida JR; Huang SH; Waldron JN; Spreafico A; Hung RJ; Xu W; Goldstein DP; Liu G, 2023, 'Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis', Cancer, 129, pp. 867 - 877, http://dx.doi.org/10.1002/cncr.34620
    Journal articles | 2023
    Lemech C; Dredge K; Bampton D; Hammond E; Clouston A; Waterhouse NJ; Stanley AC; Leveque-El Mouttie L; Chojnowski GM; Haydon A; Pavlakis N; Burge M; Brown MP; Goldstein D, 2023, 'Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors', Journal for ImmunoTherapy of Cancer, 11, http://dx.doi.org/10.1136/jitc-2022-006136
    Journal articles | 2023
    Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB, 2023, 'Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 125 - 132, http://dx.doi.org/10.6004/jnccn.2022.7074
    Journal articles | 2023
    Mekapogu AR; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka V; Janetka J; Goldstein D; Pirola R; Wilson J; Apte M, 2023, 'HGF/c-Met pathway inhibition combined with chemotherapy increases cytotoxic T-cell infiltration and inhibits pancreatic tumour growth and metastasis', Cancer Letters, 568, http://dx.doi.org/10.1016/j.canlet.2023.216286
    Journal articles | 2023
    Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB, 2023, 'Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy', Asia-Pacific Journal of Clinical Oncology, 19, pp. 243 - 249, http://dx.doi.org/10.1111/ajco.13834
    Journal articles | 2023
    Moore MJ; Goldstein D; Hamm J; Figer A; Hecht JR; Gallinger S; Au HJ; Murawa P; Walde D; Wolff RA; Campos D; Lim R; Ding K; Clark G; Voskoglou-Nomikos T; Ptasynski M; Parulekar W, 2023, 'Erlotinib Plus Gemcitabine Compared with Gemcitabine Alone in Patients with Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group', Journal of Clinical Oncology, 41, pp. 4714 - 4720, http://dx.doi.org/10.1200/JCO.22.02770
    Journal articles | 2023
    Morand GB; Eskander A; Fu R; de Almeida J; Goldstein D; Noroozi H; Hosni A; Seikaly H; Tabet P; Pyne JM; Matthews TW; Dort J; Nakoneshny S; Christopoulos A; Bahig H; Johnson-Obaseki S; Hua N; Gaudet M; Jooya A; Nichols A; Laxague F; Cecchini M; Du J; Shapiro J; Karam I; Dziegielewski PT; Hanubal K; Erovic B; Grasl S; Davies J; Monteiro E; Gete M; Witterick I; Sadeghi N; Richardson K; Shenouda G; Maniakas A; Landry V; Gupta M; Zhou K; Mlynarek AM; Pusztaszeri M; Sultanem K; Hier MP, 2023, 'The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative', Cancer, 129, pp. 3263 - 3274, http://dx.doi.org/10.1002/cncr.34932
    Journal articles | 2023
    Noel CW; Hueniken K; Forner D; Liu G; Eng L; Hosni A; Hahn E; Irish JC; Gilbert R; Yao CMKL; Monteiro E; O'Sullivan B; Waldron J; Huang SH; Goldstein DP; De Almeida JR, 2023, 'Association of Household Income at Diagnosis with Financial Toxicity, Health Utility, and Survival in Patients with Head and Neck Cancer', JAMA Otolaryngology - Head and Neck Surgery, 149, pp. 63 - 70, http://dx.doi.org/10.1001/jamaoto.2022.3755
    Journal articles | 2023
    Pavlakis N; Shitara K; Sjoquist KM; Martin AJ; Jaworski A; Yip S; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Strickland A; Rha SY; Lee K-W; Zalcberg JR; Price TJ; Simes J; Goldstein D, 2023, 'INTEGRATE IIa: A randomised, double-blind, phase III study of regorafenib versus placebo in refractory advanced gastro-oesophageal cancer (AGOC)—A study led by the Australasian Gastro-intestinal Trials Group (AGITG).', Journal of Clinical Oncology, 41, pp. LBA294 - LBA294, http://dx.doi.org/10.1200/jco.2023.41.4_suppl.lba294
    Journal articles | 2023
    Saleem A; Noel CW; Hueniken K; Grewal R; Kwinter A; Peralta G; de Almeida JR; Goldstein DP, 2023, 'Quantifying Neck Fibrosis: Establishing the Domain Structure of the Neck Fibrosis Scale', Laryngoscope, 133, pp. 2198 - 2202, http://dx.doi.org/10.1002/lary.30497
    Journal articles | 2023
    Sjoquist KM; Martin A; Pavlakis N; Goldstein D; Tsobanis E; Moses D; Maher R; Hague W; Gebski V; Stockler MR; Simes RJ, 2023, 'Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancer', Journal of Cancer Research and Clinical Oncology, 149, pp. 4959 - 4965, http://dx.doi.org/10.1007/s00432-022-04404-4
    Journal articles | 2023
    Symons R; Daly D; Gandy R; Goldstein D; Aghmesheh M, 2023, 'Progress in the Treatment of Small Intestine Cancer', Current Treatment Options in Oncology, 24, pp. 241 - 261, http://dx.doi.org/10.1007/s11864-023-01058-3
    Journal articles | 2023
    Tempero MA; Pelzer U; O'Reilly EM; Winter J; Oh DY; Li CP; Tortora G; Chang HM; Lopez CD; Bekaii-Saab T; Ko AH; Santoro A; Park JO; Noel MS; Frassineti GL; Shan YS; Dean A; Riess H; Van Cutsem E; Berlin J; Philip P; Moore M; Goldstein D; Tabernero J; Li M; Ferrara S; Le Bruchec Y; Zhang G; Lu B; Biankin AV; Reni M; Epstein R; Vasey P; Shapiro J; Burge M; Chua YJ; Harris M; Pavlakis N; Tebbutt N; Prager G; Dittrich C; Längle F; Philipp-Abbrederis K; Greil R; Stöger H; Girschikofsky M; Kuehr T; Van Laethem JL; Laurent S; Dhani N; Ko YJ; Dowden S; Kavan P; Tehfe MÉ; Kubala E; Kohoutek M; Pfeiffer P; Yilmaz M; Parner V; Salminen T; Soveri LM; Korkeila E; Osterlund P; Taieb J; Tougeron D; Artru P; Caroli-Bosc FX; Guimbaud R; Turpin A; Walter T; Bachet JB; Kunzmann V; Kreth F; Block A; Venerito M; Oettle H; Karthaus M; Trojan J; Folprecht G; Lerch M; Kullmann F; Reiser M; Heinemann V; Wörns MA; Schulz H; Garlipp B; Yau T; Chan LS; Juhasz B; Landherr L; Pinter T; Bodoky G; Kahán Z; McDermott R; Power D; Gianni L; Siena S; Milella M; Falcone A; Berardi R, 2023, 'Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial', Journal of Clinical Oncology, 41, pp. 2007 - 2019, http://dx.doi.org/10.1200/JCO.22.01134
    Journal articles | 2023
    Thavaneswaran S; Lin FP-Y; Napier CE; Grady JP; Ballinger ML; Kansara M; Grimison PS; Pavlakis N; Wong MK; Sjoquist KM; Goldstein D; Chantrill LA; Simes J; Thomas DM, 2023, 'Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.', Journal of Clinical Oncology, 41, pp. 4093 - 4093, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.4093
    Journal articles | 2023
    Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB, 2023, 'Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review', Journal of Cancer Survivorship, 17, pp. 222 - 236, http://dx.doi.org/10.1007/s11764-021-00988-x
    Journal articles | 2023
    Tzelnick S; Soroka HP; Tasnim N; Gilbert RW; Irish JC; Goldstein DP; Brown D; Gullane P; Chepeha DB; Yao CMKL; Sahovaler A; Witterick IJ; Monteiro E; Davies J; Huang SH; O'Sullivan B; Hahn E; Hosni A; Razak AA; Gupta AA; de Almeida JR, 2023, 'The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study', Oral Oncology, 145, http://dx.doi.org/10.1016/j.oraloncology.2023.106495
    Journal articles | 2023
    Watson E; El Maghrabi A; Lee JH; Pu J; Xu W; Joudah S; D'Souza V; Quiñonez C; Mojdami ZD; Huang SH; O'Sullivan B; Ringash J; Kim J; Cho J; Bratman S; Waldron J; Goldstein D; Abdalaty AH; Glogauer M; Hope A, 2023, 'Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients', Oral Oncology, 145, http://dx.doi.org/10.1016/j.oraloncology.2023.106527
    Journal articles | 2023
    White D; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G; Lees JG, 2023, 'Targeting translation: A review of preclinical animal models in the development of treatments for chemotherapy-induced peripheral neuropathy', Journal of the Peripheral Nervous System, 28, pp. 179 - 190, http://dx.doi.org/10.1111/jns.12544
    Journal articles | 2023
    Yeung N; Lin H-M; Timmins H; Li T; Goldstein D; Friedlander M; Harrison ML; Mahon KL; Meikle P; Park S; Horvath L, 2023, 'Plasma lipidomic profiling of chemotherapy-induced peripheral neuropathy.', Journal of Clinical Oncology, 41, pp. 3031 - 3031, http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3031
    Journal articles | 2023
    de Guzman RB; Chua MLK; Goldstein D; Aung S; Eaton V; Park K, 2023, 'ASCO's Leadership Development Program: Focusing on the Next Generation of Leaders in Asia Pacific', JCO global oncology, 9, pp. e2200313, http://dx.doi.org/10.1200/GO.22.00313
    Journal articles | 2023
    de Oliveira Faria S; Hueniken K; Kunaratnam V; Hui Huang S; Goldstein D; Ringash J; Pun J; Hope A; Spreafico A; Xu W; Howell D; Liu G, 2023, 'Associations between Human Papillomavirus Status, Weight Change, and Survival of Oropharyngeal Cancer Patients', Nutrition and Cancer, 75, pp. 1541 - 1550, http://dx.doi.org/10.1080/01635581.2023.2212427
    Journal articles | 2022
    Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2022, 'Effectively communicating comprehensive tumor genomic profiling results: Mitigating uncertainty for advanced cancer patients', Patient Education and Counseling, 105, pp. 452 - 459, http://dx.doi.org/10.1016/j.pec.2021.05.018
    Journal articles | 2022
    Berania I; Hosni A; Thomas CM; Goldstein D; Bayley A; Mohan R; Hendler A; Cooper RM; de Almeida JR, 2022, 'Evaluating contralateral neck failure in patients with lateralized OPSCC treated with transoral robotic surgery and neck management based on pre-operative SPECT-CT lymphatic mapping', Journal of Otolaryngology - Head and Neck Surgery, 51, http://dx.doi.org/10.1186/s40463-022-00563-z
    Journal articles | 2022
    Best MC; Bartley N; Napier CE; Fisher A; Ballinger ML; Thomas DM; Goldstein D; Tucker K; Biesecker BB; Butow P, 2022, 'Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study', Supportive Care in Cancer, 30, pp. 8201 - 8210, http://dx.doi.org/10.1007/s00520-022-07272-3
    Journal articles | 2022
    Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC, 2022, 'Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study', Journal of Genetic Counseling, 31, pp. 96 - 108, http://dx.doi.org/10.1002/jgc4.1455
    Journal articles | 2022
    Butow PN; Best MC; Davies G; Schlub T; Napier CE; Bartley N; Ballinger ML; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas DM, 2022, 'Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients', Patient Education and Counseling, 105, pp. 2206 - 2216, http://dx.doi.org/10.1016/j.pec.2022.01.011
    Journal articles | 2022
    Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2022, 'Tear film substance P in patients treated with neurotoxic chemotherapy', Experimental Eye Research, 224, http://dx.doi.org/10.1016/j.exer.2022.109253
    Journal articles | 2022
    Chiang JCB; Khou V; Tavakoli A; Park SB; Goldstein D; Krishnan AV; Markoulli M, 2022, 'Reproducibility and Reliability of Subbasal Corneal Nerve Parameters of the Inferior Whorl in the Neurotoxic and Healthy Cornea', Cornea, 41, pp. 1487 - 1494, http://dx.doi.org/10.1097/ICO.0000000000002947
    Journal articles | 2022
    Chiang JCB; Krishnan AV; Goldstein D; Markoulli M, 2022, 'The Impact of Post-Tear Collection Storage on Tear Film Substance P Concentration', Current Eye Research, 47, pp. 1116 - 1120, http://dx.doi.org/10.1080/02713683.2022.2067565
    Journal articles | 2022
    Foo T; Goldstein D; Segelov E; Shapiro J; Pavlakis N; Desai J; Yip D; Zalcberg J; Price TJ; Nagrial A; Chantrill L; Burge M; Karapetis CS; Tebbutt N; Roy AC, 2022, 'The Management of Unresectable, Advanced Gastrointestinal Stromal Tumours', Targeted Oncology, 17, pp. 95 - 110, http://dx.doi.org/10.1007/s11523-022-00869-y
    Journal articles | 2022
    Hooshmand K; Goldstein D; Timmins HC; Li T; Harrison M; Friedlander ML; Lewis CR; Lees JG; Moalem-Taylor G; Guennewig B; Park SB; Kwok JB, 2022, 'Polygenic risk of paclitaxel-induced peripheral neuropathy: a genome-wide association study', Journal of Translational Medicine, 20, http://dx.doi.org/10.1186/s12967-022-03754-4
    Journal articles | 2022
    Hosen SMZ; Uddin MN; Xu Z; Buckley BJ; Perera C; Pang TCY; Mekapogu AR; Moni MA; Notta F; Gallinger S; Pirola R; Wilson J; Ranson M; Goldstein D; Apte M, 2022, 'Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)', Frontiers in Immunology, 13, http://dx.doi.org/10.3389/fimmu.2022.1060957
    Journal articles | 2022
    Krasovitsky MS; Goldstein D, 2022, 'Destructive soft tissue metastases in advanced colorectal cancer: a case report', Annals of Palliative Medicine, 11, pp. 2170 - 2174, http://dx.doi.org/10.21037/apm-21-362
    Journal articles | 2022
    Li T; Park SB; Battaglini E; King MT; Kiernan MC; Goldstein D; Rutherford C, 2022, 'Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use', Quality of Life Research, 31, pp. 3091 - 3107, http://dx.doi.org/10.1007/s11136-022-03154-7
    Journal articles | 2022
    Livni L; Keating BA; Fiore NT; Lees JG; Goldstein D; Moalem-Taylor G, 2022, 'Effects of combined chemotherapy and anti-programmed cell death protein 1 treatment on peripheral neuropathy and neuroinflammation in mice', Pain, 163, pp. 110 - 124, http://dx.doi.org/10.1097/j.pain.0000000000002384
    Journal articles | 2022
    Maharaj AD; Evans SM; Ioannou LJ; Croagh D; Earnest A; Holland JF; Pilgrim CHC; Neale RE; Goldstein D; Kench JG; Merrett ND; White K; Burmeister EA; Evans PM; Hayes TM; Houli N; Knowles B; Leong T; Nikfarjam M; Philip J; Quinn M; Shapiro J; Smith MD; Spillane JB; Wong R; Zalcberg JR, 2022, 'The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer', HPB, 24, pp. 950 - 962, http://dx.doi.org/10.1016/j.hpb.2021.11.005
    Journal articles | 2022
    Mahfouz FM; Park SB; Li T; Timmins HC; Horvath LG; Harrison M; Grimison P; King T; Goldstein D; Mizrahi D, 2022, 'Association of electrochemical skin conductance with neuropathy in chemotherapy-treated patients', Clinical Autonomic Research, 32, pp. 497 - 506, http://dx.doi.org/10.1007/s10286-022-00895-w
    Journal articles | 2022
    Mcnamara MG; Bridgewater J; Goyal L; Jacobs T; Wagner AD; Goldstein D; Shroff R; Moehler M; Lowery M; Bekaii-Saab T; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox J; Valle J, 2022, 'What is the gender representation in authorship in later phase systemic clinical trials in biliary tract cancer (BTC)? - a retrospective review of the published literature', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2022-064954
    Journal articles | 2022
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC; Young M-A, 2022, 'Psychological predictors of advanced cancer patients’ preferences for return of results from comprehensive tumor genomic profiling', American Journal of Medical Genetics, Part A, 188, pp. 725 - 734, http://dx.doi.org/10.1002/ajmg.a.62563
    Journal articles | 2022
    Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2022, 'Corrigendum to “Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy” [Gait Posture 89 (2021) 178–185](S0966636221002514)(10.1016/j.gaitpost.2021.07.010)', Gait and Posture, 92, pp. 1, http://dx.doi.org/10.1016/j.gaitpost.2021.11.006
    Journal articles | 2022
    Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus process for a clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, 30, pp. 5965 - 5974, http://dx.doi.org/10.1007/s00520-022-07024-3
    Journal articles | 2022
    Nguyen M; Segelov E; Goldstein D; Pavlakis N; Shapiro J; Price TJ; Nagrial A; Chantrill L; Leong T; Chen J; Burge M; Karapetis CS; Chau I; Lordick F; Renouf D; Tebbutt N; Roy AC, 2022, 'Update on optimal management for pancreatic cancer: expert perspectives from members of the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, 22, pp. 39 - 51, http://dx.doi.org/10.1080/14737140.2022.2002689
    Journal articles | 2022
    Perez-Concha O; Goldstein D; Harris MF; Laaksonen MA; Hanly M; Suchy S; Vajdic CM, 2022, 'Uptake of Team Care Arrangements for adults newly diagnosed with cancer', Australian Journal of Primary Health, 29, pp. 20 - 29, http://dx.doi.org/10.1071/py22078
    Journal articles | 2022
    Rahman B; McEwen A; Phillips JL; Tucker K; Goldstein D; Jacobs C, 2022, 'Genetic and genomic learning needs of oncologists and oncology nurses in the era of precision medicine: A scoping review', Personalized Medicine, 19, pp. 139 - 153, http://dx.doi.org/10.2217/pme-2021-0096
    Journal articles | 2022
    Siu DHW; Ali A; Tjokrowidjaja A; De Silva M; Lee J; Clingan PR; Aghmesheh M; Brungs D; Mapagu C; Goldstein D; O'Neill S; Liauw WS; Sjoquist KM; Thomas D; Pavlakis N; Clarke SJ; Diakos C; Chantrill LA, 2022, 'Clinical and molecular profile of young adults with early-onset colorectal cancer: Experience from four Australian tertiary centers', Asia-Pacific Journal of Clinical Oncology, 18, pp. 660 - 668, http://dx.doi.org/10.1111/ajco.13745
    Journal articles | 2022
    Timmins HC; Li T; Goldstein D; Trinh T; Mizrahi D; Harrison M; Horvath LG; Friedlander M; Kiernan MC; Park SB, 2022, 'The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors', Journal of Cancer Survivorship, 16, pp. 223 - 232, http://dx.doi.org/10.1007/s11764-021-01012-y
    Journal articles | 2022
    Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2022, 'Psychological Outcomes in Advanced Cancer Patients After Receiving Genomic Tumor Profiling Results', Health Psychology, 41, pp. 396 - 408, http://dx.doi.org/10.1037/hea0001181
    Journal articles | 2022
    2022, 'Clinical Predictors And Levels Of Physical Activity Among Cancer Survivors Treated With Neurotoxic Chemotherapy', Medicine & Science in Sports & Exercise, 54, pp. 322 - 322, http://dx.doi.org/10.1249/01.mss.0000879060.88938.0b
    Journal articles | 2021
    Aughton K; Elander NO; Evans A; Jackson R; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; Carter R; Cunningham D; Tebbutt NC; Goldstein D; Shannon J; Glimelius B; Hackert T; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Palmer DH; Büchler MW; Ghaneh P; Neoptolemos JP; Greenhalf W, 2021, 'HENT1 predicts benefit from gemcitabine in pancreatic cancer but only with low CDA mRNA', Cancers, 13, pp. 5758, http://dx.doi.org/10.3390/cancers13225758
    Journal articles | 2021
    Battaglini E; Goldstein D; Grimison P; McCullough S; Mendoza-Jones P; Park SB, 2021, 'Chemotherapy-induced peripheral neurotoxicity in cancer survivors: Predictors of long-term patient outcomes', JNCCN Journal of the National Comprehensive Cancer Network, 19, pp. 821 - 828, http://dx.doi.org/10.6004/jnccn.2021.7026
    Journal articles | 2021
    Blinman P; Martin A; Jefford M; Goldstein D; Boadle D; Morris M; Tebbutt N; Aiken C; Harkin A; Segelov E; Haydon A; Iveson T; Stockler MR, 2021, 'Patients' Preferences for 3 Months vs 6 Months of Adjuvant Chemotherapy for Colon Cancer', JNCI CANCER SPECTRUM, 5, http://dx.doi.org/10.1093/jncics/pkaa107
    Journal articles | 2021
    Butow P; Müller F; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub TE; Thomas DM; Goldstein D; Best MC; Newson A; Tucker K; Vines R; Vines K; Kirk J; Young MA; Savard J; Jacobs C, 2021, 'Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling', Psycho-Oncology, 30, pp. 1920 - 1929, http://dx.doi.org/10.1002/pon.5764
    Journal articles | 2021
    Cameron B; Webber K; Li H; Bennett BK; Boyle F; de Souza P; Wilcken N; Lynch J; Friedlander M; Goldstein D; Lloyd AR, 2021, 'Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study', Brain, Behavior, and Immunity - Health, 10, pp. 100189, http://dx.doi.org/10.1016/j.bbih.2020.100189
    Journal articles | 2021
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Penel N; Hartmann JT; Duffaud F; Goldstein D; Martin-Broto J; Gronchi A; Wardelmann E; Marréaud S; Zalcberg JR; Litière S; Blay JY, 2021, 'Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)', Annals of Oncology, 32, pp. 533 - 541, http://dx.doi.org/10.1016/j.annonc.2021.01.004
    Journal articles | 2021
    Chiang JCB; Goldstein D; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal nerve changes following treatment with neurotoxic anticancer drugs', Ocular Surface, 21, pp. 221 - 237, http://dx.doi.org/10.1016/j.jtos.2021.06.007
    Journal articles | 2021
    Chiang JCB; Goldstein D; Tavakoli A; Trinh T; Klisser J; Lewis CR; Friedlander M; Naduvilath TJ; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'Corneal dendritic cells and the subbasal nerve plexus following neurotoxic treatment with oxaliplatin or paclitaxel', Scientific Reports, 11, pp. 22884, http://dx.doi.org/10.1038/s41598-021-02439-0
    Journal articles | 2021
    Chiang JCB; Goldstein D; Trinh T; Au K; Mizrahi D; Muhlmann M; Crowe P; O’neill S; Edwards K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of sub-basal corneal nerve reduction following neurotoxic chemotherapy', Translational Vision Science and Technology, 10, pp. 1 - 11, http://dx.doi.org/10.1167/tvst.10.1.24
    Journal articles | 2021
    Chiang JCB; Goldstein D; Trinh T; Au K; Park SB; Krishnan AV; Markoulli M, 2021, 'A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer', Scientific Reports, 11, pp. 1786, http://dx.doi.org/10.1038/s41598-021-81398-y
    Journal articles | 2021
    Clifford BK; Jones MD; Simar D; Barry BK; Goldstein D, 2021, 'The effect of exercise intensity on exercise-induced hypoalgesia in cancer survivors: A randomized crossover trial', Physiological Reports, 9, pp. e15047, http://dx.doi.org/10.14814/phy2.15047
    Journal articles | 2021
    Giraud P; Racadot S; Vernerey D; Goldstein D; Glimelius B; Van Houtte P; Gubanski M; Spry N; Van Laethem JL; Hammel P; Huguet F, 2021, 'Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, 110, pp. 993 - 1002, http://dx.doi.org/10.1016/j.ijrobp.2021.01.055
    Journal articles | 2021
    Kokkinos J; Ignacio RM; Haghighi K; Kopecky C; Sharbeen G; Gonzales-Aloy E; Youkhana J; Butler L; Goldstein D; McCarroll J; Phillips P, 2021, 'Patient-derived pancreatic tumours in a dish: implications for real-time precision medicine', HPB, 23, pp. S235 - S235, http://dx.doi.org/10.1016/j.hpb.2020.11.590
    Journal articles | 2021
    Kokkinos J; Jensen A; Sharbeen G; McCarroll JA; Goldstein D; Haghighi KS; Phillips PA, 2021, 'Does the microenvironment hold the hidden key for functional precision medicine in pancreatic cancer?', Cancers, 13, http://dx.doi.org/10.3390/cancers13102427
    Journal articles | 2021
    Kokkinos J; Sharbeen G; Haghighi KS; Ignacio RMC; Kopecky C; Gonzales-Aloy E; Youkhana J; Timpson P; Pereira BA; Ritchie S; Pandzic E; Boyer C; Davis TP; Butler LM; Goldstein D; McCarroll JA; Phillips PA, 2021, 'Ex vivo culture of intact human patient derived pancreatic tumour tissue', Scientific Reports, 11, pp. 1944, http://dx.doi.org/10.1038/s41598-021-81299-0
    Journal articles | 2021
    Lees JG; Abdulla M; Barkl-Luke ME; Livni L; Keating BA; Hayes J; Fiore NT; Park SB; Moalem-Taylor G; Goldstein D, 2021, 'Effect of exercise on neuromuscular toxicity in oxaliplatin-treated mice', Muscle and Nerve, 64, pp. 225 - 234, http://dx.doi.org/10.1002/mus.27329
    Journal articles | 2021
    Li T; Mizrahi D; Goldstein D; Kiernan MC; Park SB, 2021, 'Chemotherapy and peripheral neuropathy', Neurological Sciences, 42, pp. 4109 - 4121, http://dx.doi.org/10.1007/s10072-021-05576-6
    Journal articles | 2021
    Lundy J; Harris M; Zalcberg J; Zimet A; Goldstein D; Gebski V; Borsaru A; Desmond C; Swan M; Jenkins BJ; Croagh D, 2021, 'EUS-FNA Biopsies to Guide Precision Medicine in Pancreatic Cancer: Results of a Pilot Study to Identify KRAS Wild-Type Tumours for Targeted Therapy', Frontiers in Oncology, 11, pp. 770022, http://dx.doi.org/10.3389/fonc.2021.770022
    Journal articles | 2021
    Maharaj AD; Evans SM; Zalcberg JR; Ioannou LJ; Graco M; Croagh D; Pilgrim CHC; Dodson T; Goldstein D; Philip J; Kench JG; Merrett ND; Neale RE; White K; Evans P; Leong T, 2021, 'Barriers and enablers to the implementation of multidisciplinary team meetings: A qualitative study using the theoretical domains framework', BMJ Quality and Safety, 30, pp. 792 - 803, http://dx.doi.org/10.1136/bmjqs-2020-011793
    Journal articles | 2021
    McNamara MG; Bridgewater JA; Goyal L; Goldstein D; Shroff RT; Moehler MH; Lowery MA; Bekaii-Saab TS; Kelley RK; Furuse J; Rimassa L; Morizane C; Lamarca A; Hubner R; Knox JJ; Valle JW, 2021, 'Gender representation in authorship in later-phase systemic clinical trials in biliary tract cancer (BTC).', Journal of Clinical Oncology, 39, pp. 348 - 348, http://dx.doi.org/10.1200/jco.2021.39.3_suppl.348
    Journal articles | 2021
    Menant JC; Goldstein D; Au K; Trinh T; van Schooten KS; McCrary JM; Harris CA; Forster BC; Park SB, 2021, 'Evidence of slow and variable choice-stepping reaction time in cancer survivors with chemotherapy-induced peripheral neuropathy', Gait and Posture, 89, pp. 178 - 185, http://dx.doi.org/10.1016/j.gaitpost.2021.07.010
    Journal articles | 2021
    Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D, 2021, 'Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy', JAMA Network Open, 4, pp. E2036695, http://dx.doi.org/10.1001/jamanetworkopen.2020.36695
    Journal articles | 2021
    Oar A; Kneebone A; Lee M; Goldstein D; Sjoquist KM; Le H; Chu J; Barbour A; Gholamrezaei L; Lynam JF; Bece A; Bahamad S; Yip S; Espinoza D; Chantrill LA; Moore A; Lee D; Nguyen QN; Samra J; Mumford J, 2021, 'Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.', JOURNAL OF CLINICAL ONCOLOGY, 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS4172
    Journal articles | 2021
    Oar A; Lee M; Le H; Wilson K; Aiken C; Chantrill L; Simes J; Nguyen N; Barbour A; Samra J; Sjoquist KM; Moore A; Espinoza D; Gebski V; Yip S; Chu J; Kneebone A; Goldstein D, 2021, 'AGITG MASTERPLAN: a randomised phase II study of modified FOLFIRINOX alone or in combination with stereotactic body radiotherapy for patients with high-risk and locally advanced pancreatic cancer', BMC Cancer, 21, http://dx.doi.org/10.1186/s12885-021-08666-y
    Journal articles | 2021
    Pang TCY; Po JW; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2021, 'Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications', Pancreatology, 21, pp. 103 - 114, http://dx.doi.org/10.1016/j.pan.2020.11.022
    Journal articles | 2021
    Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker T; Corley S; Wilkins MR; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Hgf/c-met inhibition as adjuvant therapy improves outcomes in an orthotopic mouse model of pancreatic cancer', Cancers, 13, pp. 2763, http://dx.doi.org/10.3390/cancers13112763
    Journal articles | 2021
    Priya Mathew E; MacMillan CA; Goldstein DP; Smith SM, 2021, 'Primary extraoral sclerosing microcystic adenocarcinoma of the salivary gland', Human Pathology Reports, 26, http://dx.doi.org/10.1016/j.hpr.2021.300577
    Journal articles | 2021
    Quinn CM; Porwal M; Meagher NS; Hettiaratchi A; Power C; Jonnaggadala J; McCullough S; Macmillan S; Tang K; Liauw W; Goldstein D; Zeps N; Crowe PJ; Jonnagaddala J, 2021, 'Moving with the Times: The Health Science Alliance (HSA) Biobank, Pathway to Sustainability', Biomarker Insights, 16, pp. 1 - 10, http://dx.doi.org/10.1177/11772719211005745
    Journal articles | 2021
    Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; van Houtte P; Bonnetain F; Louvet C; Hammel P; Huguet F, 2021, 'Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma', International Journal of Radiation Oncology Biology Physics, 110, pp. 1022 - 1031, http://dx.doi.org/10.1016/j.ijrobp.2021.01.052
    Journal articles | 2021
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2021, 'Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to slc7a11 inhibition', Cancer Research, 81, pp. 3461 - 3479, http://dx.doi.org/10.1158/0008-5472.CAN-20-2496
    Journal articles | 2021
    Smit AK; Bartley N; Best MC; Napier CE; Butow P; Newson AJ; Tucker K; Ballinger ML; Thomas DM; Jacobs C; Meiser B; Goldstein D; Savard J; Juraskova I, 2021, 'Family communication about genomic sequencing: A qualitative study with cancer patients and relatives', Patient Education and Counseling, 104, pp. 944 - 952, http://dx.doi.org/10.1016/j.pec.2020.10.022
    Journal articles | 2021
    Taggart J; Chin M; Liauw W; Goldstein D; Dolezal A; Plahn J; Harris MF, 2021, 'Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice', Public Health Research and Practice, 31, http://dx.doi.org/10.17061/PHRP31122108
    Journal articles | 2021
    Tempero M; O'Reilly E; Van Cutsem E; Berlin J; Philip P; Goldstein D; Tabernero J; Borad M; Bachet J; Parner V; Tebbutt N; Chua Y; Corrie P; Harris M; Taieb J; Burge M; Kunzmann V; Zhang G; McGovern D; Marks H; Biankin A; Reni M, 2021, 'LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival', Annals of Oncology, 32, pp. S226 - S226, http://dx.doi.org/10.1016/j.annonc.2021.06.009
    Journal articles | 2021
    Thavaneswaran S; Ballinger M; Butow P; Meiser B; Goldstein D; Lin F; Napier C; Thomas D; Best M, 2021, 'The experiences and needs of australian medical oncologists in integrating comprehensive genomic profiling into clinical care: A nation-wide survey', Oncotarget, 12, pp. 2169 - 2176, http://dx.doi.org/10.18632/ONCOTARGET.28076
    Journal articles | 2021
    Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB, 2021, 'Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response', Oncologist, 26, pp. 366 - 374, http://dx.doi.org/10.1002/onco.13697
    Journal articles | 2021
    Trinh T; Park SB; Murray J; Pickering H; Lin CSY; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV, 2021, 'Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy—a randomised controlled trial', Supportive Care in Cancer, 29, pp. 1103 - 1110, http://dx.doi.org/10.1007/s00520-020-05591-x
    Journal articles | 2021
    Yu A; Street D; Viney R; Goodall S; Pearce A; Haywood P; Haas M; Battaglini E; Goldstein D; Timmins H; Park SB, 2021, 'Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences', Supportive Care in Cancer, 29, pp. 6379 - 6387, http://dx.doi.org/10.1007/s00520-021-06196-8
    Journal articles | 2020
    Barbour AP; Samra JS; Haghighi KS; Donoghoe MW; Burge M; Harris MT; Chua YJ; Mitchell J; O’Rourke N; Chan H; Gebski VJ; Gananadha S; Croagh DG; Kench JG; Goldstein D; Barbour A; Goldstein D; Samra JS; Harris M; Chua YJ; Yip S; Simes J; Hicks R; Coates A; Gurney H; Do V; Marschner I; Mitchell J; Donoghoe M; Goldstone S; Yip S; Pavlakis N; Goldstein D; Aghmesheh M; Joubert W; Grimes D; Harris M; Burge M; Bagia S; Jaber M; Bryant R; Nathanson L; Cavallucci D; Barbour A; Fawcett J; O’Rourke T; Croagh D; Jones R, 2020, 'The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer', Annals of Surgical Oncology, 27, pp. 2506 - 2515, http://dx.doi.org/10.1245/s10434-020-08205-2
    Journal articles | 2020
    Battaglini E; Goldstein D; Park S, 2020, 'Determining the impact of chemotherapy-induced peripheral neuropathy: A survey of cancer survivors.', Journal of Clinical Oncology, 38, pp. e24080 - e24080, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e24080
    Journal articles | 2020
    Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ, 2020, 'Who should access germline genome sequencing? A mixed methods study of patient views', Clinical Genetics, 97, pp. 329 - 337, http://dx.doi.org/10.1111/cge.13664
    Journal articles | 2020
    Butow P; Butow P; Davies G; Napier CE; Schlub T; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker B; Goldstein D; Thomas DM, 2020, 'Assessment of the Value of Tumor Variation Profiling Perceived by Patients with Cancer', JAMA Network Open, 3, pp. e204721, http://dx.doi.org/10.1001/jamanetworkopen.2020.4721
    Journal articles | 2020
    Butow P; Davies G; Napier C; Thomas DM; Bartley N; Goldstein D; Ballinger ML; Juraskova I; Schlub TE; Tucker K; Meiser B; Young M-A, 2020, 'Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.', Journal of Clinical Oncology, 38, pp. 1541 - 1541, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1541
    Journal articles | 2020
    Chiang JCB; Zahari I; Markoulli M; Krishnan AV; Park SB; Semmler A; Goldstein D; Edwards K, 2020, 'The impact of anticancer drugs on the ocular surface', Ocular Surface, 18, pp. 403 - 417, http://dx.doi.org/10.1016/j.jtos.2020.03.008
    Journal articles | 2020
    Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK, 2020, 'Nomogram for Estimating Overall Survival in Patients with Metastatic Pancreatic Cancer', Pancreas, 49, pp. 744 - 750, http://dx.doi.org/10.1097/MPA.0000000000001563
    Journal articles | 2020
    Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; Van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG, 2020, 'Quality of surgery and outcome in localized gastrointestinal stromal tumors treated within an international intergroup randomized clinical trial of adjuvant imatinib', JAMA Surgery, 155, http://dx.doi.org/10.1001/jamasurg.2020.0397
    Journal articles | 2020
    Kokkinos J; Ignacio RMC; Sharbeen G; Boyer C; Gonzales-Aloy E; Goldstein D; McCarroll JA; Phillips PA, 2020, 'Targeting the undruggable in pancreatic cancer using nano-based gene silencing drugs', Biomaterials, 240, http://dx.doi.org/10.1016/j.biomaterials.2019.119742
    Journal articles | 2020
    Kokkinos J; Sharbeen G; Haghighi K; Ignacio RM; Kopecky C; Gonzales-Aloy E; Youkhana J; Pandzic E; Boyer C; Davis T; Butler L; Goldstein D; McCarroll J; Phillips P, 2020, 'Bringing the pancreas patient back to the bench: Ex vivo culture of intact human patient derived pancreatic tumour tissue', , http://dx.doi.org/10.1101/2020.07.30.223925
    Journal articles | 2020
    Lees JG; White D; Keating BA; Barkl-Luke ME; Makker PGS; Goldstein D; Moalem-Taylor G, 2020, 'Oxaliplatin-induced haematological toxicity and splenomegaly in mice', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0238164
    Journal articles | 2020
    Li T; Timmins HC; King T; Kiernan MC; Goldstein D; Park SB, 2020, 'Characteristics and risk factors of bortezomib induced peripheral neuropathy: A systematic review of phase III trials', Hematological Oncology, 38, pp. 229 - 243, http://dx.doi.org/10.1002/hon.2706
    Journal articles | 2020
    Li T; Timmins HC; McCrary JM; Trinh T; Horvath LG; Friedlander ML; Kiernan MC; Goldstein D; Park SB, 2020, '5. Neurophysiological characteristics in the development and recovery of peripheral neuropathy in oxaliplatin and paxlitaxel treated patients', Clinical Neurophysiology, 131, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2019.11.038
    Journal articles | 2020
    Lim BT; Butow P; Sze ML; Girgis A; Jefford M; Goldstein D; Costa D, 2020, 'Impact of migrancy on cancer clinical trial participation: Factors associated with approach and consent in Australian-born versus migrant groups', Asia-Pacific Journal of Clinical Oncology, 16, pp. 115 - 122, http://dx.doi.org/10.1111/ajco.13290
    Journal articles | 2020
    Maharaj AD; Evans SM; Zalcberg JR; Ioannou LJ; Graco M; Croagh D; Pilgrim CHC; Dodson T; Goldstein D; Philip J; Kench JG; Merrett ND; Neale RE; White K; Evans P; Leong T; Green SE, 2020, 'Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework', PLoS ONE, 15, http://dx.doi.org/10.1371/journal.pone.0243312
    Journal articles | 2020
    Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G, 2020, 'Acute changes in nerve excitability following oxaliplatin treatment in mice', Journal of Neurophysiology, 124, pp. 232 - 244, http://dx.doi.org/10.1152/jn.00260.2020
    Journal articles | 2020
    McGahan W; Waterhouse MA; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Burmeister EA; Jordan SJ; Neale RE, 2020, 'Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: A population-based analysis', Pancreatology, 20, pp. 1458 - 1464, http://dx.doi.org/10.1016/j.pan.2020.07.405
    Journal articles | 2020
    McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; André T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater J; Valle JW, 2020, 'Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer', Journal of Hepatology, 73, pp. 1109 - 1117, http://dx.doi.org/10.1016/j.jhep.2020.05.014
    Journal articles | 2020
    Oar A; Lee M; Le H; Hruby G; Dalfsen R; Pryor D; Lee D; Chu J; Holloway L; Briggs A; Barbour A; Chander S; Ng SP; Samra J; Shakeshaft J; Goldstein D; Nguyen N; Goodman KA; Chang DT; Kneebone A, 2020, 'Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)', Practical Radiation Oncology, 10, pp. e136 - e146, http://dx.doi.org/10.1016/j.prro.2019.07.018
    Journal articles | 2020
    Pang TCY; Xu Z; Mekapogu AR; Pothula S; Becker TM; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'An orthotopic resectional mouse model of pancreatic cancer', Journal of Visualized Experiments, 2020, pp. 1 - 13, http://dx.doi.org/10.3791/61726
    Journal articles | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, '1133 PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES.', Gastroenterology, 158, pp. S - 221, http://dx.doi.org/10.1016/s0016-5085(20)31245-2
    Journal articles | 2020
    Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'Targeting hgf/c-met axis in pancreatic cancer', International Journal of Molecular Sciences, 21, pp. 1 - 18, http://dx.doi.org/10.3390/ijms21239170
    Journal articles | 2020
    Reni M; Riess H; O'Reilly EM; Reeves JA; Chiorean E; George TJ; Scheithauer W; Pascal A; Lerch M; Brenner WS; Ko Y-J; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Biankin A; Tempero MA, 2020, 'Concordance between independent and investigator assessment of disease-free survival (DFS) in the APACT trial.', Journal of Clinical Oncology, 38, pp. 4618 - 4618, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.4618
    Journal articles | 2020
    Sahai V; Tabernero J; Van Cutsem E; Reni M; Tempero MA; O'Reilly EM; Berlin J; Riess H; Goldstein D; Li M; Lu B; Ferrara S; Philip PA, 2020, 'Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns.', Journal of Clinical Oncology, 38, pp. 704 - 704, http://dx.doi.org/10.1200/jco.2020.38.4_suppl.704
    Journal articles | 2020
    Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Boyle F; Goldstein D; Park SB, 2020, 'Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, 131, pp. 1979 - 1985, http://dx.doi.org/10.1016/j.clinph.2020.02.028
    Journal articles | 2020
    Timmins HC; Li T; Huynh W; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, '8. Electrophysiological and phenotypic profiles of taxane-induced neuropathy', Clinical Neurophysiology, 131, pp. e4 - e4, http://dx.doi.org/10.1016/j.clinph.2019.11.041
    Journal articles | 2020
    Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB, 2020, 'Taxane-induced peripheral neuropathy: differences in patient report and objective assessment', Supportive Care in Cancer, 28, pp. 4459 - 4466, http://dx.doi.org/10.1007/s00520-020-05299-y
    Journal articles | 2020
    Timmins HC; Li T; Kiernan MC; Horvath LG; Goldstein D; Park SB, 2020, 'Quantification of Small Fiber Neuropathy in Chemotherapy-Treated Patients', Journal of Pain, 21, pp. 44 - 58, http://dx.doi.org/10.1016/j.jpain.2019.06.011
    Journal articles | 2020
    Tjokrowidjaja A; Goldstein D; Hudson HM; Lord SJ; Gebski V; Clarke S; de Souza P; Motzer RJ; Lee CK, 2020, 'The impact of neutrophil-lymphocyte ratio on risk reclassification of patients with advanced renal cell cancer to guide risk-directed therapy', Acta Oncologica, 59, pp. 20 - 27, http://dx.doi.org/10.1080/0284186X.2019.1656342
    Journal articles | 2020
    Tran B; Vajdic CM; Webber K; Laaksonen MA; Stavrou EP; Tiller K; Suchy S; Bosco AM; Harris MF; Lloyd AR; Goldstein D, 2020, 'Self-reported health, lifestyle and social circumstances of Australian adult cancer survivors: A propensity score weighted cross-sectional study', Cancer Epidemiology, 67, http://dx.doi.org/10.1016/j.canep.2020.101773
    Journal articles | 2020
    Wang X; Yeo RX; Hogg PJ; Goldstein D; Crowe P; Dilda PJ; Yang JL, 2020, 'The synergistic inhibitory effect of combining therapies targeting EGFR and mitochondria in sarcomas', Oncotarget, 11, pp. 46 - 61, http://dx.doi.org/10.18632/oncotarget.27416
    Journal articles | 2020
    Xu Z; Pang TCY; Liu AC; Pothula SP; Mekapogu AR; Perera CJ; Murakami T; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis', British Journal of Cancer, 122, pp. 1486 - 1495, http://dx.doi.org/10.1038/s41416-020-0782-1
    Journal articles | 2020
    Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2020, 'Reply letter to comments on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis', British Journal of Cancer, 123, pp. 1466, http://dx.doi.org/10.1038/s41416-020-1004-6
    Journal articles | 2019
    Best MC; Bartley N; Jacobs C; Juraskova I; Goldstein D; Newson AJ; Savard J; Meiser B; Ballinger M; Napier C; Thomas D; Biesecker B; Butow P; Tucker K; Schlub T; Vines R; Vines K; Kirk J; Young MA, 2019, 'Patient perspectives on molecular tumor profiling: "why wouldn't you?"', BMC Cancer, 19, pp. 753, http://dx.doi.org/10.1186/s12885-019-5920-x
    Journal articles | 2019
    Chua YJ; Pavlakis N; Sjoquist KM; Martin AJ; Tsobanis E; Yip S; Bang Y-J; Alcindor T; O’callaghan CJ; Bekaii-Saab TS; Grothey A; Chen L-T; Simes J; Zalcberg JR; Goldstein D; Komatsu Y; Machida N; Esaki T; Hara H; Shitara K, 2019, 'Randomised Phase 3 Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (AGOC) - INTEGRATE II', Annals of Oncology, 30, pp. vi137 - vi137, http://dx.doi.org/10.1093/annonc/mdz343.087
    Journal articles | 2019
    Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP, 2019, 'The Impact of Positive Resection Margins on Survival and Recurrence following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma', Annals of Surgery, 269, pp. 520 - 529, http://dx.doi.org/10.1097/SLA.0000000000002557
    Journal articles | 2019
    Kaur R; Meiser B; Zilliacus E; Tim Wong WK; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Norris C; Goldstein D, 2019, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, 27, pp. 1951 - 1960, http://dx.doi.org/10.1007/s00520-018-4507-4
    Journal articles | 2019
    Knox JJ; McNamara MG; Palmer DH; Evans TRJ; Goldstein D; Bridgewater JA; Valle JW, 2019, 'NUC-1031 in combination with cisplatin for first-line treatment of advanced biliary tract cancer.', Journal of Clinical Oncology, 37, pp. TPS4156 - TPS4156, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.tps4156
    Journal articles | 2019
    Lee B; Lipton L; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Burge M; Cooray P; Nagrial A; Tebbutt NC; Thomson B; Nikfarjam M; Harris M; Haydon A; Lawrence B; Tai DWM; Simons K; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2019, 'Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer', Annals of Oncology, 30, pp. 1472 - 1478, http://dx.doi.org/10.1093/annonc/mdz200
    Journal articles | 2019
    Li T; Timmins H; King T; Kiernan M; Goldstein D; Park S, 2019, 'Bortezomib Induced Peripheral Neuropathy: A Systematic Review of Phase III Trials', CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 19, pp. E346 - E346, http://dx.doi.org/10.1016/j.clml.2019.09.571
    Journal articles | 2019
    Lim BT; Butow P; Mills J; Miller A; Pearce A; Goldstein D, 2019, 'Challenges and perceived unmet needs of Chinese migrants affected by cancer: Focus group findings', Journal of Psychosocial Oncology, 37, pp. 383 - 397, http://dx.doi.org/10.1080/07347332.2018.1551261
    Journal articles | 2019
    Livni L; Lees JG; Barkl-Luke ME; Goldstein D; Moalem-Taylor G, 2019, 'Dorsal root ganglion explants derived from chemotherapy-treated mice have reduced neurite outgrowth in culture', Neuroscience Letters, 694, pp. 14 - 19, http://dx.doi.org/10.1016/j.neulet.2018.11.016
    Journal articles | 2019
    Maharaj AD; Holland JF; Scarborough RO; Evans SM; Ioannou LJ; Brown W; Croagh DG; Pilgrim CHC; Kench JG; Lipton LR; Leong T; McNeil JJ; Nikfarjam M; Aly A; Burton PR; Cashin PA; Chu J; Duong CP; Evans P; Goldstein D; Haydon A; Hii MW; Knowles BPF; Merrett ND; Michael M; Neale RE; Philip J; Porter IWT; Smith M; Spillane J; Tagkalidis PP; Zalcberg JR, 2019, 'The Upper Gastrointestinal Cancer Registry (UGICR): A clinical quality registry to monitor and improve care in upper gastrointestinal cancers', BMJ Open, 9, pp. e031434, http://dx.doi.org/10.1136/bmjopen-2019-031434
    Journal articles | 2019
    Maharaj AD; Ioannou L; Croagh D; Zalcberg J; Neale RE; Goldstein D; Merrett N; Kench JG; White K; Pilgrim CHC; Chantrill L; Cosman P; Kneebone A; Lipton L; Nikfarjam M; Philip J; Sandroussi C; Tagkalidis P; Chye R; Haghighi KS; Samra J; Evans SM, 2019, 'Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus', HPB, 21, pp. 444 - 455, http://dx.doi.org/10.1016/j.hpb.2018.08.016
    Journal articles | 2019
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB, 2019, 'Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy', Supportive Care in Cancer, 27, pp. 3849 - 3857, http://dx.doi.org/10.1007/s00520-019-04680-w
    Journal articles | 2019
    McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Friedlander M; Bosco A; Harrison M; Maier N; O'Neill S; Park SB, 2019, 'Optimizing Clinical Screening for Chemotherapy-Induced Peripheral Neuropathy', Journal of Pain and Symptom Management, 58, pp. 1023 - 1032, http://dx.doi.org/10.1016/j.jpainsymman.2019.07.021
    Journal articles | 2019
    McCrary JM; Goldstein D; Trinh T; Timmins HC; Li T; Menant J; Friedlander M; Lewis CR; Hertzberg M; O'Neill S; King T; Bosco A; Harrison M; Park SB, 2019, 'Balance deficits and functional disability in cancer survivors exposed to neurotoxic cancer treatments', JNCCN Journal of the National Comprehensive Cancer Network, 17, pp. 949 - 955, http://dx.doi.org/10.6004/jnccn.2019.7290
    Journal articles | 2019
    McCrary JM; Goldstein D; Wyld D; Henderson R; Lewis CR; Park SB, 2019, 'Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test', Journal of Cancer Survivorship, 13, pp. 495 - 502, http://dx.doi.org/10.1007/s11764-019-00769-7
    Journal articles | 2019
    McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; Andre T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater JA; Valle JW, 2019, 'Impact of anatomic site of biliary tract tumour origin and conditional probability of survival (CS): Results from 15 prospective advanced first-line clinical trial', ANNALS OF ONCOLOGY, 30, pp. 274 - 274, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295502144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2019
    Michael M; Wong R; Gill SS; Goldstein D; Ngan S; Heriot AG; Link E; Farrell M; Neeson PJ; Ramsay RG; Wilson K; Mitchell C; Tie J; Pavlakis N; Zalcberg JR; Segelov E, 2019, 'Phase II trial PD-L1/PD-1 blockade avelumab with chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer: The Ave-Rec trial.', JOURNAL OF CLINICAL ONCOLOGY, 37, http://dx.doi.org/10.1200/JCO.2019.37.15_suppl.TPS3622
    Journal articles | 2019
    Oxford LE; Urken M; Lazarus C; Cheney J; Scharpf J; Fritz MA; Puscas L; Mlynarek AM; Sela E; Ibrahim B; Hier MP; Hanasono MM; Yu P; Hornig JD; Miles B; Teng M; Genden E; Patel UA; Lin AC; Malone JP; Rosenthal EL; Clemons L; Zhang H; O'Connell DA; Ansari K; Harris JR; Seikaly H; Moreno MA; Luu Q; Jacobson J; Farwell DG; Blackwell K; Zaghi S; Nabili V; Wang SJ; Burgess BC; Casper K; Goddard J; Bayon R; Pagedar NA; Chang KE; Hoffman HT; Shnayder Y; Bond J; Sykes KJ; Girod DA; Tsue TT; Gal TJ; Way TJ; Leibowitz JM; Mantravadi AV; Grobman AB; Weed DT; Civantos F; Chepeha DB; Rosko A; Belile E; Chanowski EJP; Wolf GT; Bradford CR; Prince ME; Moyer JS; Spector ME; Khariwala SS; Lassig AA; Jorgensen JB; Showmaker J; Umstattd LA; Lai E; Zitsch RP; Renner GJ; Militsakh O; Flohr J; van der Sloot P; Miller M; Myers LL; Sumer BD; Truelson JM; Goldstein D; Cohen M; Gilbert R; Irish J; Gullane P; Brown D; Buchmann L; Hunt J; Jameson MJ; Shonka DC; Futran ND; Mendez E; Fung K; Belzile M; Dowthwaite SA; Yoo JH; Nichols AC; Franklin JH; Nussenbaum B; Desai S; Diaz J, 2019, 'Salvage laryngectomy and laryngopharyngectomy: Multicenter review of outcomes associated with a reconstructive approach', Head and Neck, 41, pp. 16 - 29, http://dx.doi.org/10.1002/hed.25192
    Journal articles | 2019
    Reni M; Riess H; O'Reilly E; Santoro A; Park J; Bekaii-Saab T; Tempero M; Shan Y; Macarulla T; Van Cutsem E; Noel M; Berlin J; Biankin A; Dhani N; Frassineti G; Goldstein D; Romano A; Bruchec YL; Philip P, 2019, 'An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes', Annals of oncology : official journal of the European Society for Medical Oncology, 30, pp. iv126, http://dx.doi.org/10.1093/annonc/mdz154
    Journal articles | 2019
    Reni M; Winter J; Tortora G; Pelzer U; Riess H; Chang H; O'Reilly E; Oh D; Diaz IA; Milella M; Bendell J; Garlipp B; Tempero M; Macarulla T; Van Cutsem E; Berlin J; Goldstein D; Lu B; Jeanes J; Philip P, 2019, 'Analysis of patient screening in the phase III, international, randomized, open-label APACT trial', Annals of oncology : official journal of the European Society for Medical Oncology, 30, pp. iv110, http://dx.doi.org/10.1093/annonc/mdz156
    Journal articles | 2019
    Sclafani F; Hesselberg G; Thompson SR; Truskett P; Haghighi K; Rao S; Goldstein D, 2019, 'Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review', Journal of Surgical Oncology, 119, pp. 489 - 496, http://dx.doi.org/10.1002/jso.25320
    Journal articles | 2019
    Sonbol MB; Ahn DH; Goldstein D; Okusaka T; Tabernero J; Macarulla T; Reni M; Li CP; O'Neil B; Van Cutsem E; Bekaii-Saab T, 2019, 'CanStem111P trial: A Phase III study of napabucasin plus nab-paclitaxel with gemcitabine', Future Oncology, 15, pp. 1295 - 1302, http://dx.doi.org/10.2217/fon-2018-0903
    Journal articles | 2019
    Tan AC; McCrary JM; Park SB; Trinh T; Goldstein D, 2019, 'Chemotherapy-induced peripheral neuropathy—patient-reported outcomes compared with NCI-CTCAE grade', Supportive Care in Cancer, 27, pp. 4771 - 4777, http://dx.doi.org/10.1007/s00520-019-04781-6
    Journal articles | 2019
    Tang M; Chen J; Goldstein D; Links M; Lord S; Marschner I; Simes RJ; Lee CK, 2019, 'Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer', Pancreas, 48, pp. 1274 - 1284, http://dx.doi.org/10.1097/MPA.0000000000001429
    Journal articles | 2019
    Tempero MA; Reni M; Riess H; O’Reilly EM; Krishnamurthi S; Österlund P; Ales-Diaz IC; Milella M; Siena S; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin JD; Li M; Ferrara S; Bruchec YL; McGovern D; Biankin A, 2019, 'Phase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancreatic adenocarcinoma (APACT): Subgroup analyses', Annals of Oncology, 30, pp. v259 - v260, http://dx.doi.org/10.1093/annonc/mdz247.010
    Journal articles | 2019
    Tempero MA; Reni M; Riess H; Pelzer U; O'Reilly EM; Winter JM; Oh D-Y; Li C-P; Tortora G; Chang H-M; Lopez CD; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Ferrara S; Li M; Lu BD; Biankin A, 2019, 'APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma.', Journal of Clinical Oncology, 37, pp. 4000 - 4000, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4000
    Journal articles | 2019
    Thavaneswaran S; Napier C; Goldstein D; Meiser B; Butow P; Thomas DM; Ballinger ML; Best M, 2019, 'Medical oncologists’ experience with returning molecular tumor profiling to patients.', Journal of Clinical Oncology, 37, pp. 10521 - 10521, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10521
    Journal articles | 2019
    Vasista A; Stockler M; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Snow S; Burge M; Harris D; Jonker D; Chua YJ; Epstein R; Bonaventura A; Kiely B, 2019, 'Accuracy and Prognostic Significance of Oncologists’ Estimates and Scenarios for Survival Time in Advanced Gastric Cancer', Oncologist, 24, pp. e1102 - e1107, http://dx.doi.org/10.1634/theoncologist.2018-0613
    Journal articles | 2018
    Akerman A; Sharbeen G; Holst J; Youkhana J; McCarroll J; Goldstein D; Erkan M; Phillips P, 2018, 'Targeting a solute carrier to metabolically reprogram tumour-promoting stromal cells in pancreatic cancer', Pancreatology, 18, pp. S156 - S156, http://dx.doi.org/10.1016/j.pan.2018.05.419
    Journal articles | 2018
    Battaglini E; Park SB; Barnes EH; Goldstein D, 2018, 'A double blind, placebo controlled, phase II randomised cross-over trial investigating the use of duloxetine for the treatment of chemotherapy-induced peripheral neuropathy', Contemporary Clinical Trials, 70, pp. 135 - 138, http://dx.doi.org/10.1016/j.cct.2018.04.011
    Journal articles | 2018
    Beesley VL; Janda M; Burmeister EA; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Wyld DK; Chan RJ; Young JM; Neale RE, 2018, 'Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes', Palliative and Supportive Care, 16, pp. 534 - 543, http://dx.doi.org/10.1017/S1478951517000608
    Journal articles | 2018
    Bekaii-Saab T; Okusaka T; Goldstein D; O'Neill B; Tabernero J; Li C; Reni M; Jin B; Oh C; Borodyansky L; Van Cutsem E, 2018, 'CanStem111P trial: A Phase 3 Study of napabucasin (NAPA) plus nab-paclitaxel (nPTX) with gemcitabine (Gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC) - Trial in progress', Annals of oncology : official journal of the European Society for Medical Oncology, 29, pp. v51 - v52, http://dx.doi.org/10.1093/annonc/mdy151.183
    Journal articles | 2018
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P, 2018, 'The PiGeOn project: Protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer', BMC Cancer, 18, pp. 389, http://dx.doi.org/10.1186/s12885-018-4366-x
    Journal articles | 2018
    Blinman PL; Martin AJ; Jefford M; Goldstein D; Boadle D; Morris MF; Tebbutt NC; Aiken C; Paul J; Segelov E; Haydon AM; Iveson T; Stockler MR, 2018, 'Patients’ preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?', Journal of Clinical Oncology, 36, pp. 3602 - 3602, http://dx.doi.org/10.1200/jco.2018.36.15_suppl.3602
    Journal articles | 2018
    Chiorean EG; Von Hoff D; Wan Y; Margunato-Debay S; Botteman M; Goldstein D, 2018, 'Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer', Cancer Management and Research, 10, pp. 1389 - 1396, http://dx.doi.org/10.2147/CMAR.S163475
    Journal articles | 2018
    Clifford BK; Mizrahi D; Sandler CX; Barry BK; Simar D; Wakefield CE; Goldstein D, 2018, 'Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review', Supportive Care in Cancer, 26, pp. 685 - 700, http://dx.doi.org/10.1007/s00520-017-3964-5
    Journal articles | 2018
    Dumbrava MI; Burmeister EA; Wyld D; Goldstein D; O'Connell DL; Beesley VL; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Waterhouse MA; Neale RE, 2018, 'Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival', Asia-Pacific Journal of Clinical Oncology, 14, pp. 326 - 336, http://dx.doi.org/10.1111/ajco.12862
    Journal articles | 2018
    Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Oláh A; Büchler MW; Greenhalf W, 2018, 'Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer', British Journal of Cancer, 118, pp. 947 - 954, http://dx.doi.org/10.1038/s41416-018-0004-2
    Journal articles | 2018
    Elander NO; Aughton K; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Campbell F; Costello E; Halloran CM; Mackey JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Anthoney A; Lerch MM; Mayerle J; Oláh A; Büchler MW; Greenhalf W, 2018, 'Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy', British Journal of Cancer, 118, pp. 1084 - 1088, http://dx.doi.org/10.1038/s41416-018-0005-1
    Journal articles | 2018
    Feather CE; Lees JG; Makker PGS; Goldstein D; Kwok JB; Moalem-Taylor G; Polly P, 2018, 'Oxaliplatin induces muscle loss and muscle-specific molecular changes in Mice', Muscle and Nerve, 57, pp. 650 - 658, http://dx.doi.org/10.1002/mus.25966
    Journal articles | 2018
    Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CSY; Kiernan MC; Park SB, 2018, 'Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy', Muscle and Nerve, 57, pp. 615 - 621, http://dx.doi.org/10.1002/mus.25968
    Journal articles | 2018
    Kaur R; Meiser B; Ziliacus E; Wong WKT; Woodland L; Watts K; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Norris C; Goldstein D, 2018, 'Evaluation of an online communication skills training programme for oncology nurses working with patients from minority backgrounds', Supportive Care in Cancer, http://dx.doi.org/10.1007/s00520-018-4507-4
    Journal articles | 2018
    Lee B; Lipton LR; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Cooray P; Nagrial A; Burge ME; Tebbutt NC; Nikfarjam M; Harris M; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2018, 'Circulating tumor DNA as a prognostic biomarker in early stage pancreatic cancer.', JOURNAL OF CLINICAL ONCOLOGY, 36, http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.e16206
    Journal articles | 2018
    Martin AJ; Gibbs E; Sjoquist K; Pavlakis N; Simes J; Price T; Shannon J; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Kim JW; Goldstein D, 2018, 'Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma', Gastric Cancer, 21, pp. 473 - 480, http://dx.doi.org/10.1007/s10120-017-0754-1
    Journal articles | 2018
    Pang T; Xu Z; Pothula S; Yang MH; Becker T; Goldstein D; Heeschen C; Pirola R; Wilson J; Apte MV, 2018, '517 - World-First Identification of Circulating Pancreatic Stellate Cells in Metastatic Pancreatic Cancer', Gastroenterology, 154, pp. S - 114, http://dx.doi.org/10.1016/s0016-5085(18)30816-3
    Journal articles | 2018
    Payne M; Burmeister EA; Waterhouse M; Jordan SJ; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Beesley VL; Gooden H; Janda M; Neale RE, 2018, 'Biliary Stenting in Patients with Pancreatic Cancer: Results from a Population-Based Cohort Study', Pancreas, 47, pp. 80 - 86, http://dx.doi.org/10.1097/MPA.0000000000000960
    Journal articles | 2018
    Shitara K; Özgüroğlu M; Bang YJ; Di Bartolomeo M; Mandalà M; Ryu MH; Fornaro L; Olesiński T; Caglevic C; Chung HC; Muro K; Goekkurt E; Mansoor W; McDermott RS; Shacham-Shmueli E; Chen X; Mayo C; Kang SP; Ohtsu A; Fuchs CS; Lerzo G; O'Connor JM; Mendez GA; Lynam J; Tebbutt N; Wong M; Strickland A; Karapetis C; Goldstein D; Vasey P; Van Laethem JL; Van Cutsem E; Berry S; Vincent M; Muller B; Rey F; Zambrano A; Guerra J; Krogh M; Baeksgaard L; Yilmaz M; Elme A; Magi A; Auvinen P; Alanko T; Moehler M; Kunzmann V; Seufferlein T; Thuss-Patience P; Hoehler T; Haag G; Al-Batran SE; Castro H; Lopez K; Aguilar Vasquez M; Sandoval M; Lam KO; Cuffe S; Kelly C; Geva R; Hubert A; Beny A; Brenner B; Giuseppe A; Falcone A; Maiello E; Passalacqua R; Montesarchio V; Hara H; Chin K; Nishina T; Komatsu Y; Machida N; Hironaka S; Satoh T; Tamura T; Sugimoto N; Cho H; Omuro Y; Kato K; Goto M; Hyodo I; Yoshida K; Baba H; Esaki T; Furuse J; Wan Mohammed WZ; Hernandez Hernandez C; Casas Garcia J; Dominguez Andrade A; Clarke K; Hjortland G; Glenjen N; Kubiatowski T; Jacek J; Wojtukiewicz M; Lazarev S; Lancukhay Y, 2018, 'Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial', The Lancet, 392, pp. 123 - 133, http://dx.doi.org/10.1016/S0140-6736(18)31257-1
    Journal articles | 2018
    Tan SYS; O’Neill S; Goldstein D; Ward RL; Daniels B; Vajdic CM, 2018, 'Predictors of care for patients with cancer of unknown primary site in three Australian hospitals', Asia-Pacific Journal of Clinical Oncology, 14, pp. e512 - e520, http://dx.doi.org/10.1111/ajco.12815
    Journal articles | 2018
    Thompson SR; Lee ISY; Carroll S; Bishop S; Douglas P; Lam F; Brown C; Williams J; Goldstein D, 2018, 'Radiotherapy for anal squamous cell carcinoma: must the upper pelvic nodes and the inguinal nodes be treated?', ANZ Journal of Surgery, 88, pp. 870 - 875, http://dx.doi.org/10.1111/ans.14398
    Journal articles | 2018
    Tie J; Cohen JD; Wang Y; Li L; Christie M; Simons K; Elsaleh H; Kosmider S; Wong R; Yip D; Lee M; Tran B; Rangiah D; Burge M; Goldstein D; Singh M; Skinner I; Faragher I; Croxford M; Bampton C; Haydon A; Jones IT; S Karapetis C; Price T; Schaefer MJ; Ptak J; Dobbyn L; Silliman N; Kinde I; Tomasetti C; Papadopoulos N; Kinzler K; Volgestein B; Gibbs P, 2018, 'Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: A prospective biomarker study', Gut, 68, pp. 663 - 671, http://dx.doi.org/10.1136/gutjnl-2017-315852
    Journal articles | 2018
    Timmins HC; Li T; Grimison P; Murray JE; Cox KM; Horvath LG; Lewis CR; Goldstein D; Kiernan MC; Park SB, 2018, '5. Neurophysiological dysfunction in chemotherapy-treated patients: Comparison of different platinum analogues', Clinical Neurophysiology, 129, pp. e2 - e3, http://dx.doi.org/10.1016/j.clinph.2017.12.018
    Journal articles | 2018
    Wang X; Goldstein D; Crowe PJ; Yang JL, 2018, 'Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell lines', International Journal of Oncology, 52, pp. 2143 - 2154, http://dx.doi.org/10.3892/ijo.2018.4337
    Journal articles | 2018
    ter Veer E; van Rijssen LB; Besselink MG; Mali RMA; Berlin JD; Boeck S; Bonnetain F; Chau I; Conroy T; Van Cutsem E; Deplanque G; Friess H; Glimelius B; Goldstein D; Herrmann R; Labianca R; Van Laethem JL; Macarulla T; van der Meer JHM; Neoptolemos JP; Okusaka T; O'Reilly EM; Pelzer U; Philip PA; van der Poel MJ; Reni M; Scheithauer W; Siveke JT; Verslype C; Busch OR; Wilmink JW; van Oijen MGH; van Laarhoven HWM, 2018, 'Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease', The Lancet Oncology, 19, pp. e151 - e160, http://dx.doi.org/10.1016/S1470-2045(18)30098-6
    Journal articles | 2017
    Atlin CR; Johnson-Obaseki S; Chung J; Bloom JA; Jaakkimainen L; Waldron J; Goldstein D, 2017, 'Assessing the need for an educational intervention for primary care practitioners on HPV-related oropharyngeal cancer', University of Toronto Medical Journal, 94, pp. 17 - 21
    Journal articles | 2017
    Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2017, 'Systemic treatment in advanced biliary cancers: A multicenter Australian analysis and review', Asia-Pacific Journal of Clinical Oncology, 13, pp. e291 - e297, http://dx.doi.org/10.1111/ajco.12638
    Journal articles | 2017
    Casali PG; Le Cesne A; Poveda A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson I; Italiano A; Gelderblom H; Penel N; Kopp H-G; Goldstein D; Martin Broto J; Gronchi A; Wardelmann E; Marreaud S; Zalcberg J; Litiere S; Blay J-Y, 2017, 'Time to definitive failure to the first tyrosine kinase inhibitor in localized gastrointestinal stromal tumors (GIST) treated with imatinib as an adjuvant: Final results of the EORTC STBSG, AGITG, UNICANCER, FSG, ISG, and GEIS randomized trial', ANNALS OF ONCOLOGY, 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324005130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2017
    Chan DL; Sjoquist KM; Goldstein D; Price TJ; Martin AJ; Bang YJ; Kang YK; Pavlakis N, 2017, 'The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis', PLoS ONE, 12, pp. e0172307, http://dx.doi.org/10.1371/journal.pone.0172307
    Journal articles | 2017
    Cubillo Gracian A; Dean A; Munoz A; Hidalgo M; Pazo-Cid R; Martin M; Macarulla Mercade T; Lipton L; Harris M; Manzano-Mozo JL; Maurel J; Guillen-Ponce C; Tebbutt N; Cooray P; Sohal D; Zalupski M; Kolevska T; Stagg R; Goldstein D, 2017, 'YOSEMITE: A 3 arm double-blind randomized phase 2 study of gemcitabine, paclitaxel protein-bound particles for injectable suspension, and placebo (GAP) versus gemcitabine, paclitaxel protein-bound particles for injectable suspension and either 1 or 2 truncated courses of demcizumab (GAD)', ANNALS OF ONCOLOGY, 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324001135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2017
    Goldstein D; Lemech C; Valle J, 2017, 'New molecular and immunotherapeutic approaches in biliary cancer', ESMO Open, 2, pp. e000152, http://dx.doi.org/10.1136/esmoopen-2016-000152
    Journal articles | 2017
    Goldstein D; Von Hoff D; Chiorean E; Reni M; Tabernero J; Ramanathan R; Wilkerson J; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis C; Renschler M; McGovern D; Lee C, 2017, 'Relative contribution of baseline variables in a nomogram to predict survival in patients treated with nab-paclitaxel plus gemcitabine or gemcitabine alone for metastatic pancreatic cancer', Annals of oncology : official journal of the European Society for Medical Oncology, 28, pp. iii142 - iii144, http://dx.doi.org/10.1093/annonc/mdx262.016
    Journal articles | 2017
    Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Aly A; Botteman M; Wilkersen J; Margunato-Debay S; Lu B; Louis CU; Renschler MF; McGovern DMT; Lee CK, 2017, 'Nomogram for predicting overall survival (OS) in patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) or Gem alone for metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, 35, pp. 4109 - 4109, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4109
    Journal articles | 2017
    Hyatt A; Lipson-Smith R; Schofield P; Gough K; Sze M; Aldridge L; Goldstein D; Jefford M; Bell ML; Butow P, 2017, 'Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients', Health Expectations, 20, pp. 886 - 895, http://dx.doi.org/10.1111/hex.12529
    Journal articles | 2017
    Janda M; Neale RE; Klein K; O'Connell DL; Gooden H; Goldstein D; Merrett ND; Wyld DK; Rowlands IJ; Beesley VL, 2017, 'Anxiety, depression and quality of life in people with pancreatic cancer and their carers', Pancreatology, 17, pp. 321 - 327, http://dx.doi.org/10.1016/j.pan.2017.01.008
    Journal articles | 2017
    Kandula T; Farrar MA; Kiernan MC; Krishnan AV; Goldstein D; Horvath L; Grimison P; Boyle F; Baron-Hay S; Park SB, 2017, 'Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer', Clinical Neurophysiology, 128, pp. 1166 - 1175, http://dx.doi.org/10.1016/j.clinph.2017.04.009
    Journal articles | 2017
    Kunzmann V; Ramanathan RK; Goldstein D; Liu H; Ferrara S; Lu B; Renschler MF; Von Hoff DD, 2017, 'Tumor reduction in primary andmetastatic pancreatic cancer lesions with nab-paclitaxel and gemcitabine: An exploratory analysis from a phase 3 study', Pancreas, 46, pp. 203 - 208, http://dx.doi.org/10.1097/MPA.0000000000000742
    Journal articles | 2017
    Lee B; Cohen J; Lipton LR; Tie J; Javed AA; Li L; Goldstein D; Cooray P; Nagrial A; Burge ME; Tebbutt NC; Nikfarjam M; Harris M; O'Broin-Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2017, 'Potential role of circulating tumor DNA (ctDNA) in the early diagnosis and post-operative management of localised pancreatic cancer.', Journal of Clinical Oncology, 35, pp. 4101 - 4101, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4101
    Journal articles | 2017
    Lees JG; Makker PGS; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy', European Journal of Cancer, 73, pp. 22 - 29, http://dx.doi.org/10.1016/j.ejca.2016.12.006
    Journal articles | 2017
    Lim BT; Butow P; Mills J; Miller A; Goldstein D, 2017, 'Information needs of the Chinese community affected by cancer: A systematic review', Psycho-Oncology, 26, pp. 1433 - 1443, http://dx.doi.org/10.1002/pon.4347
    Journal articles | 2017
    Makker PGS; Duffy SS; Lees JG; Perera CJ; Tonkin RS; Butovsky O; Park SB; Goldstein D; Moalem-Taylor G, 2017, 'Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy', PLoS ONE, 12, pp. e0170814, http://dx.doi.org/10.1371/journal.pone.0170814
    Journal articles | 2017
    McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB, 2017, 'Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey', Supportive Care in Cancer, 25, pp. 3485 - 3493, http://dx.doi.org/10.1007/s00520-017-3772-y
    Journal articles | 2017
    Pang TCY; Xu Z; Pothula S; Becker T; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2017, 'Circulating pancreatic stellate (stromal) cells in pancreatic cancer-a fertile area for novel research', Carcinogenesis, 38, pp. 588 - 591, http://dx.doi.org/10.1093/carcin/bgx030
    Journal articles | 2017
    Pothula SP; Xu Z; Goldstein D; Merrett N; Pirola RC; Wilson JS; Apte MV, 2017, 'Targeting the HGF/c-MET pathway: Stromal remodelling in pancreatic cancer', Oncotarget, 8, pp. 76722 - 76739, http://dx.doi.org/10.18632/oncotarget.20822
    Journal articles | 2017
    Ritchie GE; Fernando M; Goldstein D, 2017, 'Rituximab to treat gemcitabine-induced hemolytic–uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review', Cancer Chemotherapy and Pharmacology, 79, http://dx.doi.org/10.1007/s00280-016-3123-6
    Journal articles | 2017
    Sandler CX; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; segelov E; Boyle FM; Chin MT; webber K; Barry BK; Lloyd AR, 2017, 'Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue.', Journal of Pain and Symptom Management, http://dx.doi.org/10.1016/j.jpainsymman.2017.03.015
    Journal articles | 2017
    Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; Van Houtte P; Bonnetain F; Louvet C; Hammel P; Huguet F, 2017, 'Neutrophil count and efficacy of chemoradiation in patients with locally advanced unresectable pancreatic carcinoma: An ancillary study of in the LAP 07 trial.', Journal of Clinical Oncology, 35, pp. 4120 - 4120, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.4120
    Journal articles | 2017
    Schernberg A; Vernerey D; Goldstein D; Van Laethem JL; Van Houtte PJ; Bonnetain F; Glimelius B; Louvet C; Hammel P; Huguet F, 2017, 'Neutrophils Predicting Tumor Local Control After Chemoradiation Therapy in Locally Advanced Pancreatic Carcinoma in the LAP 07 Trial', International Journal of Radiation Oncology*Biology*Physics, 99, pp. S88 - S89, http://dx.doi.org/10.1016/j.ijrobp.2017.06.213
    Journal articles | 2017
    Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ, 2017, 'Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty', Expert Review of Anticancer Therapy, 17, pp. 951 - 964, http://dx.doi.org/10.1080/14737140.2017.1369882
    Journal articles | 2017
    Sharbeen G; Youkhana J; Mawson A; McCarroll J; Nunez A; Biankin A; Johns A; Goldstein D; Phillips P, 2017, 'MutY-Homolog (MYH) inhibition reduces pancreatic cancer cell growth and increases chemosensitivity', Oncotarget, 8, pp. 9216 - 9229, http://dx.doi.org/10.18632/oncotarget.13985
    Journal articles | 2017
    Sjoquist KM; Pavlakis N; Martin AJ; Tsobanis E; Yip S; Bang Y-J; Alcindor T; O'Callaghan CJ; Shitara K; Bekaii-Saab TS; Grothey A; Chen L-T; Simes J; Zalcberg JR; Goldstein D, 2017, 'Integrate II: A randomised phase 3 double-blind placebo-controlled study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC)—An international study organized by the Australasian Gastrointestinal Trials Group (AGITG).', Journal of Clinical Oncology, 35, pp. TPS4136 - TPS4136, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.tps4136
    Journal articles | 2017
    Tang M; Chen J; Goldstein D; Links M; Lord S; Marschner I; Simes J; Lee CK, 2017, 'Correlation of phase 2 trials (Ph2t) results with outcomes of phase 3 trials (Ph3t) of investigational agents (IA) in locally advanced and metastatic pancreas cancer (LAMPC).', JOURNAL OF CLINICAL ONCOLOGY, 35, http://dx.doi.org/10.1200/JCO.2017.35.4_suppl.227
    Journal articles | 2017
    Tie J; Cohen J; Wang Y; Li L; Kinde I; Elsaleh H; Wong R; Kosmider S; Yip D; Lee M; Tran B; Burge ME; Goldstein D; Singh MS; Diaz LA; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P, 2017, 'The potential of circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy decision making in locally advanced rectal cancer (LARC).', Journal of Clinical Oncology, 35, pp. 3521 - 3521, http://dx.doi.org/10.1200/jco.2017.35.15_suppl.3521
    Journal articles | 2017
    Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Goldstein D; Hale S; Perry A; Aranda SK; Kissane DW, 2017, 'Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals', European Journal of Oncology Nursing, 26, pp. 83 - 90, http://dx.doi.org/10.1016/j.ejon.2016.12.001
    Journal articles | 2017
    Watts KJ; Meiser B; Zilliacus E; Kaur R; Taouk M; Girgis A; Butow P; Kissane D; Hale S; Perry A; Aranda SK; Goldstein D, 2017, 'Perspectives of oncology nurses and oncologists regarding barriers to working with patients from a minority background: systemic issues and working with interpreters.', European Journal of Cancer Care, 27, pp. e12758, http://dx.doi.org/10.1111/ecc.12758
    Journal articles | 2017
    Yang JL; Gupta RD; Goldstein D; Crowe PJ, 2017, 'Significance of phosphorylated epidermal growth factor receptor and its signal transducers in human soft tissue sarcoma', International Journal of Molecular Sciences, 18, pp. 1159, http://dx.doi.org/10.3390/ijms18061159
    Journal articles | 2017
    van Rijssen LB; ter Veer E; Besselink MG; Mali RMA; Berlin J; Boeck S; Bonnetain F; Conroy T; Deplanque G; Goldstein D; Glimelius B; Neoptolemos JP; Reni M; Scheithauer W; van der Meer J; Wilmink JW; van der Poel MJ; Busch OR; van Oijen MGH; van Laarhoven HWM, 2017, 'COnsensus statement on mandatory measurements in PAncreatic cancer trials for systemic treatment of unresectable disease (COMMPACT)', ANNALS OF ONCOLOGY, 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000411324001259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2017
    McNamara MG; Bridgewater J; Lopes A; Wasan H; Malka D; Jensen LH; Okusaka T; Knox JJ; Wagner D; Cunningham D, 2017, 'Systemic therapy in younger and elderly patients with advanced biliary cancer: Sub-analysis of ABC-02 and twelve other prospective trials', , http://dx.doi.org/10.1186/s12885-017-3266-9
    Journal articles | 2017
    Tang M; Goldstein D, 2017, 'The role of chemotherapy in gastric cancer-related microangiopathic haemolytic anaemia', , http://dx.doi.org/10.21037/jgo.2016.11.14
    Journal articles | 2016
    Barbour A; O'Rourke N; Chan H; Chua YJ; Kench J; Hicks RJ; Samra JS; Pavlakis N; Haghighi KS; Yip S; Donoghoe M; Friend C; Burge ME; Fawcett J; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2016, 'Initial survival outcomes for the AGITG GAP study - a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)', JOURNAL OF CLINICAL ONCOLOGY, 34, http://dx.doi.org/10.1200/JCO.2016.34.15_suppl.4105
    Journal articles | 2016
    Beesley V; Wockner L; O'Rourke P; Janda M; Merrett H; Goldstein D; Gooden H; Merrett N; O'Connell D; Rowlands I; Wyld D; Neale R, 2016, 'Erratum to: Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (Support Care Cancer, 10.1007/s00520-016-3212-4)', Supportive Care in Cancer, 24, pp. 3601 - 3602, http://dx.doi.org/10.1007/s00520-016-3251-x
    Journal articles | 2016
    Beesley VL; Janda M; Goldstein D; Gooden H; Merrett ND; O'Connell DL; Rowlands IJ; Wyld D; Neale RE, 2016, 'A tsunami of unmet needs: Pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services', Psycho-Oncology, 25, pp. 150 - 157, http://dx.doi.org/10.1002/pon.3887
    Journal articles | 2016
    Beesley VL; Wockner LF; O’Rourke P; Janda M; Goldstein D; Gooden H; Merrett ND; O’Connell DL; Rowlands IJ; Wyld DK; Neale RE, 2016, 'Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study', Supportive Care in Cancer, 24, pp. 3589 - 3599, http://dx.doi.org/10.1007/s00520-016-3212-4
    Journal articles | 2016
    Bridgewater J; Lopes A; Wasan H; Malka D; Jensen L; Okusaka T; Knox J; Wagner D; Cunningham D; Shannon J; Goldstein D; Moehler M; Bekaii-Saab T; McNamara MG; Valle JW, 2016, 'Prognostic factors for progression-free and overall survival in advanced biliary tract cancer', Annals of Oncology, 27, pp. 134 - 140, http://dx.doi.org/10.1093/annonc/mdv483
    Journal articles | 2016
    Burmeister EA; Jordan SJ; O’Connell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Merrett ND; Wyld D; Neale RE; Cosman PH; Bullen A; Burge M; Eastgate M; Powell J; Deuble M; Pryor D; Whelan J; Algie L; Gupta S; Lynch SV; Burmeister BH; Slater K; Fletcher D; Van Hazel G; Raftopoulos S; Spry N; Agar M; Brecciaroli F; Caird S; Cameron D; Chan P; Chantrill L; Christie D; Chua YJ; Croese J; Cronk M; Gani J; Grimison P; Hruby G; Jefford M; Samra JS; Wysocki AP, 2016, 'Using a Delphi process to determine optimal care for patients with pancreatic cancer', Asia-Pacific Journal of Clinical Oncology, 12, pp. 105 - 114, http://dx.doi.org/10.1111/ajco.12450
    Journal articles | 2016
    Burmeister EA; O’Connell DL; Jordan SJ; Goldstein D; Merrett N; Wyld DK; Beesley VL; Gooden HM; Janda M; Neale RE, 2016, 'Factors associated with quality of care for patients with pancreatic cancer in Australia', Medical Journal of Australia, 205, pp. 459 - 465, http://dx.doi.org/10.5694/mja16.00567
    Journal articles | 2016
    Burmeister EA; Waterhouse M; Jordan SJ; O'Connell DL; Merrett ND; Goldstein D; Wyld D; Beesley V; Gooden H; Janda M; Neale RE, 2016, 'Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study', Pancreatology, 16, pp. 873 - 881, http://dx.doi.org/10.1016/j.pan.2016.06.010
    Journal articles | 2016
    Chantrill L; Goldstein D, 2016, 'Pancreatic cancer', Cancer Forum, 40, pp. 3 - 5
    Journal articles | 2016
    Chiorean EG; Von Hoff DD; Reni M; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; McGovern D; Lu B; Ko A, 2016, 'CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Annals of Oncology, 27, pp. 654 - 660, http://dx.doi.org/10.1093/annonc/mdw006
    Journal articles | 2016
    Chiorean EG; Von Hoff DD; Tabernero J; El-Maraghi R; Ma WW; Reni M; Harris M; Whorf R; Liu H; Li JS; Manax V; Romano A; Lu B; Goldstein D, 2016, 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer (vol 115, pg 188, 2016)', BRITISH JOURNAL OF CANCER, 115, pp. E13 - U13, http://dx.doi.org/10.1038/bjc.2016.306
    Journal articles | 2016
    Chiorean EG; Von Hoff DD; Tabernero J; El-Maraghi R; Ma WW; Reni M; Harris M; Whorf R; Liu H; Li JS; Manax V; Romano A; Lu B; Goldstein D, 2016, 'Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer', British Journal of Cancer, 115, pp. 188 - 194, http://dx.doi.org/10.1038/bjc.2016.185
    Journal articles | 2016
    Ferraro D; Goldstein D; O'Connell RL; Zalcberg JR; Sjoquist KM; Tebbutt NC; Grimison P; McLachlan S; Lipton LL; Vasey P; Gebski VJ; Aiken C; Cronk M; Ng S; Karapetis CS; Shannon J; Do V; Marschner I; Friedlander M; Gurney H; Simes J; Hague W; O’Connell R; Gorzeman M; Pike R; Miranda K; Waring P; Lau D; Fox S; Liu Y; Wood T; Cocks C; Simmons K; McCourt J; Jefford M; Hobinchet A; Mirco B; Sagong J; Dudukovic S; Aghmesheh M; Parker S; Segelov E; Ratnayake L; Ranieri N; Varma S; Page J; Heyer E; Abdi E; Chorlton C; Wilkinson L; Marshall I, 2016, 'TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer', Cancer Chemotherapy and Pharmacology, 78, pp. 361 - 367, http://dx.doi.org/10.1007/s00280-016-3089-4
    Journal articles | 2016
    Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: The AGITG Pancreatic Cancer Workshop consensus', Medical Journal of Australia, 204, pp. 419 - 422.e1, http://dx.doi.org/10.5694/mja16.00061
    Journal articles | 2016
    Gandy RC; Barbour AP; Samra J; Nikfarjam M; Haghighi K; Kench JG; Saxena P; Goldstein D, 2016, 'Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus', MEDICAL JOURNAL OF AUSTRALIA, 204, pp. 419 - +, http://dx.doi.org/10.5694/mja16.00061
    Journal articles | 2016
    Goldstein D; Chiorean EG; Tabernero J; El-Maraghi RH; Ma WW; Reni M; Harris M; Whorf RC; Coughlin S; Li J; Manax VG; Lu BD; Romano A; Von Hoff DD, 2016, 'Outcome of second-line treatment (2L Tx) following nab-paclitaxel (nab-P) + gemcitabine (G) or G alone for metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, 34, pp. 333 - 333, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.333
    Journal articles | 2016
    Goldstein D; Rosenberg JE; Figlin RA; Townsend RR; McCann L; Carpenter C; Pandite L, 2016, 'Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?', European Journal of Cancer, 53, pp. 96 - 104, http://dx.doi.org/10.1016/j.ejca.2015.10.006
    Journal articles | 2016
    Goldstein D; Von Hoff DD; Moore M; Greeno E; Tortora G; Ramanathan RK; Macarulla T; Liu H; Pilot R; Ferrara S; Lu B, 2016, 'Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)', European Journal of Cancer, 52, pp. 85 - 91, http://dx.doi.org/10.1016/j.ejca.2015.10.017
    Journal articles | 2016
    Gormly KL; Coscia C; Wells T; Tebbutt N; Harvey JA; Wilson K; Schmoll HJ; Price T; Hruby G; Jeffery M; Karapetis C; Ng W; Singhal N; Burge M; Lynch R; Briscoe K; Begbie S; Gill S; Sebesan S; Goldstein D; Ng S; Asghari R; Blum R; Walpole E; Byard I, 2016, 'MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial', Journal of Medical Imaging and Radiation Oncology, 60, pp. 607 - 615, http://dx.doi.org/10.1111/1754-9485.12493
    Journal articles | 2016
    Hammel P; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Borbath I; Bouché O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2016, 'Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial', JAMA - Journal of the American Medical Association, 315, pp. 1844 - 1853, http://dx.doi.org/10.1001/jama.2016.4324
    Journal articles | 2016
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study', ONCOLOGIST, 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530
    Journal articles | 2016
    He EYJ; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL, 2016, 'The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: An Australian population-based multicenter study', Oncologist, 21, pp. 618 - 625, http://dx.doi.org/10.1634/theoncologist.2015-0530
    Journal articles | 2016
    Huguet F; Goldstein D; Hammel P, 2016, 'Radiation therapy deviations in trial of locally advanced pancreatic cancer: In Reply', JAMA - Journal of the American Medical Association, 316, pp. 1409 - 1410, http://dx.doi.org/10.1001/jama.2016.9781
    Journal articles | 2016
    Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA; Goldstein D, 2016, 'Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge', Cancer Treatment Reviews, 50, pp. 118 - 128, http://dx.doi.org/10.1016/j.ctrv.2016.09.005
    Journal articles | 2016
    McCarroll JA; Teo J; Boyer C; Youkhana J; Sagnella S; Duong H; Sharbeen G; Goldstein D; Davis T; Kavallaris M; Phillips P; Liu J, 2016, 'A rationally optimized nanoparticle system for the delivery of RNA interference therapeutics into pancreatic tumors in vivo.', Biomacromolecules, 17, pp. 2337 - 2351, http://dx.doi.org/10.1021/acs.biomac.6b00185
    Journal articles | 2016
    McLachlan SA; Fisher RJ; Zalcberg J; Solomon M; Burmeister B; Goldstein D; Leong T; Ackland SP; McKendrick J; McClure B; MacKay J; Ngan SY, 2016, 'The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)', European Journal of Cancer, 55, pp. 15 - 26, http://dx.doi.org/10.1016/j.ejca.2015.10.060
    Journal articles | 2016
    Oar AJ; Wong W; Chen C; Haghighi KS; Thompson S; Goldstein D, 2016, 'Stereotactic body hypofractionated radiotherapy for inoperable pancreatic cancer, with or without metastases', HPB, 18, pp. e359 - e359, http://dx.doi.org/10.1016/j.hpb.2016.02.932
    Journal articles | 2016
    O’Callaghan C; Schofield P; Butow P; Nolte L; Price M; Tsintziras S; Sze M; Thein T; Yiu D; Mireskandari S; Goldstein D; Jefford M, 2016, '“I might not have cancer if you didn’t mention it”: a qualitative study on information needed by culturally diverse cancer survivors', Supportive Care in Cancer, 24, pp. 409 - 418, http://dx.doi.org/10.1007/s00520-015-2811-9
    Journal articles | 2016
    Pavlakis N; Sjoquist KM; Martin AJ; Tsobanis E; Yip S; Kang YK; Bang YJ; Alcindor T; O'Callaghan CJ; Burnell MJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Wong M; Strickland A; Kim JW; Zalcberg JR; Simes J; Goldstein D, 2016, 'Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial', Journal of Clinical Oncology, 34, pp. 2728 - 2735, http://dx.doi.org/10.1200/JCO.2015.65.1901
    Journal articles | 2016
    Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV, 2016, 'Hepatocyte growth factor inhibition: A novel therapeutic approach in pancreatic cancer', British Journal of Cancer, 114, pp. 269 - 280, http://dx.doi.org/10.1038/bjc.2015.478
    Journal articles | 2016
    Pothula SP; Xu Z; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2016, 'Key role of pancreatic stellate cells in pancreatic cancer', Cancer Letters, http://dx.doi.org/10.1016/j.canlet.2015.10.035
    Journal articles | 2016
    Ramanathan RK; Goldstein D; Korn RL; Arena F; Moore M; Siena S; Teixeira L; Tabernero J; Van Laethem JL; Liu H; McGovern D; Lu B; Von Hoff DD, 2016, 'Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas', Annals of Oncology, 27, pp. 648 - 653, http://dx.doi.org/10.1093/annonc/mdw020
    Journal articles | 2016
    Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im SA; Gupta S; Kang YK; Schöffski P; Schuette J; Soulières D; Blay JY; Goldstein D; Fly K; Huang X; Corsaro M; Lechuga MJ; Martini JF; Heinrich MC, 2016, 'Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial', BMC Cancer, 16, pp. 22, http://dx.doi.org/10.1186/s12885-016-2051-5
    Journal articles | 2016
    Scheithauer W; Ramanathan RK; Moore M; Macarulla T; Goldstein D; Hammel P; Kunzmann V; Liu H; McGovern D; Romano A; Von Hoff DD, 2016, 'Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: Phase III MPACT trial', Journal of Gastrointestinal Oncology, 7, pp. 469 - 478, http://dx.doi.org/10.21037/jgo.2016.01.03
    Journal articles | 2016
    Sharbeen G; McCarroll J; Liu J; Youkhana J; Limbri LF; Biankin AV; Johns A; Kavallaris M; Goldstein D; Phillips PA, 2016, 'Delineating the Role of βIV-Tubulins in Pancreatic Cancer: βIVb-Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids', Neoplasia (United States), 18, pp. 753 - 764, http://dx.doi.org/10.1016/j.neo.2016.10.011
    Journal articles | 2016
    Sharbeen G; Youkhana J; McCarroll J; Akerman A; Goldstein D; Phillips P, 2016, 'MutY-Homolog modulates pancreatic cancer cell survival and chemoresistance', Pancreatology, 16, pp. S5 - S5, http://dx.doi.org/10.1016/j.pan.2016.05.024
    Journal articles | 2016
    Shaw JM; Shepherd HL; Durcinoska I; Butow PN; Liauw W; Goldstein D; Young JM, 2016, 'It’s all good on the surface: care coordination experiences of migrant cancer patients in Australia', Supportive Care in Cancer, 24, pp. 2403 - 2410, http://dx.doi.org/10.1007/s00520-015-3043-8
    Journal articles | 2016
    Vernerey D; Huguet F; Vienot A; Goldstein D; Paget-Bailly S; Van Laethem JL; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Benetkiewicz M; Louvet C; Hammel P; Bonnetain F, 2016, 'Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)', British Journal of Cancer, 115, pp. 281 - 289, http://dx.doi.org/10.1038/bjc.2016.212
    Journal articles | 2016
    Vickers MM; Lee C; Tu D; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2016, 'Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3', Pancreatology, 16, pp. 1106 - 1112, http://dx.doi.org/10.1016/j.pan.2016.08.013
    Journal articles | 2016
    Wang X; Goldstein D; Crowe P; Yang M; Garrett K; Zeps N; Yang JL, 2016, 'Overcoming resistance of targeted egfr monotherapy by inhibition of stat3 escape pathway in soft tisue sarcoma', Oncotarget, 7, pp. 21496 - 21509, http://dx.doi.org/10.18632/oncotarget.7452
    Journal articles | 2016
    Wang X; Goldstein D; Crowe PJ; Yang JL, 2016, 'Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: A review of the evidence', OncoTargets and Therapy, 9, pp. 5461 - 5473, http://dx.doi.org/10.2147/OTT.S94745
    Journal articles | 2016
    Waterhouse MA; Burmeister EA; O’Connell DL; Ballard EL; Jordan SJ; Merrett ND; Goldstein D; Wyld D; Janda M; Beesley VL; Payne ME; Gooden HM; Neale RE, 2016, 'Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study', Journal of Gastrointestinal Surgery, 20, pp. 1471 - 1481, http://dx.doi.org/10.1007/s11605-016-3157-4
    Journal articles | 2016
    Yang JL; Lim HJ; Wang X; Crowe PJ; Goldstein D, 2016, 'Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines', Anticancer research, 36, pp. 5765 - 5772, http://dx.doi.org/10.21873/anticanres.11160
    Journal articles | 2016
    de Souza P; Chua W; Clarke S; Goldstein D; Lee C, 2016, 'Inflammatory Markers Have a Role in Renal Cell Carcinoma Prognosis', European Urology Focus, 2, pp. 341 - 342, http://dx.doi.org/10.1016/j.euf.2016.04.007
    Journal articles | 2015
    Apte MV; Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS, 2015, 'Pancreatic cancer: The microenvironment needs attention too!', Pancreatology, 15, pp. S32 - S38, http://dx.doi.org/10.1016/j.pan.2015.02.013
    Journal articles | 2015
    Burmeister E; Jordan S; O'Connell D; Beesley V; Goldstein D; Gooden H; Janda M; Merrett N; Wyld D; Neale R, 2015, 'Determinants of attempted resection for patients with non-metastatic pancreatic cancer', Pancreatology, 15, pp. S84 - S85, http://dx.doi.org/10.1016/j.pan.2015.05.312
    Journal articles | 2015
    Burmeister EA; O'Connell DL; Beesley VL; Goldstein D; Gooden HM; Janda M; Jordan SJ; Merrett ND; Payne ME; Wyld D; Neale RE, 2015, 'Describing patterns of care in pancreatic cancer a population-based study', Pancreas, 44, pp. 1259 - 1265, http://dx.doi.org/10.1097/MPA.0000000000000384
    Journal articles | 2015
    Casali PG; Le Cesne A; Velasco AP; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom H; Adenis A; Hartmann JT; Duffaud F; Goldstein D; Broto JM; Gronchi A; Dei Tos AP; Marréaud S; Van Der Graaf WTA; Zalcberg JR; Litière S; Blay JY, 2015, 'Time to definitive failure to the first tyrosine kinase inhibitor in localized GI stromal tumors treated with imatinib as an adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in collaboration with the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas', Journal of Clinical Oncology, 33, pp. 4276 - 4283, http://dx.doi.org/10.1200/JCO.2015.62.4304
    Journal articles | 2015
    Chan DL; Goldstein D; Zalcberg JR, 2015, 'Neuroendocrine tumours - Models for rare tumour management', Cancer Forum, 39, pp. 13 - 16
    Journal articles | 2015
    Chandrasegaram MD; Goldstein D; Simes J; Gebski V; Kench JG; Gill AJ; Samra JS; Merrett ND; Richardson AJ; Barbour AP; Fawcett J; Grimison PS; Christophi C; Padbury R; Haghighi KS; Chen JW; Nikfarjam M; O'Rourke N; Spry N, 2015, 'Meta-analysis of radical resection rates and margin assessment in pancreatic cancer', British Journal of Surgery, 102, pp. 1459 - 1472, http://dx.doi.org/10.1002/bjs.9892
    Journal articles | 2015
    Davis ID; Long A; Yip S; Espinoza D; Thompson JF; Kichenadasse G; Harrison M; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro J; Harvie R; Jovanovic L; Hudson AL; Nelson CC; Stockler MR; Martin A, 2015, 'EVERSUN: A phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinoma', Annals of Oncology, 26, pp. 1118 - 1123, http://dx.doi.org/10.1093/annonc/mdv078
    Journal articles | 2015
    Donskov F; Michaelson MD; Puzanov I; Davis MP; Bjarnason GA; Motzer RJ; Goldstein D; Lin X; Cohen DP; Wiltshire R; Rini BI, 2015, 'Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients', British Journal of Cancer, 113, pp. 1571 - 1580, http://dx.doi.org/10.1038/bjc.2015.368
    Journal articles | 2015
    Goldstein D; El-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L; Tortora G; Van Laethem JL; Young R; Penenberg DN; Lu B; Romano A; Von Hoff DD, 2015, 'Nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: Long-term survival from a phase III trial', Journal of the National Cancer Institute, 107, http://dx.doi.org/10.1093/jnci/dju413
    Journal articles | 2015
    Goldstein D; Fawcett J; Bridgewater J; Choti M; Wilson K; Gebski V; Aiken C; Eminton Z; Falk S; Stanton L; Primrose J, 2015, 'Feasibility of trials to assess safety and toxicity of peri-operative and post-operative adjuvant therapy for hepatic metastases from colorectal cancer', EUROPEAN JOURNAL OF CANCER, 51, pp. S343 - S343, http://dx.doi.org/10.1016/S0959-8049(16)30967-4
    Journal articles | 2015
    Jaeger U; Trneny M; Melzer H; Praxmarer M; Nawarawong W; Yehuda DB; Goldstein D; Mihaljevic B; Ilhan O; Ballova V; Hedenus M; Hsiao LT; Au WY; Burgstaller S; Weidinger G; Keil F; Dittrich C; Skrabs C; Klingler A; Chott A; Fridrik MA; Greil R, 2015, 'Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: Results of the randomized NHL13 trial', Haematologica, 100, pp. 955 - 963, http://dx.doi.org/10.3324/haematol.2015.125344
    Journal articles | 2015
    Kunzmann V; Ramanathan RK; Goldstein D; Penenberg DN; Ferrara S; Lu B; Von Hoff DD, 2015, 'Tumor reduction in pancreatic versus metastatic sites in a randomized phase III study (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.', Journal of Clinical Oncology, 33, pp. 382 - 382, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.382
    Journal articles | 2015
    Lee CK; Goldstein D; Gibbs E; Joensuu H; Zalcberg J; Verweij J; Casali PG; Maki RG; Cioffi A; McArthur G; Lord SJ; Yip D; Kanjanapan Y; Rutkowski P, 2015, 'Development and validation of prognostic nomograms for metastatic gastrointestinal stromal tumour treated with imatinib', European Journal of Cancer, 51, pp. 852 - 860, http://dx.doi.org/10.1016/j.ejca.2015.02.015
    Journal articles | 2015
    McCarroll JA; Sharbeen G; Liu J; Youkhana J; Goldstein D; McCarthy N; Limbri LF; Dischl D; Ceyhan GO; Erkan M; Johns AL; Biankin AV; Kavallaris M; Phillips PA; Johns A, 2015, 'βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer', Oncotarget, 6, pp. 2235 - 2249, http://dx.doi.org/10.18632/oncotarget.2946
    Journal articles | 2015
    Murphy C; Sabesan S; Steer C; Yates P; Booms A; Jones V; Simpson A; Clarke K; Eek R; Ashley D; Goldstein D; Packer C; Tuthill F; Boyce A; Underhill C, 2015, 'Oncology service initiatives and research in regional Australia', Australian Journal of Rural Health, 23, pp. 40 - 48, http://dx.doi.org/10.1111/ajr.12173
    Journal articles | 2015
    Neale R; Burmeister E; O'Connell D; Beesley V; Goldstein D; Gooden H; Janda M; Jordan S; Merrett N; Payne M; Wyld D, 2015, 'Describing patterns of care in pancreatic cancer – A population-based study', Pancreatology, 15, pp. S83 - S83, http://dx.doi.org/10.1016/j.pan.2015.05.306
    Journal articles | 2015
    Neale R; Waterhouse M; Burmeister E; Ballard E; O'Connell D; Beesley V; Goldstein D; Gooden H; Janda M; Jordan S; Merrett N; Payne M; Wyld D, 2015, 'Determinants of outcomes following resection for pancreatic cancer – An Australian population-based study', Pancreatology, 15, pp. S85 - S85, http://dx.doi.org/10.1016/j.pan.2015.05.313
    Journal articles | 2015
    Pantaleo MA; Lolli C; Nannini M; Astolfi A; Indio V; Saponara M; Urbini M; La Rovere S; Gill A; Goldstein D; Ceccarelli C; Santini D; Rossi G; Fiorentino M; Di Scioscio V; Fusaroli P; Mandrioli A; Gatto L; Catena F; Basso U; Ercolani G; Pinna AD; Biasco G, 2015, 'Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations', Genetics in Medicine, 17, pp. 391 - 395, http://dx.doi.org/10.1038/gim.2014.115
    Journal articles | 2015
    Pavlakis N; Sjoquist KM; Tsobanis E; Martin A; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Wong M; Kim JW; Simes J; Zalcberg JR; Goldstein D, 2015, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG), first results', JOURNAL OF CLINICAL ONCOLOGY, 33, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.9
    Journal articles | 2015
    Pavlakis N; Sjoquist KM; Tsobanis E; Martin AJ; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Kim JW; Yip S; Simes J; Zalcberg JR; Goldstein D, 2015, 'LBA-06 INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib (REG) in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG): Final overall and subgroup results', Annals of Oncology, 26, pp. iv119 - iv119, http://dx.doi.org/10.1093/annonc/mdv262.06
    Journal articles | 2015
    Sandler C; Goldstein D; Horsfield S; Bennett BK; Friedlander M; Bastick PA; Lewis CR; Segelov E; Boyle FM; Chin MTM; Barry BK; Webber K; Lloyd AR, 2015, 'TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue.', Journal of Clinical Oncology, 33, pp. 9571 - 9571, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.9571
    Journal articles | 2015
    Sharbeen G; McCarroll J; Goldstein D; Phillips PA, 2015, 'Exploiting Base Excision Repair to Improve Therapeutic Approaches for Pancreatic Cancer', Frontiers in Nutrition, 2, pp. 10, http://dx.doi.org/10.3389/fnut.2015.00010
    Journal articles | 2015
    Stein A; Arnold D; Bridgewater J; Goldstein D; Jensen LH; Klümpen HJ; Lohse AW; Nashan B; Primrose J; Schrum S; Shannon J; Vettorazzi E; Wege H, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial', BMC Cancer, 15, pp. 564, http://dx.doi.org/10.1186/s12885-015-1498-0
    Journal articles | 2015
    Sze M; Butow P; Bell M; Vaccaro L; Dong S; Eisenbruch M; Jefford M; Girgis A; King M; McGrane J; Ng W; Asghari R; Parente P; Liauw W; Goldstein D; Psycho-oncology Co-operative Research Group Culturally and Linguistically Diverse (CALD) TEAM , 2015, 'Migrant health in cancer: outcome disparities and the determinant role of migrant-specific variables', Oncologist, 20, pp. 523 - 531, http://dx.doi.org/10.1634/theoncologist.2014-0274
    Journal articles | 2015
    Tabernero J; Gabrielachiorean E; Infante JR; Hingorani SR; Ganju V; Weekes C; Scheithauer W; Ramanathan RK; Goldstein D; Penenberg DN; Romano A; Ferrara S; Von Hoff DD, 2015, 'Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer', Oncologist, 20, pp. 143 - 150, http://dx.doi.org/10.1634/theoncologist.2014-0394
    Journal articles | 2015
    Tebbutt N; Kotasek D; Burris HA; Schwartzberg LS; Hurwitz H; Stephenson J; Warner DJ; Chen L; Hsu CP; Goldstein D, 2015, 'Motesanib with or without panitumumab plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, 75, pp. 993 - 1004, http://dx.doi.org/10.1007/s00280-015-2694-y
    Journal articles | 2015
    Tempero M; Cardin D; Biankin A; Goldstein D; Moore M; O'Reilly E; Philip P; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'P-185 Randomized phase III trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant therapy for patients with resected pancreatic cancer: APACT', Annals of Oncology, 26, pp. iv54 - iv54, http://dx.doi.org/10.1093/annonc/mdv233.185
    Journal articles | 2015
    Tempero M; Cardin D; Biankin AV; Goldstein D; Moore M; O'Reilly E; Philip P; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'Tu1953 Nab-Paclitaxel Plus Gemcitabine vs Gemcitabine Alone for Resected Pancreatic Cancer in a Phase III Trial (APACT)', Gastroenterology, 148, pp. S - 944, http://dx.doi.org/10.1016/s0016-5085(15)33220-0
    Journal articles | 2015
    Vajdic CM; Goldstein D, 2015, 'Cancer of unknown primary site', Australian Family Physician, 44, pp. 640 - 643
    Journal articles | 2015
    Vernerey D; Goldstein D; Huguet F; Paget-Bailly S; Van Laethem J-L; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Louvet C; Hammel P; Bonnetain F, 2015, 'Prognostic score and nomogram to predict overall survival in locally advanced pancreatic cancer', Pancreatology, 15, pp. S107 - S107, http://dx.doi.org/10.1016/j.pan.2015.05.383
    Journal articles | 2015
    Vernerey D; Hammel P; Paget-Bailly S; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Moore MJ; André T; Mineur L; Chibaudel B; Louvet C; Bonnetain F, 2015, 'Prognosis model for overall survival in locally advanced unresecable pancreatic carcinoma: An ancillary study of the LAP 07 trial.', Journal of Clinical Oncology, 33, pp. 235 - 235, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.235
    Journal articles | 2015
    Wang X; Batty KM; Crowe PJ; Goldstein D; Yang JL, 2015, 'The Potential of panHER Inhibition in Cancer', Frontiers in Oncology, 5, pp. 2, http://dx.doi.org/10.3389/fonc.2015.00002
    Journal articles | 2014
    Bennett BK; Goldstein D; Chen M; Davenport TA; Vollmer-Conna U; Scott EM; Hickie IB; Lloyd AR, 2014, 'Characterization of fatigue states in medicine and psychiatry by structured interview', Psychosomatic Medicine, 76, pp. 379 - 388, http://dx.doi.org/10.1097/PSY.0000000000000061
    Journal articles | 2014
    Davis ID; Long A; Martin A; Espinoza D; Yip S; Thompson JF; Kichenadasse G; Harrison M; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro J; Stockler MR, 2014, 'EVERSUN: A PHASE 2 TRIAL OF EVEROLIMUS ALTERNATING WITH SUNITINIB AS FIRST-LINE THERAPY FOR ADVANCED RENAL CELL CARCINOMA (ANZUP TRIAL 0901)', EUROPEAN JOURNAL OF CANCER, 50, pp. E68 - E69, http://dx.doi.org/10.1016/j.ejca.2014.03.255
    Journal articles | 2014
    Goldstein D; Bell ML; Butow P; Sze M; Vaccaro L; Dong S; Liauw W; Hui R; Tattersall M; Ng W; Asghari R; Steer C; Vardy J; Parente P; Harris M; Karanth NV; King M; Girgis A; Eisenbruch M; Jefford M, 2014, 'Immigrants' perceptions of the quality of their cancer care: An Australian comparative study, identifying potentially modifiable factors', Annals of Oncology, 25, pp. 1643 - 1649, http://dx.doi.org/10.1093/annonc/mdu182
    Journal articles | 2014
    Goldstein D; EI-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Macarulla T; Teixeira L; Tortora G; Van Laethem JL; Penenberg DN; Lu B; Romano A; Von Hoff DD, 2014, 'Analyses of updated overall survival (OS) and prognostic effect of neutrophil-to-lymphocyte ratio (NLR) and CA 19-9 from the phase III MPACT study of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem for patients (pts) with metastatic pancreatic cancer (PC).', JOURNAL OF CLINICAL ONCOLOGY, 32, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4027
    Journal articles | 2014
    Goldstein D; El Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L; Tortora G; Van Laethem J-L; Young R; Wei X; Lu B; Romano A; Von Hoff DD, 2014, 'Updated survival from a randomized phase III trial (MPACT) of nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients (pts) with metastatic adenocarcinoma of the pancreas', JOURNAL OF CLINICAL ONCOLOGY, 32, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.178
    Journal articles | 2014
    Greenhalf W; Ghaneh P; Neoptolemos JP; Palmer DH; Cox TF; Lamb RF; Garner E; Campbell F; MacKey JR; Costello E; Moore MJ; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Shannon J; Dervenis C; Glimelius B; Deakin M; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Halloran CM; Mayerle J; Oláh A; Jackson R; Rawcliffe CL; Scarpa A; Bassi C; Büchler MW, 2014, 'Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial', Journal of the National Cancer Institute, 106, http://dx.doi.org/10.1093/jnci/djt347
    Journal articles | 2014
    Hammel P; Huguet F; Dewi V; Laethem J-LV; Goldstein D; Glimelius B; Artru P; Borbath Y; Bonnetain F; Louvet C, 2014, 'Impact of chemoradiotherapy (CRT) on local tumour control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study', Pancreatology, 14, pp. S6 - S6, http://dx.doi.org/10.1016/j.pan.2014.05.398
    Journal articles | 2014
    Hillman RJ; Garland SM; Gunathilake MPW; Stevens M; Kumaradevan N; Lemech C; Ward RL; Meagher A; McHugh L; Jin F; Carroll S; Goldstein D; Grulich AE; Tabrizi SN, 2014, 'Human papillomavirus (HPV) genotypes in an Australian sample of anal cancers', International Journal of Cancer, 135, pp. 996 - 1001, http://dx.doi.org/10.1002/ijc.28730
    Journal articles | 2014
    Huguet F; Hammel P; Vernerey D; Goldstein D; Van Laethem JL; Glimelius B; Spry N; Paget-Bailly S; Bonnetain F; Louvet C, 2014, 'Impact of chemoradiotherapy (CRT) on local control and time without treatment in patients with locally advanced pancreatic cancer (LAPC) included in the international phase III LAP 07 study.', Journal of Clinical Oncology, 32, pp. 4001 - 4001, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4001
    Journal articles | 2014
    Huguet F; Hammel P; Vernerey D; Van Laethem J; Goldstein D; Glimelius B; Bonnetain F; Louvet C, 2014, 'Impact de la chimioradiothérapie sur le contrôle local et le temps sans traitement dans l’essai de phase III LAP07', Cancer/Radiothérapie, 18, pp. 587 - 587, http://dx.doi.org/10.1016/j.canrad.2014.07.013
    Journal articles | 2014
    Jefford M; Nolte L; Tsintziras S; Butow P; Sze M; Yiu D; Schofield P; Goldstein D; Price M, 2014, 'HOW IS POST-TREATMENT SURVIVORSHIP CONCEPTUALISED BY PEOPLE FROM DIFFERENT CULTURAL GROUPS?', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 10, pp. 158 - 158, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000346343700480&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2014
    McCarroll J; Teo J; Boyer C; Goldstein D; Kavallaris M; Phillips PA, 2014, 'Potential applications of nanotechnology for the diagnosis and treatment of pancreatic cancer', Frontiers in Physiology, 5, pp. 1 - 10, http://dx.doi.org/10.3389/fphys.2014.00002
    Journal articles | 2014
    McCarroll JA; Naim S; Sharbeen G; Russia N; Lee J; Kavallaris M; Goldstein D; Phillips PA, 2014, 'Role of pancreatic stellate cells in chemoresistance in pancreatic cancer', Frontiers in Physiology, 5 APR, pp. 141, http://dx.doi.org/10.3389/fphys.2014.00141
    Journal articles | 2014
    McGrane J; Butow P; Sze M; Eisenbruch M; Goldstein D; King M, 2014, 'Assessing the Invariance of a Culturally Competent Multi-lingual Unmet Needs Survey for Immigrant and Australian-born Cancer Patients: A Rasch Analysis', PSYCHO-ONCOLOGY, 23, pp. 153 - 153, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344003700220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2014
    McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, http://dx.doi.org/10.1007/s11136-014-0717-5
    Journal articles | 2014
    McGrane JA; Butow PN; Sze M; Eisenbruch M; Goldstein D; King MT, 2014, 'Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis', Quality of Life Research, 23, pp. 2819 - 2830, http://dx.doi.org/10.1007/s11136-014-0717-5
    Journal articles | 2014
    Murray JE; Pickering HR; Lin CS-Y; Goldstein D; Friedlander ML; Kiernan MC; Krishnan AV, 2014, '6. Functional impact of neuropathy in patients receiving oxaliplatin chemotherapy', Clinical Neurophysiology, 125, pp. e3 - e3, http://dx.doi.org/10.1016/j.clinph.2013.10.028
    Journal articles | 2014
    Park SB; Kwok JB; Loy CT; Friedlander ML; Lin CSY; Krishnan AV; Lewis CR; Kiernan MC; Goldstein D, 2014, 'Paclitaxel-induced neuropathy: Potential association of MAPT and GSK3B genotypes', BMC Cancer, 14, pp. 993, http://dx.doi.org/10.1186/1471-2407-14-993
    Journal articles | 2014
    Patel MB; Pothula SP; Xu Z; Lee AK; Goldstein D; Pirola RC; Apte MV; Wilson JS, 2014, 'The role of the hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: Anti-angiogenic implications in pancreatic cancer', Carcinogenesis, 35, http://dx.doi.org/10.1093/carcin/bgu122
    Journal articles | 2014
    Ramanathan RK; Von Hoff DD; Moore MJ; Teixeira L; Siena S; Tabernero J; Goldstein D; Wei X; Lu B, 2014, 'Analysis of metabolic response (MR) by positron emission tomography (PET) compared with tumor response by computed tomography (CT) from MPACT, a phase III trial comparing nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone for patients (pts) with metastatic adenocarcinoma of the pancreas', JOURNAL OF CLINICAL ONCOLOGY, 32, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.254
    Journal articles | 2014
    Reichardt P; Demetri GD; Gelderblom H; Rutkowski P; Im S-A; Gupta S; Kang Y-K; Schoffski P; Schuette J; Soulieres D; Blay J-Y; Goldstein D; Fly KD; Huang X; Corsaro M; Lechuga M; Martini J-F; Heinrich MC, 2014, 'Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial.', JOURNAL OF CLINICAL ONCOLOGY, 32, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.10549
    Journal articles | 2014
    Sears K; Broderick B; Goldstein D; Stockley D, 2014, 'The Development of a New Master’s of Science in Healthcare Quality Program', Collected Essays on Learning and Teaching, 7, pp. 39 - 45, http://dx.doi.org/10.22329/celt.v7i1.3991
    Journal articles | 2014
    Siena S; Lipton L; Letourneau R; Tjulandin SA; Guillen Ponce C; Schwarz M; Ramanathan RK; Macarulla T; Goldstein D; Romano A; Ferrara S; Penenberg D; Von Hoff DD, 2014, 'Regional Subanalysis of the Phase III Mpact Trial: Nab-Paclitaxel (Nab-P) Plus Gemcitabine (Gem) Vs Gem Alone for Patients (Pts) with Metastatic Pancreatic Cancer (Pc)', Annals of Oncology, 25, pp. iv235 - iv235, http://dx.doi.org/10.1093/annonc/mdu334.76
    Journal articles | 2014
    Tempero M; Cardin D; Biankin A; Goldstein D; Moore M; O’Reilly E; Philip P; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'APACT: A Phase III Trial of Nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) Versus Gem Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (PC)', American Journal of Gastroenterology, 109, pp. S72 - S72, http://dx.doi.org/10.14309/00000434-201410002-00232
    Journal articles | 2014
    Tempero MA; Cardin D; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'Apact: a Phase III Trial of Nab-Paclitaxel (Nab-P) Plus Gemcitabine (Gem) Vs Gem Alone for Resected Pancreatic Cancer (Pc)', Annals of Oncology, 25, pp. iv252 - iv252, http://dx.doi.org/10.1093/annonc/mdu334.131
    Journal articles | 2014
    Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA).', Journal of Clinical Oncology, 32, pp. TPS4162 - TPS4162, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.tps4162
    Journal articles | 2014
    Valle JW; Palmer D; Jackson R; Cox T; Neoptolemos JP; Ghaneh P; Rawcliffe CL; Bassi C; Stocken DD; Cunningham D; O'Reilly D; Goldstein D; Robinson BA; Karapetis C; Scarfe A; Lacaine F; Sand J; Izbicki JR; Mayerle J; Dervenis C; Oláh A; Butturini G; Lind PA; Middleton MR; Anthoney A; Sumpter K; Carter R; Büchler MW, 2014, 'Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: Ongoing lessons from the ESPAC-3 study', Journal of Clinical Oncology, 32, pp. 504 - 512, http://dx.doi.org/10.1200/JCO.2013.50.7657
    Journal articles | 2014
    Vernerey D; Hammel P; Paget-Bailly S; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Moore M; André T; Mineur L; Chibaudel B; Louvet C; Bonnetain F, 2014, 'Prognosis Model for Overall Survival in Locally Advanced Pancreatic Cancer (LAPC): An Ancillary Study of the Lap 07 Trial', Annals of Oncology, 25, pp. ii105, http://dx.doi.org/10.1093/annonc/mdu193.2
    Journal articles | 2014
    Vernerey D; Hammel P; Paget-Bailly S; Huguet F; Van Laethem JL; Goldstein D; Glimelius B; Artru P; Moore M; André T; Mineur L; Chibaudel B; Louvet C; Bonnetain F, 2014, 'Prognosis model for overall survival in locally advanced pancreatic cancer (LAPC): An ancillary study of the LAP 07 trial.', Journal of Clinical Oncology, 32, pp. 4024 - 4024, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.4024
    Journal articles | 2014
    Von Hoff DD; Goldstein D; Renschler MF, 2014, 'The authors reply', New England Journal of Medicine, 370, pp. 479 - 480, http://dx.doi.org/10.1056/NEJMc1314761
    Journal articles | 2014
    Wang X; Goldstein D; Crowe PJ; Yang JL, 2014, 'Impact of STAT3 inhibition on survival of osteosarcoma cell lines', Anticancer Research, 34, pp. 6537 - 6545
    Journal articles | 2013
    Ackland S; Goldstein D; McJannett M, 2013, 'Forty years of COSA - Contributions to oncology teaching and research', Cancer Forum, 37, pp. 238 - 242
    Journal articles | 2013
    Bell ML; Butow PN; Goldstein D, 2013, 'Informatively missing quality of life and unmet needs sex data for immigrant and Anglo-Australian cancer patients and survivors', Quality of Life Research, 22, pp. 2757 - 2760, http://dx.doi.org/10.1007/s11136-013-0392-y
    Journal articles | 2013
    Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-beri P; Goldstein D, 2013, 'Inferior health-related quality of life and psychological well-being in immigrant cancer survivors: A population-based study', European Journal of Cancer, 49, pp. 1948 - 1956, http://dx.doi.org/10.1016/j.ejca.2013.01.011
    Journal articles | 2013
    Butow PN; Bell M; Aldridge L; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; King M; Duggal-beri P; McGrane J; Goldstein D, 2013, 'Unmet needs in immigrant cancer survivors: a cross-sectional population-based study', Supportive Care in Cancer, 21, pp. 2509 - 2520, http://dx.doi.org/10.1007/s00520-013-1819-2
    Journal articles | 2013
    Butow PN; Sze M; Eisenbruch M; Bell M; Aldridge L; Vardy JL; Hui R; Boyle F; Liauw WS; Goldstein D, 2013, 'Should culture affect practice? Prognostic discussions with immigrants.', Journal of Clinical Oncology, 31, pp. 6556 - 6556, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.6556
    Journal articles | 2013
    Butow PN; Sze M; Eisenbruch M; Bell ML; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J; Hui R; Boyle F; Liauw W; Goldstein D, 2013, 'Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients', Patient Education and Counseling, 92, pp. 246 - 252, http://dx.doi.org/10.1016/j.pec.2013.03.006
    Journal articles | 2013
    Chiorean EG; Von Hoff DD; Ervin TJ; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; Ko A; Lu B, 2013, 'CA19-9 decrease at 8 weeks as a predictor of overall survival (OS) in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients with metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, 31, pp. 4058 - 4058, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4058
    Journal articles | 2013
    Chou A; Waddell N; Cowley MJ; Gill AJ; Chang DK; Patch AM; Nones K; Wu J; Pinese M; Johns AL; Miller DK; Kassahn KS; Nagrial AM; Wasan H; Goldstein D; Toon CW; Chin V; Chantrill L; Humphris J; Mead RS; Rooman I; Samra JS; Pajic M; Musgrove EA; Pearson JV; Morey AL; Grimmond SM; Biankin AV, 2013, 'Clinical and molecular characterization of HER2 amplified-pancreatic cancer', Genome Medicine, 5, pp. 78, http://dx.doi.org/10.1186/gm482
    Journal articles | 2013
    Grimison P; Phillips F; Butow P; White K; Yip D; Sardelic F; Underhill C; Tse R; Simes R; Turley K; Raymond C; Goldstein D, 2013, 'Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals', Asia-Pacific Journal of Clinical Oncology, 9, pp. 226 - 238, http://dx.doi.org/10.1111/ajco.12014
    Journal articles | 2013
    Hammel P; Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', Journal of Clinical Oncology, 31, pp. LBA4003 - LBA4003, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.lba4003
    Journal articles | 2013
    Hammel P; Huguet F; van Laethem J-L; Goldstein D; Glimelius B; Borbath I; Bouché O; Shannon J; André T; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study', Pancreatology, 13, pp. S89 - S89, http://dx.doi.org/10.1016/j.pan.2013.04.312
    Journal articles | 2013
    Huguet F; Hammel P; Goldstein D; Spry N; Van Laethem J-L; Van Houtte P; Glimelius B; Gubanski M; Bonnetain F; Racadot S, 2013, 'Étude de la relation entre le score d’assurance qualité de la radiothérapie, la toxicité et la survie dans l’essai de phase III LAP07 dans le cancer du pancréas localement évolué', Cancer/Radiothérapie, 17, pp. 581 - 582, http://dx.doi.org/10.1016/j.canrad.2013.06.018
    Journal articles | 2013
    Huguet F; Racadot S; Goldstein D; Spry N; Van Laethem J; Van Houtte P; Glimelius B; Gubanski M; Bonnetain F; Hammel P, 2013, 'Investigation of Relation of Radiation Therapy Quality Assurance Scores (RTQASc) With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma (LAPC)', INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87, pp. S29 - S30, http://dx.doi.org/10.1016/j.ijrobp.2013.06.080
    Journal articles | 2013
    Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; André T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', J Clin Oncol, 31, pp. LBA4003, http://dx.doi.org/10.1200/jco.2013.31.18_suppl.lba4003
    Journal articles | 2013
    Kashigar A; Habbous S; Eng L; Irish B; Bissada E; Irish J; Brown D; Gilbert R; Gullane P; Xu W; Huang SH; Witterick I; Freeman J; O'Sullivan B; Waldron J; Liu G; Goldstein D, 2013, 'Erratum: Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients. (Cancer (2013) 119 (27019))', Cancer, 119, pp. 3895 - 3896, http://dx.doi.org/10.1002/cncr.28281
    Journal articles | 2013
    Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken NRC; Wyld DK; Abdi EA; Glasgow A; Beale PJ; Jefford M; Glare PA; Stockler MR, 2013, 'The median informs the message: Accuracy of individualized scenarios for survival time based on oncologists' estimates', Journal of Clinical Oncology, 31, pp. 3565 - 3571, http://dx.doi.org/10.1200/JCO.2012.44.7821
    Journal articles | 2013
    Moore MJ; Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Hon JK; Biakhov MY; Hingorani SR; Ganju V; Weekes CD; Scheithauer W; Ramanathan RK; Tabernero J; Goldstein D; Wei X; Romano A, 2013, 'Prognostic factors (PFs) of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with metastatic pancreatic cancer (MPC).', Journal of Clinical Oncology, 31, pp. 4059 - 4059, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4059
    Journal articles | 2013
    Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, http://dx.doi.org/10.1002/caac.21204
    Journal articles | 2013
    Park SB; Goldstein D; Krishnan AV; Lin CSY; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC, 2013, 'Chemotherapy-induced peripheral neurotoxicity: A critical analysis', CA Cancer Journal for Clinicians, 63, pp. 419 - 437, http://dx.doi.org/10.3322/caac.21204
    Journal articles | 2013
    Pavlakis N; Goldstein D; Sjoquist KM; Martin A; Tsobanis E; Yip S; Shannon J; Burge ME; Cronk MF; Tebbutt NC; Strickland A; Lipton LR; Price TJ; Nott LM; Harris DL; Burnell MJ; Alcindor T; Bang Y-J; Kang Y-K; O'Callaghan CJ, 2013, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer (AOGC)—A study by the Australasian Gastrointestinal Trials Group (AGITG).', Journal of Clinical Oncology, 31, pp. TPS4157 - TPS4157, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.tps4157
    Journal articles | 2013
    Reni M; Von Hoff D; Chiorean E; Ervin T; Arena F; Infante J; Bathini V; Clingan P; Kunzmann V; Ramanathan R; Tabernero J; Goldstein D; Ko A; Lu B, 2013, 'CA19-9 Decrease and Kinetics in a Randomized Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer', Annals of Oncology, 24, pp. iv31 - iv31, http://dx.doi.org/10.1093/annonc/mdt202.19
    Journal articles | 2013
    Shaw J; Butow P; Sze M; Young J; Goldstein D, 2013, 'Reducing disparity in outcomes for immigrants with cancer: A qualitative assessment of the feasibility and acceptability of a culturally targeted telephone-based supportive care intervention', Supportive Care in Cancer, 21, pp. 2297 - 2301, http://dx.doi.org/10.1007/s00520-013-1786-7
    Journal articles | 2013
    Short M; Goldstein D; Halkett G; Reece W; Borg M; Zissiadis Y; Kneebone A; Spry N, 2013, 'Impact of gemcitabine chemotherapy and 3-dimensional conformal radiation therapy/5-fluorouracil on quality of life of patients managed for pancreatic cancer', International Journal of Radiation Oncology Biology Physics, 85, pp. 157 - 162, http://dx.doi.org/10.1016/j.ijrobp.2012.03.003
    Journal articles | 2013
    Tabernero J; Von Hoff D; Moore M; Ervin T; Arena F; Chiorean E; Infante J; Hingorani S; Ganju V; Weekes C; Scheithauer W; Ramanathan R; Goldstein D; Wei X; Romano A, 2013, 'Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: Influence of Prognostic Factors on Survival', Annals of Oncology, 24, pp. iv11 - iv12, http://dx.doi.org/10.1093/annonc/mdt201.1
    Journal articles | 2013
    Tan CJ; Yang JL; Crowe P; Goldstein D, 2013, 'Targeted therapy in soft tissue sarcoma-A novel direction in therapeutics', Chinese Clinical Oncology, 2, http://dx.doi.org/10.3978/j.issn.2304-3865.2013.08.01
    Journal articles | 2013
    Tan K; Goldstein D; Crowe P; Yang JL, 2013, 'Uncovering a key to the process of metastasis in human cancers: A review of critical regulators of anoikis', Journal of Cancer Research and Clinical Oncology, 139, pp. 1795 - 1805, http://dx.doi.org/10.1007/s00432-013-1482-5
    Journal articles | 2013
    Teo J; Erlich RB; Sagnella S; Dwarte T; Davis TP; Kavallaris M; McCarroll J; Boyer C; Duong HTT; Phillips P; Sharbeen G; Goldstein D, 2013, 'Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers', Molecular Pharmaceutics, 10, pp. 2435 - 2444, http://dx.doi.org/10.1021/mp400049e
    Journal articles | 2013
    Vickers MM; Tu D; Lee C; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H-J; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2013, 'Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.', Journal of Clinical Oncology, 31, pp. 4053 - 4053, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4053
    Journal articles | 2013
    Von Hoff DD; Ervin T; Arena FP; Chiorean EG; Infante J; Moore M; Seay T; Tjulandin SA; Ma WW; Saleh MN; Harris M; Reni M; Dowden S; Laheru D; Bahary N; Ramanathan RK; Tabernero J; Hidalgo M; Goldstein D; Van Cutsem E; Wei X; Iglesias J; Renschler MF, 2013, 'Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine', New England Journal of Medicine, 369, pp. 1691 - 1703, http://dx.doi.org/10.1056/NEJMoa1304369
    Journal articles | 2013
    Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT)', JOURNAL OF CLINICAL ONCOLOGY, 31, http://dx.doi.org/10.1200/jco.2013.31.4_suppl.lba148
    Journal articles | 2013
    Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates.', Journal of Clinical Oncology, 31, pp. 4005 - 4005, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4005
    Journal articles | 2013
    Wang X; Goldstein D; Crowe P; Yang J, 2013, 'S3I-201, a novel STAT3 inhibitor, inhibits growth of human soft tissue sarcoma cell lines', World Journal of Cancer Research, http://dx.doi.org/10.1166/wjcr.2013.1005
    Journal articles | 2013
    Webber K; Girgis A; Bennett BK; Bonaventura A; Boyle FM; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2013, 'The unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners (GPs).', Journal of Clinical Oncology, 31, pp. 9602 - 9602, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.9602
    Journal articles | 2012
    Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study.', Journal of Clinical Oncology, 30, pp. 9044 - 9044, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9044
    Journal articles | 2012
    Bennett BK; Park SB; Lin CS-Y; Friedlander M; Kiernan MC; Goldstein D, 2012, 'Impact of Oxaliplatin-induced Neuropathy: A Patient Perspective', Supportive Care in Cancer, 20, pp. 2959 - 2967, http://dx.doi.org/10.1007/s00520-012-1428-5
    Journal articles | 2012
    Butow P; Aldridge L; Bell M; Sze M; Eisenbruch M; Jefford M; Schofield P; Girgis A; Goldstein D; King MT, 2012, 'Inferior quality of life and psychological well-being in immigrant cancer survivors', QUALITY OF LIFE RESEARCH, 21, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209358900132&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2012
    Butow P; Lobb EA; Jefford M; Goldstein D; Eisenbruch M; Girgis A; King MT; Sze M; Aldridge L; Schofield P, 2012, 'A bridge between cultures: Interpreters' perspectives of consultations with migrant oncology patients', Supportive Care in Cancer, 20, pp. 235 - 244, http://dx.doi.org/10.1007/s00520-010-1046-z
    Journal articles | 2012
    Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; King M; Jefford M; Schofield P; Duggal-Beri P; Goldstein D, 2012, 'Cancer survivorship outcomes in immigrants.', Journal of Clinical Oncology, 30, pp. 6111 - 6111, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.6111
    Journal articles | 2012
    Butow PN; Philips F; Schweder J; White K; Underhill C; Goldstein D, 2012, 'Psychosocial well-being and supportive care needs of cancer patients living in urban and rural/regional areas: a systematic review', Supportive Care in Cancer, 20, pp. 1 - 22
    Journal articles | 2012
    Cameron BA; Bennett B; Li H; Boyle F; deSouza P; Wilcken N; Friedlander M; Goldstein D; Lloyd AR, 2012, 'Post-cancer fatigue is not associated with immune activation or altered cytokine production', Annals of Oncology, 23, pp. 2890 - 2895, http://dx.doi.org/10.1093/annonc/mds108
    Journal articles | 2012
    Chua YJ; Karapetis CS; Underhill C; Nott LM; Goldstein D; Cronk MF; Gebski V; Wong N; Sjoquist KM; Biankin AV, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', Journal of Clinical Oncology, 30, pp. TPS4137 - TPS4137, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps4137
    Journal articles | 2012
    Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Mark Jeffrey G; Tebbutt NC; Buck M; Lowenthal RM; Boland A; Gebski V; Zalcberg J; John Simes R, 2012, 'Erratum: Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis (European Journal of Cancer (2011) 47:12 (1826-1836))', European Journal of Cancer, 48, pp. 407, http://dx.doi.org/10.1016/j.ejca.2011.12.001
    Journal articles | 2012
    Demetri GD; Garrett C; Sch offski P; Shah M; Verweij J; Leyvraz S; Hurwitz HI; Lopez Pousa A; Le Cesne A; Goldstein D; Paz-Ares L; Blay J; McArthur G; Xu Q; Huang X; Harmon CS; Tassell V; Cohen DP; Casali P, 2012, 'Complete Longitudinal Analyses of the Randomized,Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure', Clinical Cancer Research, 18, pp. 3170 - 3179
    Journal articles | 2012
    Dumont AG; Rink L; Godwin AK; Miettinen M; Joensuu H; Strosberg JR; Gronchi A; Corless CL; Goldstein D; Rubin BP; Maki RG; Lazar AJ; Lev D; Trent JC; von Mehren M, 2012, 'A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients.', Annals of Oncology, 23, pp. 1335 - 1340, http://dx.doi.org/10.1093/annonc/mdr442
    Journal articles | 2012
    Fawcett J; Sjoquist KM; Padbury R; Christophi C; Tebbutt NC; Pilgrim CHC; Gebski V; Wong N; Aiken C; Goldstein D, 2012, 'ATTACHE: A phase III, multicenter, randomized comparison of chemotherapy given prior to and post surgical resection versus chemotherapy given post surgical resection for hepatic metastases from colorectal cancer.', Journal of Clinical Oncology, 30, pp. TPS3643 - TPS3643, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps3643
    Journal articles | 2012
    Goldstein D; Bennett BK; Webber K; Boyle F; De Souza P; Wilcken NRC; Scott E; Toppler R; Murie P; O''Malley L; Mccourt J; Friedlander M; Hickie IB; Lloyd AR, 2012, 'Cancer-related fatigue in women with breast cancer: outcomes of a 5 year prospective cohort study.', Journal of Clinical Oncology, 30, pp. 1805 - 1812, http://dx.doi.org/10.1200/JCO.2011.34.6148
    Journal articles | 2012
    Goldstein D; Bennett BK; Webber K; Lloyd AR, 2012, 'Reply to A. Giacalone et al', Journal of Clinical Oncology, 30, pp. 4175 - 4176, http://dx.doi.org/10.1200/JCO.2012.45.6269
    Journal articles | 2012
    Goldstein D; Spry N; Cummins MM; Brown C; Van Hazel GA; Carroll SL; Selva Nayagam S; Borg M; Ackland S; Wratten C; Shapiro J; Porter L; Hruby G; Horvath LG; Bydder S; Underhill C; Harvey JE; Gebski V, 2012, 'The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer', British Journal of Cancer, 106, pp. 61 - 69, http://dx.doi.org/10.1038/bjc.2011.526
    Journal articles | 2012
    Goldstein D; Sze M; Bell M; King M; Jefford M; Eisenbruch M; Girgis A; Vaccaro L; Butow PN, 2012, 'Disparities in quality-of-life outcomes in immigrant cancer patients.', Journal of Clinical Oncology, 30, pp. e16507 - e16507, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e16507
    Journal articles | 2012
    Grünwald V; Karakiewicz PI; Bavbek SE; Miller K; Machiels JP; Lee SH; Larkin J; Bono P; Rha SY; Castellano D; Blank CU; Knox JJ; Hawkins R; Anak O; Rosamilia M; Booth J; Pirotta N; Bodrogi I; Romedi M; Ferrandini S; Rondinon M; Pittman K; Goldstein D; Shapiro J; Troon S; Yip D; Mainwaring P; Zigeuner R; Loidl W; Greil RF; Schmidinger M; De Grève J; Rottey S; Vermorken J; Gil T; Gennigens C; Roumeguere T; Barrios C; Mathias C; Assi H; Hotte S; Karakiewicz P; Knox J; Spadafora S; Wood L; Zalewski P; Mackensie M; Bjarnason G; Lalancette A; Chan A; Higgins B; North S; Soulieres D; Asselah J; Sperlich C; Miller W; Yadav S; El-Maraghi R; Godoy J; Prausová J; Katolicka J; Petruzelka L; Kiss I; Lapela M; Miller K; Bergmann L; Beck J; Jäger E; Kindler M; Overkamp F; Wirth M; Hölzer W; Gschwend J; Stenzl A; Gauler T; Niederwieser D; Marschner N; Lück A; Tessen H; Eichelberg C; Steiner T; Goebell P; Kettner E; Bakhshandeh-Bath A; Wilhelm M; Schmitz S; Jacob A; Bierer S; Kube U; Staehler M; Engel E; Frambach M; Schellenberger U; Albers P; Simon J; Gleissler M; Klotz T; Repp R, 2012, 'An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy', European Journal of Cancer, 48, pp. 324 - 332, http://dx.doi.org/10.1016/j.ejca.2011.06.054
    Journal articles | 2012
    Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken N; Wyld D; Beale PJ; Jefford M; Glasgow AL; Abdi EA; Glare PA; Stockler MR, 2012, 'Usefulness of medical oncologists’ estimates of survival time in people with advanced cancer.', Journal of Clinical Oncology, 30, pp. 9087 - 9087, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9087
    Journal articles | 2012
    Minkovich L; Mccluskey S; Djaiani G; Goldstein D, 2012, 'High prevalence of significant hypophosphatemia in patient undergoing reconstructive surgery for head and neck cancers', European Journal of Anaesthesiology, 29, pp. 185 - 185, http://dx.doi.org/10.1097/00003643-201206001-00614
    Journal articles | 2012
    Mitchison D; Butow PN; Sze M; Aldridge L; Hui R; Vardy JL; Eisenbruch M; Iedema R; Goldstein D, 2012, 'Prognostic Communication Preferences of Migrant Patients and their Relatives', Psycho-oncology, 21, pp. 496 - 504, http://dx.doi.org/10.1002/pon.1923
    Journal articles | 2012
    Ngan S; Fisher R; Burmeister B; Mackay J; McLachlan S; Beresford J; McClure B; Goldstein D; Joseph D; Solomon M, 2012, 'Long-term Quality of Life in Patients Treated in TROG 01.04: A Randomized Trial Comparing Short Course and Long Course Preoperative Radiation Therapy for Rectal Cancer', INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 84, pp. S143 - S144, http://dx.doi.org/10.1016/j.ijrobp.2012.07.371
    Journal articles | 2012
    Ngan SY; Burmeister B; Fisher R; Solomon M; Goldstein D; Joseph D; Ackland S; Schache D; McClure B; McLachlan S; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J, 2012, 'Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04', Journal of Clinical Oncology, 30, pp. 3827 - 3833
    Journal articles | 2012
    Wang X; Crowe PJ; Goldstein D; Yang JL, 2012, 'STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers', International Journal of Oncology, 41, pp. 1181 - 1191, http://dx.doi.org/10.3892/ijo.2012.1568
    Journal articles | 2011
    Arun SJ; Xu Z; Fiala-Beer E; Phillips P; Goldstein D; Biankin A; Pirola R; Wilson JS; Apte MV, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', CANCER RESEARCH, 71, http://dx.doi.org/10.1158/1538-7445.AM2011-LB-395
    Journal articles | 2011
    Butow PN; Goldstein D; Bell ML; Sze M; Aldridge LJ; Abdo S; Tanious M; Dong S; Iedema R; Vardy J; Ashgari R; Hui R; Eisenbruch M, 2011, 'Interpretation in consultations with immigrant patients with cancer: How accurate is it?', Journal of Clinical Oncology, 29, pp. 2801 - 2807, http://dx.doi.org/10.1200/JCO.2010.34.3335
    Journal articles | 2011
    Clarke SJ; Yip S; Brown C; Van Hazel GA; Ransom DT; Goldstein D; Jeffrey GM; Tebbutt NC; Buck M; Lowenthal RM; Boland A; Gebski V; Zalcberg J; Simes RJ, 2011, 'Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; Results of a randomised phase II study (DaVINCI) and meta-analysis', European Journal of Cancer, 47, pp. 1826 - 1836, http://dx.doi.org/10.1016/j.ejca.2011.04.024
    Journal articles | 2011
    Goldstein D; Butow P; Sze M; Mikhail M; Eisenbruch M, 2011, 'Grappling with cultural differences; Communication between oncologists and immigrant cancer patients with and without interpreters', Patient Education and Counseling, 84, pp. 398 - 405
    Journal articles | 2011
    Goldstein D; Gainford M; Brown C; Tebbutt N; Ackland S; Van Hazel GA; Jefford M; Abdi E; Gebski V; Miller D; Shannon JF, 2011, 'Fixed dose rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, 16, pp. 519 - 519
    Journal articles | 2011
    Goldstein D; Gainford MC; Brown C; Tebbutt N; Ackland SP; Van Hazel G; Jefford M; Abdi E; Selva-Nayagam S; Gebski V; Miller D; Shannon J, 2011, 'Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology, 67, pp. 519 - 525, http://dx.doi.org/10.1007/s00280-010-1351-8
    Journal articles | 2011
    Goldstein D; Lee C; Tracey E; Cook-Yarborough C; Lord S, 2011, 'Validating innovation: A population-based study of gastrointestinal stromal tumors (GIST) to estimate the survival benefit of imatinib.', J Clin Oncol, 29, pp. 10060, http://www.ncbi.nlm.nih.gov/pubmed/28021288
    Journal articles | 2011
    Hammel P; Huguet F; Van Laethem J; Goldstein D; Glimelius B; Moore MJ; Chibaudel B; Bonnetain F; Louvet C, 2011, 'Randomized multicenter phase III study in patients with locally advanced adenocarcinoma of the pancreas: Gemcitabine with or without chemoradiotherapy and with or without erlotinib—LAP 07 study.', Journal of Clinical Oncology, 29, pp. e14619 - e14619, http://dx.doi.org/10.1200/jco.2011.29.15_suppl.e14619
    Journal articles | 2011
    Leighl N; Shepherd H; Butow PN; clarke SJ; Mcjannett M; Beale P; Wilken N; Moore M; Chen E; Goldstein D; Horvath LG; Knox J; Krzyzanowska M; Oza AM; Feld R; Hedley D; Xu W; Tattersall MH, 2011, 'Supporting treatment decision-making in advanced cancer: a randomized trial of a decision aid for patients considering chemotherapy in advanced colorectal cancer', Journal of Clinical Oncology, 29, pp. 2077 - 2084, http://dx.doi.org/10.1200/JCO.2010.32.0754
    Journal articles | 2011
    Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge L; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis', Lancet Oncology, 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470
    Journal articles | 2011
    Luckett T; Goldstein D; Butow PN; Gebski V; Aldridge LJ; McGrane J; Ng W; King MT, 2011, 'Psychological morbidity and quality of life of ethnic minority patients with cancer: A systematic review and meta-analysis', The Lancet Oncology, 12, pp. 1240 - 1248, http://dx.doi.org/10.1016/S1470-2045(11)70212-1
    Journal articles | 2011
    Park SB; Goldstein D; Lin CS-Y; Krishnan AV; Friedlander M; Kiernan MC, 2011, 'Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, 29, pp. e553 - e554e
    Journal articles | 2011
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Dose effects of Oxaliplatin on persistent and transient na+ conductances and the development of neurotoxicity', PLoS One, 6, pp. 1 - 7, http://dx.doi.org/10.1371/journal.pone.0018469
    Journal articles | 2011
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Long-term neuropathy after Oxaliplatin treatment: Challenging the dictum of reversibility', Oncologist, 16, pp. 708 - 716, http://dx.doi.org/10.1634/theoncologist.2010-0248
    Journal articles | 2011
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander M; Kiernan MC, 2011, 'Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy', Experimental Neurology, 227, pp. 120 - 127, http://dx.doi.org/10.1016/j.expneurol.2010.10.002
    Journal articles | 2011
    Peng J; Shi D; Goodman KA; Goldstein D; Xiao C; Guan Z; Cai S, 2011, 'Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29', Radiation Oncology, 6, pp. 93, http://dx.doi.org/10.1186/1748-717X-6-93
    Journal articles | 2011
    Sjoquist KM; Goldstein D; Bester L; Bester L, 2011, 'A serious complication of selected internal radiation therapy: case report and literature review', Oncologist, 15, pp. 830 - 835
    Journal articles | 2011
    Tebbutt N; murphy F; Zannino D; Wilson D; Cummins MM; Abdi E; Strickland A; Lowenthal RM; Marx G; Karapetis C; Shannon JF; Goldstein D; Nayagam SS; Blum R; Chantrill L; Simes RJ; Price T, 2011, 'Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab', Annals of Oncology, 22, pp. 1834 - 1838
    Journal articles | 2011
    Webber K; Cooper A; Kleiven H; Yip D; Goldstein D, 2011, 'Management of metastatic renal cell carcinoma in the era of targeted therapies', Internal Medicine Journal, 41, pp. 594 - 605
    Journal articles | 2011
    Webber K; Mok K; Bennett BK; Juraskova I; Goldstein D; Friedlander M; Lloyd AR; FOLCAN study group , 2011, 'Cancer-related fatigue and sexual functioning in women with early breast cancer: Is there a link?', J Clin Oncol, 29, pp. 9072, http://www.ncbi.nlm.nih.gov/pubmed/28021533
    Journal articles | 2011
    Webber K; Mok K; Bennett BK; Lloyd AR; Friedlander M; Juraskova I; Goldstein D, 2011, 'If I Am in the Mood, I Enjoy It: an exploration of cancer-related fatigue and sexual functioning in women with breast cancer', Oncologist, 16, pp. 1333 - 1344
    Journal articles | 2011
    Wirth A; Grigg A; Wolf M; Goldstein D; Johnson C; Davis S; Dutu G; Kypreos P; Smith C; Kneebone A; Herzberg M; Joseph D; Catalano J; Roos DE; Stone J; Reynolds J, 2011, 'Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group', Leukemia and Lymphoma, 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155
    Journal articles | 2011
    Yang JL; DasGupta R; Hopkins A; Luk F; Goldstein D; Crowe P, 2011, 'Significance of IGF-1R and Its signaling pathways in human sarcoma', CANCER RESEARCH, 71, http://dx.doi.org/10.1158/1538-7445.AM2011-4416
    Journal articles | 2011
    Zhi J; Major P; Chen E; Burns I; Robinson B; McKendrick J; Rittweger K; Abt M; Goldstein D, 2011, 'A multi-centre, randomised, open-lable study to assess the steady state paramacokinetics of Bevacizumab given with either Xeloda or FOLFOX-4 in patient with metastatic colorectal cancer', Cancer Chemotherapy and Pharmacology, 68, pp. 1199 - 1206
    Journal articles | 2010
    Blinman P; Duric V; Nowak A; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler M, 2010, 'Adjuvant chemotherapy for early colon cancer: what survival benefits make it worthwhile?', European Journal of Cancer, 46, pp. 1800 - 1807
    Journal articles | 2010
    Butow PN; Sze M; Dugal-beri P; Mikhail M; Eisenbruch M; Jefford M; Schofield P; Girgis A; king M; Goldstein D, 2010, 'From inside the bubble: Migrants' perceptions of communication with the cancer tea', Supportive Care in Cancer, 19, pp. 281 - 290
    Journal articles | 2010
    Chua YJ; Michael M; Zalcberg JR; Hicks RJ; Goldstein D; Liauw W; Price T, 2010, 'Antitumor effect of somatostatin analogs in neuroendocrine tumors', Journal of Clinical Oncology, 28, http://dx.doi.org/10.1200/JCO.2009.26.0612
    Journal articles | 2010
    Goldstein D; Ackland S; Van Hazel GA; Jefford M; Shannon JF; Gainford M; Brown C; Abdi E; Miller D; Gebski V; Tebbutt N, 2010, 'Optimising the benefit: a phase II trial of Gemcitabine in fixed dose rate infusion combined with Cisplatin in patients with inoperable biliary tract carcinomas', Cancer Chemotherapy and Pharmacology
    Journal articles | 2010
    Goldstein D; Butow PN; Boyle F; Stockler M; Lovell M; Chye R; Forder P; Briganti E, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain', Journal of Pain and Symptom Management, 49, pp. 49 - 59
    Journal articles | 2010
    Goldstein D; Gill A; Chou A; Vilain R; Clarkson A; Lui M; Jin R; Tobias VH; Samral J; Smith C; Sioson L; Parker N; Smith R; Sywak M; Wyatt S; Robinson B; Eckstein R; Benn D; Clifton-bligh R, 2010, 'Immunohistochemistry for SDHB divides gastrointestinal stromal tumours (GISTs) into two distinct types', American Journal of Surgical Pathology, 34, pp. 636 - 644
    Journal articles | 2010
    Goldstein D; Harris C; Harris C, 2010, 'Tamoxifen use in retroperitoneal fibrosis, case report and review of the literature', Internal Medicine Journal, 40, pp. e5 - e7
    Journal articles | 2010
    Goldstein D; Underhill CR; Olver IN; Kosczwara ; Kay F; Franca M, 2010, 'Reaching Further with Online Education? The Development of an Effective Online Program in Palliative Oncology', Journal of Cancer Education, 25, pp. 317 - 323
    Journal articles | 2010
    Harris C; Goldstein D, 2010, 'Tamoxifen use in retroperitoneal fibrosis.', Intern Med J, 40, pp. e5 - e7, http://dx.doi.org/10.1111/j.1445-5994.2010.02373.x
    Journal articles | 2010
    Klumpen H; Eechoute K; Hertzberg MS; Schwarer AA; Goldstein D; Hughes TP; Liddle C; Mathijssen R; Schellens JH; Gurney H, 2010, 'Pharmacogenetic factors predicting the need for a higher dose of imatinib.', Journal of Clinical Oncology, 28, pp. 3098 - 3098, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3098
    Journal articles | 2010
    Lovell MR; Forder PM; Stockler MR; Butow P; Briganti EM; Chye R; Goldstein D; Boyle FM, 2010, 'A randomized controlled trial of a standardized educational intervention for patients with cancer pain', Journal of Pain and Symptom Management, 40, pp. 49 - 59, http://dx.doi.org/10.1016/j.jpainsymman.2009.12.013
    Journal articles | 2010
    Neoptolemos J; stocken D; bassi C; Goldstein D, 2010, 'Adjuvant chemotherapy with flurouracil plus folinic acid vs gemcitabine following pancreatic cancer resection:a randomsied trial JAMA 2010', JAMA - Journal of the American Medical Association, 304, pp. 1073 - 1081
    Journal articles | 2010
    Ngan S; Fisher R; Goldstein D; Solomon M; Burmeister B; Ackland SP; Joseph DJ; McClure B; McLachlan S; Mackay J, 2010, 'A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS).', Journal of Clinical Oncology, 28, pp. 3509 - 3509, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3509
    Journal articles | 2010
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2010, '5. A novel biomarker of axonal dysfunction in oxaliplatin-induced neurotoxicity', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.025
    Journal articles | 2010
    Rossleigh MA; Goldstein D, 2010, 'Treatment of Fluorouracil-Refractory Patients with Liver Metastases from Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, 27, pp. 4089 - 4095
    Journal articles | 2010
    Seth D; D'Souza el-Guindy NB; Apte MV; Mari M; Dooley S; Neumann M; Haber P; Kundu S; Darwanto A; De villiers WJ; Vonlaufen A; Xu Z; Phillips P; Yang S; Goldstein D; Pirola RM; Wilson JS; Moles A; Fernandez A; Colell A; Garcia-ruiz C; Fernandez-checa JC; Meyer C; Meindl-beinker N, 2010, 'Alcohol, signaling, and ECM turnover', Alcoholism : Clinical and Experimental Research, 34, pp. 4 - 18, http://dx.doi.org/10.1111/j.1530-0277.2009.01060.x
    Journal articles | 2010
    Tebbutt NC; Kotasek D; Burris HA; Schwartzberg LS; Hurwitz H; Stephenson J; Adewoye H; Sun Y; Ye Y; Goldstein D, 2010, 'Motesanib with or without panitumumab (pmab) plus FOLFIRI or FOLFOX for the treatment of metastatic colorectal cancer (mCRC).', Journal of Clinical Oncology, 28, pp. 3538 - 3538, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.3538
    Journal articles | 2010
    Tebbutt NC; Wilson K; Gebski VJ; Cummins MM; Zannino D; Van Hazel GA; Robinson B; Broad A; Ganju V; Ackland SP; Forgeson G; Cunningham D; Saunders MP; Stockler MR; Chua Y; Zalcberg JR; Simes RJ; Price TJ; Coates A; O'Connell D; Brown C; Hague W; France A; Hicks S; James R; Masson R; O'Connell R; Pike R; Shoulder J; Stevens L; Tunney V; Vachan B; Wong N; Ackland S; Moylan E; Strickland A; Abdi E; Ransom D; Lowenthal R; Marx G; Nayagam SS; Shannon J; Goldstein D; Karapetis C; Blum R; Eek R; Ward R; Pavlakis N; Wilcken N; Burns I; Wyld D; Underhill C; Claringbold P; Liauw W; Clingan P; Jefford M; Horvath L; McKendrick J; Chong G; Boyce A; Cassidy J; Kirsten F; Clarke S; Guo Y; Innes-Rowe J; Smith A; Williams J; Tournier E; Maliepaard S; Vitullo E; Humm G; Nguyen V; Midolo P; Chorlton C; McDonald L; Oliver L; Sjursen AM; Inglis C; Marafioti T; McCourt J; Howard J; Richards A; Provis A; Rundle A; Whatman A; Emmett L; Raymond B; Byrne S; Withers E; Campbell J; Hodgkins C; Szwajcer M; Parker S; Welby S; Page F; Corker M; Wykes R; Goss C; Whitney S; Oates J, 2010, 'Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study', Journal of Clinical Oncology, 28, pp. 3191 - 3198, http://dx.doi.org/10.1200/JCO.2009.27.7723
    Journal articles | 2010
    Webber K; Goldstein D; Bennett BK; Boyle FM; De Souza PL; Wilcken N; Friedlander M; Lloyd AR, 2010, 'Influence of fatigue after breast cancer adjuvant theraphy on health care utilization and percieved needs', JOURNAL OF CLINICAL ONCOLOGY, 28, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.9047
    Journal articles | 2010
    Wolf M; Kneebone AB; Goldstein D; Joseph D; Wirth A; Grigg A; Johnson C; Davis S, 2010, 'Risk and Response Adapted Therapy for Early Stage Hodgkin Lymphoma: A Prospective Multi-Centre Study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group', Leukemia and Lymphoma, 52, pp. 786 - 795, http://dx.doi.org/10.3109/10428194.2010.547155
    Journal articles | 2010
    Xu ZH; Vonlaufen A; Phillips PA; Fiala-Beer E; Zhang X; Yang L; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer metastasis', American Journal of Pathology, 177, pp. 2585 - 2596, http://linkinghub.elsevier.com/retrieve/pii/S0002-9440(10)60308-2
    Journal articles | 2009
    Chua W; Goldstein D; Dhillon H; Mitchell P; Clarke SJ; Iacopetta BJ; Lee CK; Michael M, 2009, 'Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer', British Journal of Cancer, 101, pp. 998 - 1004, http://dx.doi.org/10.1038/sj.bjc.6605239
    Journal articles | 2009
    Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, 45, pp. 393 - 399
    Journal articles | 2009
    Girgis A; Hansen V; Goldstein D, 2009, 'Are Australian oncology health professionals burning out? A view from the trenches', European Journal of Cancer, 45, pp. 393 - 399
    Journal articles | 2009
    Goldstein D; Van Hazel GA; Pavlakis N, 2009, 'Treatment of 5-Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy', Journal of Clinical Oncology, 27, pp. 4085 - 4095
    Journal articles | 2009
    Goldstein D; van Hazel G; Selva-Nayagam S; Ackland S; Shapiro J; Carroll S; Cummins M; Brown C; Simes RJ; Spry N, 2009, 'GOFURTGO trial (GFG): An AGITG multicenter phase II study of fixed dose rate gemcitabine-oxaliplatin (Gem-Ox) integrated with concomitant 5FU and 3-D conformal radiotherapy (5FU-3DRT) for the treatment of locally advanced pancreatic cancer (LAPC).', J Clin Oncol, 27, pp. 4616, http://www.ncbi.nlm.nih.gov/pubmed/27964183
    Journal articles | 2009
    Lee CK; Hadley A; Desilva K; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis', World Journal of Surgical Oncology, 7, pp. 1 - 4
    Journal articles | 2009
    Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.lba4505
    Journal articles | 2009
    Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.18_suppl.lba4505
    Journal articles | 2009
    Neoptolemos J; Büchler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', Journal of Clinical Oncology, 27, pp. LBA4505 - LBA4505, http://dx.doi.org/10.1200/jco.2009.27.18s.lba4505
    Journal articles | 2009
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC, 2009, 'Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity', Journal of clinical oncology - official journal of the American Society of Clinical Oncology, 27, pp. 1243 - 1249
    Journal articles | 2009
    Park SB; Lin CS-Y; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced Lhermitte’s phenomenon as a manifestation of severe generalized nerve dysfunction', Oncology, 77, pp. 342 - 348
    Journal articles | 2009
    Park SB; Lin CS; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2009, 'Oxaliplatin-induced neurotoxicity: Changes in axonal excitability precede development of neuropathy', Brain, 132, pp. 2712 - 2723
    Journal articles | 2009
    Phillips P; Chow MW; Vonlaufen A; Xu Z; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression.', CANCER RESEARCH, 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2009
    Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', CANCER RESEARCH, 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209702804197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2009
    Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'S1820 Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', Gastroenterology, 136, pp. A - 277, http://dx.doi.org/10.1016/s0016-5085(09)61262-2
    Journal articles | 2009
    Pranavan G; Goldstein D; Yip D, 2009, 'Response of Carney`s triad-related metastatic gastrointestinal stromal tumor to sunitinib', Asia-Pacific Journal of Clinical Oncology, 4, pp. 170 - 174
    Journal articles | 2009
    Steer C; Marx GM; Singhal N; Mcjannett M; Prowse R; Goldstein D, 2009, 'Cancer in the older adult: a tale of two disciplines', Journal of Internal Medicine, 39, pp. 771 - 775
    Journal articles | 2009
    Tan TH; Hemmings C; Stafford-bell M; Robson S; Goldstein D; Yip D, 2009, 'The successful management of two pregnancies with wild type metastatic gastrointestinal stromal tumors', Asia-Pacific Journal of Clinical Oncology, 5, pp. 187 - 192
    Journal articles | 2009
    Torda AJ, 2009, 'Response', Journal of Bioethical Inquiry, 6, pp. 257 - 258
    Journal articles | 2009
    Underhill CR; Bartel R; Goldstein D; Snodgrass H; Begbie S; Yates P; White K; Jong K; Grogan P, 2009, 'Mapping oncology services in regional and rural Australia', Australian Journal of Rural Health, 17, pp. 321 - 329, http://dx.doi.org/10.1111/j.1440-1584.2009.01106.x
    Journal articles | 2009
    Xu Z; Phillips PA; Vonlaufen A; Fiala-Beer E; Yang L; Biankin A; Goldstein D; Pirola R; Wilson J; Apte M, 2009, 'Normal Pancreatic Stellate Cells Facilitate Pancreatic Cancer Progression, Exhibit Transendothelial Migration and Accompany Cancer Cells to Distant Metastatic Sites', PANCREAS, 38, pp. 1062 - 1062, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000271225300403&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2009
    Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2009, 'WITHDRAWN: Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online)
    Journal articles | 2009
    Lee CK; Hadley A; Desilva K; Smith G; Goldstein D, 2009, 'When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis.', , http://dx.doi.org/10.1186/1477-7819-7-8
    Journal articles | 2008
    Alvaro F; Young A; Goldstein D; Thomas D; McJannett M; Dillon R, 2008, 'Clinical oncological society of Australia: Adolescent and young adult cancer forum', Cancer Forum, 32, pp. 116 - 119
    Journal articles | 2008
    Blinman PL; Duric VM; Nowak AK; Beale P; Clarke SJ; Briscoe K; Boyce A; Goldstein D; Hudson M; Stockler MR, 2008, 'Patients' preferences for adjuvant chemotherapy (ACT) in early colon cancer (ECC): What makes it worthwhile?', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.4050
    Journal articles | 2008
    Goldstein D; Bennett B; Cameron B; Boyle F; DeSouza P; Wilcken N; Friedlander M; Scott E; Hickie I; Lloyd AAM, 2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters', JOURNAL OF CLINICAL ONCOLOGY, 26, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.9596
    Journal articles | 2008
    Lin CS-Y; Krishnan A; Goldstein D; Friedlander M; Kiernan M, 2008, '457: Sensory nerve excitability in cancer patients treated with oxaliplatin', Journal of Clinical Neuroscience, 15, pp. 362 - 362, http://dx.doi.org/10.1016/j.jocn.2007.07.067
    Journal articles | 2008
    Park SB; Krishnan AV; Lin CS; Goldstein D; Friedlander ML; Kiernan MC, 2008, 'Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies', Current Medicinal Chemistry: Cardiovascular and Hematological Agents, 15, pp. 3081 - 3094
    Journal articles | 2008
    Park SB; Lin CS-Y; Krishnan AV; Friedlander M; Goldstein D; Kiernan MC, 2008, 'Oxaliplatin-induced chronic changes in sensory nerve excitability', Clinical Neurophysiology, 119, pp. e22 - e22, http://dx.doi.org/10.1016/j.clinph.2007.10.044
    Journal articles | 2008
    Shepherd LM; Goldstein D; Olver IN; Parle MD, 2008, 'Enhancing psychosocial care for people with cancer in rural communities: what can remote counselling offer?', Australian Health Review, 32, pp. 423 - 438
    Journal articles | 2008
    Spry N; Macleod C; Borg M; Ngan SY; Millar J; Graham PH; Zissiadis Y; Kneebone AB; Carroll SL; Davies T; Reece W; Iacopetta BJ; Goldstein D; Harvey JE, 2008, '3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: Factors influencing outcome', International Journal of Radiation Oncology and Biology Physics, 70, pp. 1438 - 1446, http://dx.doi.org/10.1016/j.ijrobp.2007.08.070
    Journal articles | 2008
    Underhill CR; Goldstein D; Gorbounova VA; Biakhov MY, 2008, 'Randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-Modulated 5-FU plus Irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', Oncology, 73, pp. 9 - 20
    Journal articles | 2008
    Vonlaufen A; Phillips PA; Xu ZH; Goldstein D; Pirola RC; Wilson JS; Apte MV, 2008, 'Lending a helping hand: Role of pancreatic stellate in pancreatic cancer', Cancer Research, 68, pp. 7707 - 7710
    Journal articles | 2007
    Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135
    Journal articles | 2007
    Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135
    Journal articles | 2007
    Butow PN; Eisenbruch M; Goldstein D; Duggal-Beri P; Jefford M; Schofield P; Girgis A; King M, 2007, 'Unmet needs in Chinese, Greek and arabic speaking cancer patients in Australia', PSYCHO-ONCOLOGY, 16, pp. S77 - S78, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000249687400142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 2007
    Clarke S; Goldstein D; Mitchell P; Michael M; Beale P; Friedlander ML, 2007, 'Modification of leucovorin dose within a simplified FOLFOX regimen improves tolerability without compromising efficacy', Clinical Colorectal Cancer, 6, pp. 578 - 582
    Journal articles | 2007
    Goldstein D; Shannon J; Brown C; Tebbutt N; Ackland S; Van Hazel G; Abdi E; Jefford M; Gainford MC; Adams K, 2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', Journal of Clinical Oncology, 25, pp. 15015 - 15015, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15015
    Journal articles | 2007
    Goldstein D; Underhill C, 2007, 'Regional cancer services in Australia: Some evidence of improvement but a long way to go', Cancer Forum, 31, pp. 67 - 69
    Journal articles | 2007
    Leighl NB; Shepherd H; Butow P; Clarke SJ; McJannett M; Beale P; Wilcken N; Moore MJ; Chen EX; Tattersall MH; Goldstein D, 2007, 'When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer', Journal of Clinical Oncology, 25, pp. 6509 - 6509, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.6509
    Journal articles | 2007
    Ngan S; Fisher R; Mackay J; Solomon M; Burmeister B; Goldstein D; Schache D; Joseph D; Ackland S; McClure B, 2007, 'Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: a Trans-Tasman Radiation Oncology Group trial (TROG 01.04)', EJC SUPPLEMENTS, 5, pp. 237 - 237, http://dx.doi.org/10.1016/S1359-6349(07)70936-9
    Journal articles | 2007
    Schwartzberg LS; Hurwitz H; Stephenson J; Kotasek D; Goldstein D; Tebbutt N; McGreivy J; Sun Y; Yang L; Burris H, 2007, 'Safety and pharmacokinetics (PK) of AMG 706 with panitumumab plus FOLFIRI or FOLFOX for the treatment of patients (pts) with metastatic colorectal cancer (mCRC)', Journal of Clinical Oncology, 25, pp. 4081 - 4081, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.4081
    Journal articles | 2007
    Stockler MR; O'Connell R; Nowak AK; Goldstein D; Turner J; Wilcken NR; Wyld D; Abdi EA; Glasgow A; Beale PJ; Jefford M; Dhillon H; Heritier S; Carter C; Hickie IB; Simes RJ, 2007, 'Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial', Lancet Oncology, 8, pp. 603 - 612, http://dx.doi.org/10.1016/S1470-2045(07)70148-1
    Journal articles | 2007
    Wilcken NR; Goldstein D; Nowak AK; Beale PJ; Jefford M; Dhillon H; O'Connell R; Heritier S; Simes RJ; Stockler M, 2007, 'A placebo-controlled trial of Sertraline's effects on symptoms, well-being and survival in advanced cancer: The ZEST Trial', Journal of Clinical Oncology, 25, pp. 9002 - 9002, http://dx.doi.org/10.1200/jco.2007.25.18_suppl.9002
    Journal articles | 2007
    Yang JL; Qu XJ; Hayes V; Brenner PC; Russell PJ; Goldstein D, 2007, 'Erlotinib (OSI-774)-induced inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha', British Journal of Urology, 99, pp. 1539 - 1545
    Journal articles | 2006
    Barlow-Stewart K; Yeo SS; Meiser B; Goldstein D; Tucker K; Eisenbruch M, 2006, 'Towards cultural competence in cancer genetic counselling and genetics education: lessons learned from Chinese-Australians', Genetics in Medicine, 8, pp. 24 - 32
    Journal articles | 2006
    Dalton L; Luxford K; Boyle F; Goldstein D; Underhill CR; Yates P, 2006, 'An Educational Workshop Program for Rural Practitioners to Encourage Best practice for Delivery of Systemic Adjuvant Therapy', Journal of Cancer Education, 21, pp. 35 - 39
    Journal articles | 2006
    Goldstein D; Ackland S; Bell DR; Olver IN; Davis ID; Rosenthal M; Toner GC; Pinel MC; Byrne M, 2006, 'Phase II study of vinflunine in patients with metastatic renal cell carcinoma', Investigational New Drugs, 24, pp. 429 - 434
    Journal articles | 2006
    Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240
    Journal articles | 2006
    Goldstein D; Spry N; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Australia EL, 2006, 'Combined modality therapy for pancreatic carcinoma: An Australian Pancreatic Cancer Group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI 5FU) and 3D conformal radiotherapy (RT)-Final outcomes.', J Clin Oncol, 24, pp. 4104, http://www.ncbi.nlm.nih.gov/pubmed/27953934
    Journal articles | 2006
    Grimison PS; T Chin M; Harrison ML; Goldstein D; Chin M, 2006, 'Primary pancreatic lymphoma - pancreatic tumours that are potentially curable without resection, a retrospective review of four cases', BMC Cancer, 6, pp. 117, http://dx.doi.org/10.1186/1471-2407-6-117
    Journal articles | 2006
    Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, 36, pp. 367 - 377
    Journal articles | 2006
    Harrison ML; Goldstein D, 2006, 'Management of metastatic gastrointestinal stromal tumour in the Glivec era: a practical case-based approach', Internal Medicine Journal, 36, pp. 367 - 377
    Journal articles | 2006
    Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2006, 'Oxaliplatin and axonal Na+ channel function in vivo', Clinical Cancer Research, 12, pp. 4481 - 4484
    Journal articles | 2006
    Mitchell P; Goldstein D; Beale P; Friedlander ML; Zalcberg J; White S; Thomson JA; Clarke S; Michael M, 2006, 'Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity', Clinical Colorectal Cancer, 6, pp. 146 - 151
    Journal articles | 2006
    Mok KW; Goldstein D, 2006, 'Hypersensitivity reactions to oxaliplatin: Can patients be rechallenged?', Asia-Pacific Journal of Clinical Oncology, 2, pp. 175 - 179, http://dx.doi.org/10.1111/j.1743-7563.2006.00066.x
    Journal articles | 2006
    Shepherd LM; Goldstein D; Whitford H; Thewes B; Brummell V; Hicks M, 2006, 'The Utility of Videoconferencing to Provide Innovative Delivery of Psychological Treatment for Rural Cancer Patients: Results of a Pilot Study', Journal of Pain and Symptom Management, 32, pp. 453 - 461
    Journal articles | 2006
    Stockler MR; Heritier S; Nowak AK; Goldstein D; Turner J; Jefford M; Glasgow A; Abdi E; Beale PJ; Carter C, 2006, 'The time taken to complete quality of life questionnaires in an advanced cancer trial', Journal of Clinical Oncology, 24, pp. 8592 - 8592, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.8592
    Journal articles | 2006
    Tebbutt N; Gebski V; Strickland A; Gibbs D; Walpole E; Ganju V; Goldstein D; Munro S; Harrod M; Van Hazel G, 2006, 'Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer', Journal of Clinical Oncology, 24, pp. 4067 - 4067, http://dx.doi.org/10.1200/jco.2006.24.18_suppl.4067
    Journal articles | 2006
    Underhill CR; Goldstein D; Grogan PB, 2006, 'Inequity in rural cancer survival in Australia is not an insurmountable problem', Medical Journal of Australia, 6, pp. 479 - 480
    Journal articles | 2006
    Yip D; Karapetis C; Strickland A; Steer CB; Goldstein D, 2006, 'Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer.', Cochrane database of systematic reviews (Online), 3
    Journal articles | 2006
    Yip D; Karapetis C; Strickland C; Steer C; Goldstein D, 2006, 'Chemotherapy and radiotherapy for pancreatic cancer', Cochrane Database of Systematic Reviews, 4
    Journal articles | 2005
    Burmeister B; Smithers M; Gebski V; Denham J; Devitt P; Ackland S; Findlay M; Dhillon H; Stockler M; Coates A; Matthews J; Simes J; Beller E; Fitzgerald L; Gray E; Dodds H; Marks P; Hayden P; Erratt A; Monro C; Pike R; Walpole E; Gotley D; Thomson D; Harvey J; Martin I; Burmeister E; Jamieson G; Borg M; Yeoh E; Olver I; Caruso D; Game P; Joseph D; Spry N; Minchin D; Cameron F; Faulkner K; Einhorn S; Dewar J; Gillies J; Johnson C; Kilmurray J; Neely M; Carmody M; Mackintosh J; Millar J; O'Brien P; Schwartz M; Smith R; Woods S; Nathanson L; O'Loughlin B; Grimes D; Cheuk R; Dickie G; Keller J; Archer S; Bayliss E; Gray B; Trotter J; Ransom D; Shepherd J; Stone C; Thompson I; Guiney M; Henderson M; Thomas R; Kian M; Ngan S; Rischin D; Walcher V; Zalcberg J; North J; Costello S; Perez D; Whitely D; Wyllie A; Avramovic J; Donnolly P; Fon P; Collins M; McIntosh R; Melville P; Bell R; Kirrof G; Harris I; McLennan R; Monro W; Aroney R; Falconer K; Cullingford G; Davidson A; Randell C; Berry M; Delaney G; Moylan E; Burns D; Goldstein D; Zissiadis M, 2005, 'Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial', Lancet Oncology, 6, pp. 659 - 668, http://dx.doi.org/10.1016/S1470-2045(05)70288-6
    Journal articles | 2005
    Glabbeke M; Verweij J; Casali P; Le Cesne A; Hohenberger P; Ray-Coquard I; Goldstein D; Schlemmer M; Van Oosterom AT; Sciot R; Hogendoorn P; Brown M; Bertulli R; Judson I, 2005, 'Initial and Late Resistance to Imatinib in Advanced Gastrointestinal Stromal Tumors Are Predicted by Different Prognostic Factors: A Eurpoean Organisation for Research and Treatment of Cancer etc.', Journal of Clinical Oncology, 23, pp. 5795 - 5804
    Journal articles | 2005
    Goldstein D; Grimpen F; Yip D; McArthur G; Waring P; Loughrey M; Beshay V; Chong G, 2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, 6, pp. 724 - 727
    Journal articles | 2005
    Goldstein D; Mitchell P; Friedlander ML; Michael M; Beale P; Zalcberg JR; White S; Clarke SJ, 2005, 'Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients', British Journal of Cancer, 92, pp. 832 - 837, http://dx.doi.org/10.1038/sj.bjc.6602426
    Journal articles | 2005
    Goldstein D; Tan BS; Rossleigh MA; Haindl W; Walker BM; Dixon J, 2005, 'Gastrointestinal Stromal Tumours: Correlation of 18F-FDG Gamma Camera-Based Coincidence Positron Emission tomography with CT for the Assessment of Treatment Response - An AGITG Study', Oncology, 69, pp. 326 - 332
    Journal articles | 2005
    Goldstein D; Taylor JL; Marx G, 2005, 'Outpatient treatment with subcutaneous interleukin-2, interferon alpha and fluorouracil in patients with metastatic renal cancer: an Australian experience', Internal Medicine Journal, 35, pp. 34 - 38, http://dx.doi.org/10.1111/j.1445-5994.2004.00749.x
    Journal articles | 2005
    Goldstein D; van Hazel G; Pavlakis N; Olver I, 2005, 'Selective Internal Radiation Therapy (SIRT) plus systemic chemotherapy with Irinotecan. A phase I dose escalation study', Journal of Clinical Oncology, 23, pp. 3701 - 3701, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3701
    Journal articles | 2005
    Goldstein D, 2005, 'The role of chemotherapy in the treatment of pancreatic carcinoma', Australian Prescriber, 28, pp. 42 - 44
    Journal articles | 2005
    Grimison P; Goldstein D; Schneeweiss J; Murray N, 2005, 'Corticosteroid-responsive interstitial pneumonitis related to imantinib mesylate with successful rechallenge, and potential causative mechanisms', Internal Medicine Journal, 35, pp. 136 - 137, http://dx.doi.org/10.1111/j.1445-5994.2004.00757.x
    Journal articles | 2005
    Grimison P; Goldstein D; Yeo B, 2005, 'Editor's quiz: GI snapshot. An unusual abdominal mass', Gut, 54, http://dx.doi.org/10.1136/gut.2004.051342
    Journal articles | 2005
    Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2005, 'Oxaliplatin-induced neurotoxicity and the development of neuropathy', Muscle and Nerve, 32, pp. 51 - 60
    Journal articles | 2005
    Meiser B; Yeo SS; Barlow-Stewart K; Goldstein D; Tucker K; Eisenbruch M, 2005, 'Understanding community beliefs of Chinese-Australians about cancer: Initial insights using an ethnographic approach', Psycho - Oncology, 14, pp. 174 - 186
    Journal articles | 2005
    Mitchell P; Goldstein D; Michael M; Beale P; Friedlander M; Zalcberg J; Clarke S; White S, 2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC)', Journal of Clinical Oncology, 23, pp. 3581 - 3581, http://dx.doi.org/10.1200/jco.2005.23.16_suppl.3581
    Journal articles | 2005
    Ngan SY; Fisher R; Burmeister B; Mackay J; Goldstein D; Kneebone AB; Schache D; Joseph D; McKendrick J; Long T; McClure B; Rischin D, 2005, 'Promising results of a cooperative group phase II trial of preoperative chemoradiation For locally advanced rectal cancer (TROG 9801)', Diseases of the Colon and Rectum, 48, pp. 1389 - 1396
    Journal articles | 2005
    Thewes B; Meiser B; Taylor AJ; Phillips KA; Pendlebury S; Capp A; Dalley D; Goldstein D; Baber R; Friedlander ML, 2005, 'Fertility - and Menoapuse-Related Information Needs of Younger Women With a Diagnosis of Early Breast Cancer', Journal of Clinical Oncology, 23, pp. 5155 - 5165
    Journal articles | 2005
    Van Glabbeke M; Verweij J; Casali PG; Le Cesne A; Hohenberger P; Ray-Coquard I; Schlemmer M; Van Oosterom AT; Goldstein D; Sciot R; Hogendoorn PCW; Brown M; Bertulli R; Judson IR, 2005, 'Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group Study', Journal of Clinical Oncology, 23, pp. 5795 - 5804, http://dx.doi.org/10.1200/JCO.2005.11.601
    Journal articles | 2005
    Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-alpha promotes the anti-proliferative effect of Erlotinib (OSI-774) on human colon cancer cell lines', Cancer Letters, 225, pp. 61 - 74
    Journal articles | 2005
    Yang JL; Qu XJ; Russell PJ; Goldstein D, 2005, 'Interferon-α promotes the anti-proliferative effect of gefitinib (ZD1839) on human colon cancer cell lines', Oncology, 69, pp. 224 - 238, http://dx.doi.org/10.1159/000088070
    Journal articles | 2005
    Yip D; Goldstein D, 2005, 'Adding irinotecan to first-line gemcitabine improves tumour response in advanced pancreatic cancer', Cancer Treatment Reviews, 31, pp. 236 - 241, http://dx.doi.org/10.1016/j.ctrv.2005.03.003
    Journal articles | 2004
    Apte MV; Wilson JS; Park S; Phillips PA; Santucci N; Goldstein D; Ramm GA; Buchler M; Friess H; Mccarroll JA; Merrett ND; Pirola RC, 2004, 'Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells', Pancreas, 29, pp. 179 - 187
    Journal articles | 2004
    Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695
    Journal articles | 2004
    Brown RF; Butow PN; Sharrock MA; Henman M; Boyle F; Goldstein D; Tattersall MHN, 2004, 'Education and role modelling for clinical decisions with female cancer patients', Health Expectations, 7, pp. 303 - 316, http://dx.doi.org/10.1111/j.1369-7625.2004.00294.x
    Journal articles | 2004
    Daly EB; Chen GW; Sun L; Friedlander ML; Goldstein D; Beer D; Chesterman CN; Hogg PJ, 2004, 'Blood level of phosphoglycerate kinase does not correlate with presenceor extent of tumor', International Journal of Biological Markers, 19, pp. 170 - 172
    Journal articles | 2004
    Goldstein D; Apte MV; Carroll SL; Keogh G, 2004, 'Modern management of pancreatic cancer', Internal Medicine Journal, 34, pp. 475 - 481
    Journal articles | 2004
    Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N; Eli Lilly Australia , 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy.', J Clin Oncol, 22, pp. 4100, http://www.ncbi.nlm.nih.gov/pubmed/28014508
    Journal articles | 2004
    Goldstein D; Van Hazel G; Underhill C; Kotasek D; Harvey J; Links M; Shapiro J; Iacopetta B; Spry N, 2004, 'Combined modality therapy for pancreatic carcinoma - An Australian Pancreatic Cancer Group study of the addition of gemcitabine to concurrent infusional 5-fluorouracil and 3D conformal radiotherapy', Journal of Clinical Oncology, 22, pp. 4100 - 4100, http://dx.doi.org/10.1200/jco.2004.22.14_suppl.4100
    Journal articles | 2004
    Hagerty RG; Butow PN; Ellis PA; Lobb EA; Pendlebury S; Leighl N; Goldstein D; Lo SK; Tattersall MH, 2004, 'Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting', Journal of Clinical Oncology, 22, pp. 1721 - 1730
    Journal articles | 2004
    Hughes B; Yip D; Goldstein D; Waring P; Beshay V; Chong G, 2004, 'Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: Case report', BMC Cancer, 4, pp. 74, http://dx.doi.org/10.1186/1471-2407-4-74
    Journal articles | 2004
    Hughes BGM; Yip D; Chao M; Gibbs P; Carroll S; Goldstein D; Burmeister B; Karapetis C, 2004, 'Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: An Australian multicentre experience', ANZ Journal of Surgery, 74, pp. 951 - 956, http://dx.doi.org/10.1111/j.1445-1433.2004.03218.x
    Journal articles | 2004
    Jong KE; Smith DP; Yu XQ; O Connell DL; Goldstein D; Armstrong BK, 2004, 'Remoteness of residence and survival from cancer in New South Wales', Medical Journal of Australia, 180, pp. 618 - 622
    Journal articles | 2004
    Loi S; Goldstein D; Clezy KR; Milliken ST; Hoy JF; Chipman M, 2004, 'Castleman`s disease and HIV infection in Australia', HIV Medicine, 5, pp. 157 - 162
    Journal articles | 2004
    Qu XJ; Yang JL; Russell PJ; Goldstein D, 2004, 'Change in epidermal growth factor receptor expression in human bladdercancer cell lines following interferon-alpha treatment', Journal of Urology, 172, pp. 733 - 738
    Journal articles | 2004
    Robotin M; Law MG; Milliken ST; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE, 2004, 'Clinical features and predictors of survival of AIDS-related non-Hodgkin`s lymphoma in a population-based case series in Sydney, Australia', HIV Medicine, 5, pp. 377 - 384
    Journal articles | 2004
    Yang JL; Qu XJ; Russell PJ; Goldstein D, 2004, 'Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha', Gut, 53, pp. 123 - 129
    Journal articles | 2003
    Eisenbruch IM; Yeo SS; Meiser B; Goldstein D; Tucker K; Barlow-Stewart K, 2003, 'Optimising clinical practice in cancer genetics with cultural competence: lessons to be learned from ethnographic research with Chinese-Australians', Social Science and Medicine, 59, pp. 235 - 248
    Journal articles | 2003
    Ngan SY; Fisher R; Burmeister B; Rischin D; Mackay J; Kneebone A; Joseph D; McKendrick J; Goldstein D; McClure B; Lim Joon D, 2003, 'Delayed relapse following preoperative chemoradiation and surgery for rectal cancer', International Journal of Radiation Oncology*Biology*Physics, 57, pp. S220 - S220, http://dx.doi.org/10.1016/s0360-3016(03)01035-6
    Journal articles | 2003
    Ngan SYK; Goldstein D; Solomon M; Zalcberg J; Meagher AP; Ward RL, 2003, 'Is improving local control sufficient indication for radiotherapy in the management of rectal cancer? A response [1] (multiple letters)', ANZ Journal of Surgery, 73, pp. 660 - 661, http://dx.doi.org/10.1046/j.1445-2197.2003.t01-1-02719.x
    Journal articles | 2003
    Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403
    Journal articles | 2003
    Shannon JF; Mackenzie-Wood AR; Wood G; Goldstein D, 2003, 'Cicatricial pemphigoid in non-Hodgkin`s lymphoma', Internal Medicine Journal, 33, pp. 396 - 397
    Journal articles | 2002
    Goldstein D; Thewes B; Butow P, 2002, 'Communicating in a multicultural society II: Greek community attitudes towards cancer in Australia', Internal Medicine Journal, 32, pp. 289 - 296
    Journal articles | 2002
    Harrison ML; Goldstein D, 2002, 'Prolonged survival in a patient with an occult small-cell lung cancer and a solitary brain metastasis at diagnosis', Internal Medicine Journal, 32, pp. 621 - 622
    Journal articles | 2002
    Marx GM; Boyce A; Goldstein D, 2002, 'Elevated alpha-foetoprotein and hepatic metastases - it`s not always what it seems!', Annals of Oncology, 13, pp. 167 - 169
    Journal articles | 2002
    Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'Alpha-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162
    Journal articles | 2002
    Wong M; Goldstein D; Woo H; Testa G; Gurney H, 2002, 'α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma', Internal Medicine Journal, 32, pp. 158 - 162, http://dx.doi.org/10.1046/j.1444-0903.2001.00184.x
    Journal articles | 2001
    Boyer MJ; Mitchell P; Goldstein D; Millward MJ; Olver IN; Clarke SJ; Richardson GD; Davis I, 2001, 'Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer', Lung Cancer, pp. 89 - 94
    Journal articles | 2001
    Eisenbruch IM; Barlow-Stewart K; Tucker K; Steel ZP; Goldstein D; Meiser B, 2001, 'Cultural aspects of cancer genetics: setting a research agenda', Journal of Medical Genetics, pp. 425 - 429
    Journal articles | 2001
    Goldstein D; Margo J, 2001, 'Cancer in the bush - Optimising clinical services', Cancer Forum, 25, pp. 121 - 125
    Journal articles | 2001
    Ngan S; Burmeister B; Fisher R; Rischin D; Schache D; Kneebone A; Mackay J; Joseph D; Bell A; Goldstein D, 2001, 'Early Toxicity from Preoperative Radiotherapy with Continuous Infusion 5-Fluorouracil for Resectable Adenocarcinoma of the Rectum: A Phase II Trial for the Trans-Tasman Radiation', International Journal of Radiation Oncology and Biology Physics, pp. 883 - 887
    Journal articles | 2000
    Herz H; Cooke B; Goldstein D, 2000, 'Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature', Annals of Oncology, 11, pp. 1343 - 1347, http://dx.doi.org/10.1023/A:1008387800525
    Journal articles | 2000
    Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; Mackay JR; Joseph DJ; Bell A; Goldstein D, 2000, 'A phase II trial of preoperative radiotherapy with protracted infusion 5-fluorouracil for resectable adenocarcinoma of rectum. A multi-center trial for the Trans-Tasman Radiation Oncology Group', International Journal of Radiation Oncology*Biology*Physics, 48, pp. 119 - 120, http://dx.doi.org/10.1016/s0360-3016(00)80035-8
    Journal articles | 1999
    Bishop JF; Dewar J; Toner GC; Smith J; Tattersall MHN; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J; Canetta R, 1999, 'Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer', Journal of Clinical Oncology, 17, pp. 2355 - 2364, http://dx.doi.org/10.1200/jco.1999.17.8.2355
    Journal articles | 1999
    Huang X; Butow PN; Meiser B; Goldstein D, 1999, 'Attitudes and information needs of Chinese migrant cancer patients and their relatives', Australian and New Zealand Journal of Medicine, 29, pp. 207 - 213, http://dx.doi.org/10.1111/j.1445-5994.1999.tb00685.x
    Journal articles | 1998
    Davis AJ; Goldstein D; Milliken S, 1998, 'Long term follow-up of CEOP in the treatment of HIV related non- Hodgkin's lymphoma (NHL)', Australian and New Zealand Journal of Medicine, 28, pp. 28 - 32, http://dx.doi.org/10.1111/j.1445-5994.1998.tb04455.x
    Journal articles | 1998
    Goldstein D; Hertzog P; Tomkinson E; Couldwell D; Mccarville S; Parrish S; Cunningham PH; Newell ME; Owens M; Cooper DA, 1998, 'Administration of imiquimod, an interferon inducer, in asymptomatic human immunodeficiency virus-infected persons to determine safety and biologic response modification', Journal of Infectious Diseases, 178, pp. 856 - 861
    Journal articles | 1998
    Newell ME; Milliken ST; Goldstein D; Lewis CR; Boyle MJ; Dolan G; Ryan S; Cooper DA; boyle , 1998, 'A phase 2 study of liposomal doxorubicin in the treatment of AIDS-related Kaposi¿s sarcoma', Australian and New Zealand Journal of Medicine, pp. 777 - 783
    Journal articles | 1997
    Bishop JF; Dewar J; Toner GC; Tattersall MH; Olver IN; Ackland S; Kennedy I; Goldstein D; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first-line treatment for metastatic breast cancer', ONCOLOGY, 11, pp. 19 - 23
    Journal articles | 1997
    Goldstein D; Bishop J; Dewar J; Tattersall MH; Smith JS; Olver IN; Ackland S; Kennedy I; Toner GC; Gurney H; Walpole E; Levi J; Stephenson J, 1997, 'Paclitaxel as first line treatment for metastatic breast cancer.', Oncology, pp. 17 - 19
    Journal articles | 1997
    Goldstein D; Butow P; Tattersall MH, 1997, 'Communication with cancer patients in culturally diverse Societies.', Annals of the New York Academy of Sciences, pp. 317 - 329
    Journal articles | 1997
    Goldstein D; Douglas JR; Penny R; Matthews JP; Laidlaw CR; Gibson K; Bradstock KF; Wolf M, 1997, 'Australian leukaemia study group myeloma II: A randomised trial of intensive combination chemotherapy with or without interferon in patients with myeloma.', British Journal Haematology, pp. 38 - 45
    Journal articles | 1997
    Goldstein D; Pillay P; Hayman J; Leydman M, 1997, 'Association of hypercalcaemia, PTHrP expression and disease progression in a woman with primary squamous cell carcinoma of the breast.', Pathologe, 29, pp. 317 - 319, http://dx.doi.org/10.1080/00313029700169195
    Journal articles | 1997
    Goldstein D; Wolley I; Collett J, 1997, 'Diffuse alveolar damage following a singel adminstration of a cyclophosphamide containing chemotherapy regimen.', Australian and New Zealand Journal of Medicine, pp. 605 - 606
    Journal articles | 1997
    Joshua D; Penny R; Matthews JP; Laidlawcr ; Gibson K; Bradstock KF; Wolf M; Goldstein D, 1997, 'Australian Leukaemia Study Group Myeloma II: a randomized trial of intensive comBination chemotherapy with or without interferon in patients with myeloma', British Journal of Haematology, pp. 38 - 45
    Journal articles | 1997
    Padiglione A; Goldstein D; Law MG; Hoy JF; Kaldor JM; Mijch AM, 1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness', Annals of Oncology, pp. 871 - 875
    Journal articles | 1996
    Boyle MJ; Goldstein DA; Frazer IH; Sculley TB, 1996, 'How HIV promotes malignancies', Medical Journal of Australia, 164, pp. 230 - 232, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94147.x
    Journal articles | 1996
    Dear AE; Goldstein D; Hayman JA, 1996, 'Malignant pulmonary lymphoid disease: Case reports illustrating anatomical pattern of disease as a prognostic marker', Pathology, 28, pp. 20 - 24, http://dx.doi.org/10.1080/00313029600169443
    Journal articles | 1996
    Goldstein D, 1996, 'HIV associated malignancies', Hematology Reviews and Communications, 9, pp. 275 - 283
    Journal articles | 1996
    Millar JL; Goldstein D; Gelmon KA, 1996, '5.14 HIV and Kaposi's sarcoma', Medical Journal of Australia, 164, pp. 539 - 542, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122167.x
    Journal articles | 1996
    Millward MJ; Bishop JF; Friedlander M; Levi JA; Goldstein D; Olver IN; Smith JG; Toner GC; Rischin D; Bell DR, 1996, 'Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancer', Journal of Clinical Oncology, 14, pp. 142 - 148, http://dx.doi.org/10.1200/JCO.1996.14.1.142
    Journal articles | 1996
    Morton J; Taylor K; Bunce I; Eliadis P; Rentoul A; Moore D; Kelly C; Wright S; Bashford J; Rodwell R; Rooney K; Mulligan S; Firkin F; Dodds A; Parkin J; Lowenthal R; Kimber R; Frost T; Grigg A; Goldstein D; Stone J; Lee N, 1996, 'High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma', British Journal of Haematology, 95, pp. 110 - 115, http://dx.doi.org/10.1046/j.1365-2141.1996.d01-1868.x
    Journal articles | 1996
    Newell M; Goldstein D; Milliken S; Lewis C; Hoy J; Thomson B; Cooper D, 1996, 'Phase I/II trial of filgrastim (r-metHuG-CSF), CEOP chemotherapy and antiretroviral therapy in HIV-related non-Hodgkin's lymphoma', Annals of Oncology, 7, pp. 1029 - 1036, http://dx.doi.org/10.1093/oxfordjournals.annonc.a010495
    Journal articles | 1996
    Stricker P; Pryor K; Nicholson T; Goldstein D; Golovsky D; Ferguson R; Nash P; Ehsman S; Rumma J; Mammen G; Penny R, 1996, 'Bacillus Calmette-Guerin plus intravesical interferon alpha-2b in patients with superficial bladder cancer', Urology, 48, pp. 957 - 962, http://dx.doi.org/10.1016/S0090-4295(96)00375-5
    Journal articles | 1996
    1996, 'Efficacy and safety of stealth liposomal doxorubicin in AIDS-related Kaposi`s sarcoma', , http://dx.doi.org/10.1038/bjc.1996.193
    Journal articles | 1995
    Dear A; Goldstein D; Salem H, 1995, 'pulmonary chronic lymphocytic leukaemia: difficulty in establishing a tissue diagnosis', European Journal of Haematology, pp. 130 - 133
    Journal articles | 1995
    Nirenberg A; Meikle GR; Goldstein D; Meikle RG, 1995, 'Metastatic carcinoma infiltrating lung mimicking BOOP', Australasian Radiology, 39, pp. 405 - 407, http://dx.doi.org/10.1111/j.1440-1673.1995.tb00323.x
    Journal articles | 1995
    Pryor K; Goddard JD; Goldstein D; Stricker PD; Russell PJ; Golovsky D; Penny R, 1995, 'Bacillus Calmette-Guerein (BCG) enhances mobocyte-and lymphocyte-mediated bladder tumour cell killilng', British Journal of Cancer, 71, pp. 801 - 807, http://dx.doi.org/10.1038/bjc.1995.155
    Journal articles | 1994
    D G; E T; D C; H G; M N; P H; M O; S M; S P; D H; D C, 1994, 'PHASE I A/B TRIAL OF IMIQUIMOD, AN ORAL INTERFERON INDUCER IN ASYMPTOMATIC HTV POSITIVE INDIVIDUALS', AIDS, 8, pp. S14 - S14, http://dx.doi.org/10.1097/00002030-199411004-00054
    Journal articles | 1994
    GOLDSTEIN D; MILLIKEN S NM; LEWIS C; HOY J; THOMSON B; DOLAN G; RYAN S; SARR A; COOPER DA, 1994, 'FILGRASTIM (r-metHuG-CSF, Amgen), CEOP AND ANTIRETROVIRAL THERAPY IN HIV- RELATED NON-HODGKINS LYMPHOMA (NHL)', AIDS, 8, pp. S46 - S46, http://dx.doi.org/10.1097/00002030-199411004-00179
    Journal articles | 1994
    Kaldor J; Elford J; Grulich A; Goldstein D, 1994, 'HIV AIDS and cancer', Cancer Forum, 18, pp. 3 - 11
    Journal articles | 1994
    Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, 161, pp. 638 - 639, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127659.x
    Journal articles | 1994
    Tindall B; Forde S; Goldsten D; Ross MW; Cooper DA, 1994, 'Sexual dysfunction in advanced HIV disease', AIDS Care, 6, pp. 105 - 107, http://dx.doi.org/10.1080/09540129408258030
    Journal articles | 1994
    Tindall B; Forde S; Ross MW; Goldstein D; Barker S; Cooper DA, 1994, 'Effects of two formats of informed consent on knowledge amongst persons with advanced HIV disease in a clinical trial of didanosine', Patient Education and Counseling, 24, pp. 261 - 266, http://dx.doi.org/10.1016/0738-3991(94)90069-8
    Journal articles | 1993
    Gibson DFC; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC, 1993, 'Human recombinant interferon-βSER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse', Breast Cancer Research and Treatment, 25, pp. 141 - 150, http://dx.doi.org/10.1007/BF00662139
    Journal articles | 1993
    Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand journal of medicine, 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x
    Journal articles | 1993
    Nolten WE; Goldstein D; Lindstrom M; Mckenna MV; Carlson IH; Trump DL; Schiller J; Borden EC; Ehrlich EN, 1993, 'Effects of Cytokines on the Pituitary–Adrenal Axis in Cancer Patients', Journal of Interferon Research, 13, pp. 349 - 357, http://dx.doi.org/10.1089/jir.1993.13.349
    Journal articles | 1993
    Tindall B; Carr A; Goldstein D; Penny R; Cooper DA, 1993, 'Administration of zidovudine during primary HIV-1 infection may be associated with a less vigorous immune response [1]', AIDS, 7, pp. 127 - 128, http://dx.doi.org/10.1097/00002030-199301000-00020
    Journal articles | 1992
    GOLDSTEIN D; KAUFMANN M, 1992, 'NOVEL APPROACHES TO THE MANAGEMENT OF GYNECOLOGIC MALIGNANCIES - CHAIRMENS PREFACE - PROCEEDINGS OF A SATELLITE SYMPOSIUM HELD IN CAIRNS, AUSTRALIA, ON 22 SEPTEMBER 1991', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2, pp. 1 - 1, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1992KF21500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1992
    Greiner JW; Guadagni F; Borden EC; Ritts RE; Goldstein D; LoBuglio AF; Schlom J, 1992, 'EVIDENCE THAT RECOMBINANT INTERFERONS CAN ENHANCE THE SENSITIVITY OF THE DETECTION OF SERUM TAG-72 AND CEA IN PATIENTS DIAGNOSED WITH ADENOCARCINOMA', Journal of Immunotherapy, 11, pp. 126 - 126, http://dx.doi.org/10.1097/00002371-199202000-00021
    Journal articles | 1992
    Greiner JW; Guadagni F; Goldstein D; Smalley RV; Borden EC; Simpson JF; Molinolo A; Schlom J, 1992, 'Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells', Journal of Clinical Oncology, 10, pp. 735 - 746
    Journal articles | 1992
    Smalley RV; Goldstein D; Bulkowski D; Hannon C; Buchler D; Knudsen C; Tuttle RL, 1992, 'A phase II study of crisnatol mesylate in patients with ovarian carcinoma', Investigational New Drugs, 10, pp. 107 - 112, http://dx.doi.org/10.1007/BF00873127
    Journal articles | 1992
    Witt PL; Goldstein D; Storer BE; Grossberg SE; Flashner M; Colby CB; Borden EC, 1992, 'Absence of Biological Effects of Orally Administered Interferon-βser', Journal of Interferon Research, 12, pp. 411 - 413, http://dx.doi.org/10.1089/jir.1992.12.411
    Journal articles | 1991
    Goldstein D; Lewis C, 1991, 'Advances in drug delivery and targeting', Current Opinion in Oncology, 3, pp. 1096 - 1104, http://dx.doi.org/10.1097/00001622-199112000-00019
    Journal articles | 1991
    Goldstein D; O'Leary M; Mitchen J; Borden EC; Wilding G, 1991, 'Effects of interferon βser and transforming growth factor β on prostatic cell lines', Journal of Urology, 146, pp. 1173 - 1177, http://dx.doi.org/10.1016/S0022-5347(17)38034-5
    Journal articles | 1991
    Greiner JW; Guadagni F; Goldstein D; Borden EC; Ritts RE; Witt P; LoBuglio AF; Saleh MN; Schlom J, 1991, 'Evidence for the Elevation of Serum Carcinoembryonic Antigen and Tumor-associated Glycoprotein-72 Levels in Patients Administered Interferons', Cancer Research, 51, pp. 4155 - 4163
    Journal articles | 1991
    Sosman JA; Hank JA; Moore KH; Borchert A; Schell K; Kohler PC; Goldstein D; Bechhofer R; Storer B; Albertini MR; Leung PE; Levitt D; Sondel PM, 1991, 'Prolonged interleukin-2 (IL-2) treatment can augment immune activation without enhancing antitumor activity in renal cell carcinom', Cancer Investigation, 9, pp. 35 - 48, http://dx.doi.org/10.3109/07357909109032798
    Journal articles | 1990
    Goldstein D; Cheuvart B; Trump DL; Shiraki M; Comis RL; Tormey DC; Harris JE; Borden EC, 1990, 'Phase II trial of carboplatin in soft-tissue sarcoma', American Journal of Clinical Oncology: Cancer Clinical Trials, 13, pp. 420 - 423, http://dx.doi.org/10.1097/00000421-199010000-00011
    Journal articles | 1990
    Laszlo J; Goldstein D; Gockerman J; Hood L; Huang AT; Triozzi P; Sedwick WD; Koren H; Ellinwood EH; Tso CY, 1990, 'Phase I studies of recombinant interferon-gamma.', J Biol Response Mod, 9, pp. 185 - 193, https://www.ncbi.nlm.nih.gov/pubmed/2160521
    Journal articles | 1990
    Robinson SP; Goldstein D; Witt PL; Borden EC; Jordan VC, 1990, 'Inhibition of hormone-dependent and independent breast cancer cell growth in vivo and in vitro with the antiestrogen toremifene and recombinant human interferon-α2', Breast Cancer Research and Treatment, 15, pp. 95 - 101, http://dx.doi.org/10.1007/BF01810781
    Journal articles | 1989
    GOLDSTEIN D; SOSMAN JA; HANK JA; WEILHILLMAN G; MOORE KH; BORCHERT A; BECHHOFER R; STORER B; KOHLER PC; LEVITT D; SONDEL PM, 1989, 'REPETITIVE WEEKLY CYCLES OF INTERLEUKIN-2 - EFFECT OF OUTPATIENT TREATMENT WITH A LOWER DOSE OF INTERLEUKIN-2 ON NON-MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED KILLER ACTIVITY', CANCER RESEARCH, 49, pp. 6832 - 6839, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989CA66300061&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Journal articles | 1989
    Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC, 1989, 'Effects of Type I and II Interferons on Cultured Human Breast Cells: Interaction with Estrogen Receptors and with Tamoxifen', Cancer Research, 49, pp. 2698 - 2702
    Journal articles | 1989
    Goldstein D; Levi JA; Woods RL; Russell J; Morgan J; Kerestes Z, 1989, 'Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapy', Oncology (Switzerland), 46, pp. 105 - 108, http://dx.doi.org/10.1159/000226695
    Journal articles | 1989
    Goldstein D; Sielaff KM; Stores BE; Brown RR; Datta SP; Witt PL; Teitelbaum AP; Smalley RV; Borden EC, 1989, 'Human biologic response modification by interferon in the absence of measurable serum concentrations: A comparative trial of subcutaneous and intravenous interferon-β serine', Journal of the National Cancer Institute, 81, pp. 1061 - 1068, http://dx.doi.org/10.1093/jnci/81.14.1061
    Journal articles | 1989
    Guadagni F; Schlom J; Johnston WW; Szpak CA; Goldstein D; Smalley R; Simpson JF; Borden EC; Pestka S; Greiner JW, 1989, 'Selective interferon-induced enhancement of tumor-associated antigens on a spectrum of freshly isolated human adenocarcinoma cells', Journal of the National Cancer Institute, 81, pp. 502 - 512, http://dx.doi.org/10.1093/jnci/81.7.502
    Journal articles | 1988
    Goldstein D; Laszlo J, 1988, 'The role of interferon in cancer therapy: A current perspective', CA: A Cancer Journal for Clinicians, 38, pp. 258 - 277, http://dx.doi.org/10.3322/canjclin.38.5.258
    Journal articles | 1988
    Laszlo J; Goldstein D, 1988, 'The doctor's dilemma (the nurse's Waterloo)', Cancer Investigation, 6, pp. 361 - 363, http://dx.doi.org/10.3109/07357908809080660
    Journal articles | 1988
    Triozzi PL; Goldstein D; Laszlo J, 1988, 'Contributions of benzodiazepines to cancer therapy.', Cancer Invest, 6, pp. 103 - 111, http://dx.doi.org/10.3109/07357908809077033
    Journal articles | 1987
    Goldstein D; Gockerman J; Tso CY; Hood LE, 1987, 'Effects of 7-Interferon on the Endocrine System: Results from a Phase I Study', Cancer Research, 47, pp. 6397 - 6401
    Journal articles | 1987
    Goldstein D; Kelly R; Ralston M; Penny R; Hayes J, 1987, 'Chemotherapy influencing the course of nephrotic syndrome in colonic carcinoma', Medical Oncology and Tumor Pharmacotherapy, 4, pp. 101 - 105, http://dx.doi.org/10.1007/BF02934947
    Journal articles | 1986
    Geczy CL; Ryan J; Walsh J; Goldstein D, 1986, 'Lymphokine‐induced monocyte procoagulant activity is depressed in patients with advanced malignancies', International Journal of Cancer, 37, pp. 677 - 682, http://dx.doi.org/10.1002/ijc.2910370506
    Journal articles | 1986
    Goldstein D; Laszlo J, 1986, 'Interferon Therapy in Cancer: From Imaginon to Interferon', Cancer Research, 46, pp. 4315 - 4329
    Journal articles | 1986
    Laszlo J; Goldstein D; Vugrin D; Hood L; Tso CY, 1986, 'Does maintenance therapy with alpha interferon stabilize cancer growth? A pilot study.', J Biol Response Mod, 5, pp. 294 - 299, https://www.ncbi.nlm.nih.gov/pubmed/3734845
  • Conference Papers | 2023
    Sawka AM; Ghai S; Rotstein L; Irish JC; Pasternak JD; Gullane PJ; Monteiro E; Zahedi A; Gooden E; Eskander A; Chung J; Devon K; Su J; Xu W; Jones JM; Gafni A; Baxter NN; Goldstein DP, 2023, 'Gender Differences in Fears Related to Low-Risk Papillary Thyroid Cancer and Its Treatment', in JAMA Otolaryngology - Head and Neck Surgery, pp. 803 - 810, http://dx.doi.org/10.1001/jamaoto.2023.1642
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.c.6512931
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Data from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.c.6512931.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428180
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428180.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428177
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428177.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428168
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428168.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428165
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Figure S4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428165.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428162
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 1 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428162.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428159
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 2 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428159.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428156
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 3 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428156.v1
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428153
    Other | 2023
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Kokkinos J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey SK; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill AJ; Gonzales-Aloy E; Gebski V; Guan YF; Pajic M; Turner N; Apte MV; Davis TP; Morton JP; Haghighi KS; Kasparian J; McLean BJ; Setargew YF; Phillips PA, 2023, Supplementary Table 4 from Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition, , http://dx.doi.org/10.1158/0008-5472.22428153.v1
    Preprints | 2022
    Best M; Bartley N; Napier C; Fisher A; Ballinger M; Thomas D; Goldstein D; Tucker K; Biesecker B; Butow P, 2022, Return of comprehensive tumour genomic profiling results to advanced cancer patients: a qualitative study, , http://dx.doi.org/10.21203/rs.3.rs-1190781/v1
    Conference Abstracts | 2022
    Hosen SMZ; Xu Z; Mekapogu AR; Perera C; Goldstein D; Pirola R; Wilson J; Buckley BJ; Ranson M; Apte M, 2022, 'Targeted urokinase plasminogen activator inhibition combined with chemotherapy halts primary tumor growth and eliminates metastasis in advanced pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 36 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700069&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Preprints | 2022
    Kokkinos J; Sharbeen G; Ignacio RM; Pandzic E; Youkhana J; Boyer C; Haghighi K; Gunawarman M; Goldstein D; Gebski V; Pajic M; Pitiyarachchi O; Davis M; Schulstad G; Arkell OSM; Kopecky C; Gonzales-Aloy E; Erkan M; Morton J; Kavallaris M; Gunning P; Hardeman E; Johns A; Gill A; Whan R; Mawson A; McCarroll J; Phillips P; Australian Pancreatic Cancer Genome Initiative , 2022, βIII-Tubulin is a Brake on Extrinsic Cell-Death in Pancreatic Cancer, , http://dx.doi.org/10.1101/2022.09.29.510034
    Conference Papers | 2022
    Li T; Timmins H; Trinh T; Horvath L; Harrison M; Grimison P; Kiernan M; Goldstein D; Park S, 2022, 'LONGITUDINAL TRAJECTORIES OF CLINICAL, NEUROLOGICAL AND PATIENT-REPORTED CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY FOLLOWING TREATMENT COMPLETION', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. S169 - S169, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000822950200350&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Lin FP-Y; Thavaneswaran S; Grady JP; Napier CE; Kansara M; Sebastian L; Kee D; Oakes SR; Blackburn J; Scott HS; Glover A; Fox SB; Goldstein D; Leo P; Amanuel B; Desai J; Lee CK; Ballinger ML; Simes J; Thomas DM, 2022, 'Molecular therapy selection in treatment-refractory advanced cancers: A retrospective cohort study determining the utility of TOPOGRAPH knowledge base.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 3073 - 3073, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.3073
    Conference Abstracts | 2022
    Mizrahi D; Goldstein D; Kiernan MC; Robinson L; Pitiyarachchi O; McCullough S; Mendoza-Jones P; Grimison P; Boyle F; Park SB, 2022, 'Development and consensus of 'CIPN-path': A clinical pathway for the assessment and management of chemotherapy-induced peripheral neuropathy', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 190 - 190, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000871956500308&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2022
    Mizrahi D; Goldstein D; Trinh T; Li T; Timmins HC; Harrison M; Marx GM; Hovey EJ; Lewis CR; Friedlander M; Park SB, 2022, 'Clinical Predictors And Levels Of Physical Activity Among Cancer Survivors Treated With Neurotoxic Chemotherapy', in Medicine & Science in Sports & Exercise, LIPPINCOTT WILLIAMS & WILKINS, San Diego, California, Vol. 54, pp. 322 - 322, presented at ACSM 2022 Annual Meeting & World Congresses, San Diego, California, 31 May 2022 - 04 June 2022, http://dx.doi.org/10.1249/01.mss.0000879060.88938.0b
    Conference Papers | 2021
    Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2021, 'Effectively communicating comprehensive tumour genomic profiling results: Mitigating uncertainty for advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500295&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Caldwell R; Georgiou C; Kee D; Papadopoulos L; Krasovitsky M; Tay R; Bourne A; Turner M; Goldstein D; Scott C, 2021, 'The Australian Rare Cancer Portal: A retrospective review of referring oncologist's service requests', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 105 - 106, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Chiang JCB; Khou V; Tavakoli A; Goldstein D; Krishnan AV; Markoulli M, 2021, 'Corneal inferior whorl morphology and reproducibility with in-vivo confocal microscopy in peripheral neuropathy', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, ELECTR NETWORK, presented at ARVO Imaging in the Eye Conference, ELECTR NETWORK, 13 May 2021 - 14 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000720324200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2021
    Georgiou CL; Kee D; Caldwell R; Krasovitsky MS; Tay R; Bourne A; Turner M; Goldstein D; Scott C, 2021, 'The Australian rare cancer portal: An innovative online service co-ordinating national expert care for rare cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000680945900014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Preprints | 2021
    Habibalahi A; Moses D; Campbell J; Mahbub S; Barbour AP; Samra JS; Haghighi KS; Gebski VJ; Goldstein D; Goldys E, 2021, Computed Tomography Radiomics Signatures: Sensitive biomarkers for clinical decision support in pancreatic cancer- a pilot study, , http://dx.doi.org/10.1101/2021.12.03.21267217
    Conference Papers | 2021
    Hosen SMZ; Haar J; Xu Z; Perera C; Buckley BJ; Mekapogu AR; Pang TC; Pothula S; Ranson M; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Targeting the urokinase plasminogen activator (uPA) pathway inhibits pancreatic cancer progression', in Pancreatology, Elsevier BV, pp. S73 - S73, http://dx.doi.org/10.1016/j.pan.2021.05.196
    Conference Abstracts | 2021
    Hosen SMZ; Haar J; Xu Z; Perera C; Mekapogu AR; Pang TCY; Pothula S; Goldstein D; Pirola R; Wilson J; Buckley BJ; Ranson M; Apte M, 2021, 'Targeting the urokinase plasminogen activator pathway inhibits pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 25 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2021
    Hosen SMZ; Xu Z; Perera C; Mekapogu AR; Pang TCY; Goldstein D; Pirola RC; Wilson JS; Buckley BJ; Ranson M; Apte MV, 2021, 'Targeting the Urokinase Plasminogen Activator Pathway in Combination With Chemotherapy Inhibits Pancreatic Cancer Progression', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 50, pp. 1065 - 1065, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000706786400114&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Lemech C; Dredge K; Bampton D; Hammond E; Clouson A; Waterhouse N; Stanley A; Leveque-ElMouttie L; Chojnowski G; Haydon A; Pavlakis N; Burge M; Brown M; Goldstein D, 2021, 'A PHASE IB EXPANSION COHORT OF PIXATIMOD PLUS NIVOLUMAB IN PREVIOUSLY TREATED, MICROSATELLITE STABLE METASTATIC COLORECTAL CANCER (MSS MCRC)', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A367 - A367, http://dx.doi.org/10.1136/jitc-2021-SITC2021.341
    Conference Papers | 2021
    Lemech C; Dredge K; Bampton D; Hammond E; Stanley A; Leveque-ElMouttie L; Chojnowski G; Haydon A; Pavlakis N; Burge M; Brown M; Goldstein D, 2021, 'A PHASE IB STUDY OF THE SAFETY AND TOLERABILITY OF PIXATIMOD PLUS NIVOLUMAB IN SUBJECTS WITH ADVANCED SOLID TUMORS WITH AN EXPANSION COHORT IN METASTATIC PANCREATIC ADENOCARCINOMA (MPDAC)', in JOURNAL FOR IMMUNOTHERAPY OF CANCER, BMJ PUBLISHING GROUP, pp. A366 - A366, http://dx.doi.org/10.1136/jitc-2021-SITC2021.340
    Conference Papers | 2021
    Li T; Timmins H; Trinh T; Kiernan M; Goldstein D; Park S, 2021, 'Multifaceted approach to profiling vincristine-induced peripheral neuropathy', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, pp. 360 - 360, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000696233800123&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2021
    Li T; Timmins HC; Trinh T; Mizrahi D; Horvath L; Grimison P; Harrison M; Rutherford C; King M; Kiernan MC; Goldstein D; Park SB, 2021, 'Assessing chemotherapy-induced peripheral neuropathy - A psychometric analysis of current approaches', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 31 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Li T; Timmins HC; Trinh T; Mizrahi D; Horvath LG; Grimison P; Harrison M; Rutherford C; King M; Kiernan MC; Goldstein D; Park SB, 2021, 'A psychometric comparison of three approaches to chemotherapy-induced peripheral neuropathy assessment: Patient report, clinical grading, and sensory function', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. S96 - S96, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000712224700205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Mekapogu A; Xu Z; Pothula S; Perera C; Pang T; Hosen SMS; Damalanka V; Mahoney V; Janekta J; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte M; Perera C, 2021, 'Hepatocyte growth factor/c-MET inhibition plus chemotherapy improves tumor immunity and eliminates metastasis in pancreatic cancer', Virtual, presented at Australian Gastroenterology Week, Virtual, 10 August 2021
    Conference Abstracts | 2021
    Mekapogu A; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka V; Mahoney M; Janetka J; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte M, 2021, 'Hepatocyte growth factor/c-MET inhibition plus chemotherapy improves tumor immunity and eliminates metastasis in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 36, pp. 29 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693377800055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Mekapogu AR; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka VC; Mahoney M; Janetka JW; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte MV, 2021, '184 HEPATOCYTE GROWTH FACTOR/ C-MET PATHWAY INHIBITION COMBINED WITH CHEMOTHERAPY RETARDS PRECURSOR PANINS AND POTENTIATES LOCAL IMMUNITY IN A TRANSGENIC MODEL OF EARLY PANCREATIC CANCER', in Gastroenterology, Elsevier BV, pp. S - 45, http://dx.doi.org/10.1016/s0016-5085(21)00855-6
    Conference Papers | 2021
    Mekapogu AR; Xu Z; Pothula S; Perera C; Pang T; Hosen SMZ; Damalanka VC; Mahoney M; Janetka JW; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte MV, 2021, 'HEPATOCYTE GROWTH FACTOR/ C-MET PATHWAY INHIBITION COMBINED WITH CHEMOTHERAPY RETARDS PRECURSOR PANINS AND POTENTIATES LOCAL IMMUNITY IN A TRANSGENIC MODEL OF EARLY PANCREATIC CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, ELECTR NETWORK, pp. S45 - S45, presented at Society-for-Surgery-of-the-Alimentary-Tract Annual Meeting at Digestive Disease Week (DDW), ELECTR NETWORK, 21 May 2021 - 23 May 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000649085000104&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Pavlakis N; Shitara K; Sjoquist K; Martin AJ; Jaworski A; Yip S; Oh D-Y; Moehler M; Chen L-T; Bekaii-Saab T; Simes J; Goldstein D, 2021, 'INTEGRATE IIb: A randomised phase III open label study of regorafenib plus nivolumab vs standard chemotherapy in refractory advanced gastro-oesophageal cancer (AGOC)', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, pp. S1074 - S1074, presented at Congress of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 16 September 2021 - 21 September 2021, http://dx.doi.org/10.1016/j.annonc.2021.08.1547
    Conference Papers | 2021
    Scott CL; Lim R; Kee D; Georgiou C; Caldwell R; Papadopoulos L; Krasovitsky MS; Tay R; Bourne A; Vandenberg C; Dall G; Shield-Artin K; Carmagnac A; Ratnayak G; Tram J; Zhou W; Bedo J; Penington J; Zhu L; Vissers J; Thomas D; Grimmond S; Wakefield M; Papenfuss T; Barke H; Goldstein D, 2021, 'Delivering personalized care and research for rare cancers in the increasingly genomic world?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2021
    Vatter S; Schlub TE; Napier CE; Best MC; Bartley N; Juraskova I; Meiser B; Ballinger ML; Biesecker BB; Goldstein D; Thomas DM; Butow P, 2021, 'Psychological outcomes in advanced cancer patients after receiving genomic tumour profiling results', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 198 - 198, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Battaglini E; Goldstein D; Park S, 2020, 'Chemotherapy-induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-term Quality of Life', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 548 - 548, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Battaglini E; Goldstein D; Park S, 2020, 'Determining the impact of chemotherapy-induced peripheral neuropathy: A survey of cancer survivors.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368308496&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Best M; Butow P; Davies G; Napier C; Bartley N; Ballinger M; Biesecker BB; Juraskova I; Meiser B; Schlub T; Thomas D; Goldstein D, 2020, 'How much do cancer patients value whole genome sequencing? A cross-sectional survey using the willingness-to-pay technique', in EUROPEAN JOURNAL OF HUMAN GENETICS, SPRINGERNATURE, pp. 790 - 790, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000598482602498&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Best M; Butow P; Jacobs C; Juraskova I; Savard J; Meiser B; Goldstein D; Ballinger M; Bartley N; Napier C; Davies G; Thomas D; Tucker K; Schlub T; Newson AJ, 2020, 'Advanced cancer patient preferences for receiving molecular profiling results', in Psycho-Oncology, Vol. 29, pp. 1533 - 1539, http://dx.doi.org/10.1002/pon.5446
    Conference Papers | 2020
    Butow P; Best M; Davies G; Schlub T; Napier C; Bartley N; Ballinger M; Juraskova I; Meiser B; Goldstein D; Biesecker B; Thomas D, 2020, 'Psychological impact of comprehensive genomic profiling results to advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000790145400077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Butow P; Davies G; Napier C; Thomas DM; Bartley N; Goldstein D; Ballinger ML; Juraskova I; Schlub TE; Tucker K; Meiser B; Young M-A, 2020, 'Return of results after somatic tumor mutation profiling in advanced cancer: Psychological impacts.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 38, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 29 May 2020 - 31 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000560368301063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Chiang JCB; Goldstein D; Trinh T; Au K; Krishnan AV; Markoulli M, 2020, 'The relationship between the Ocular Surface Disease Index and conventional assessments of chemotherapy-induced peripheral neuropathy', in INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, ELECTR NETWORK, presented at Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), ELECTR NETWORK, 01 May 2020 - 07 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000554528301316&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Li T; Timmins H; McCrary J; Trinh T; Friedlander M; Horvath L; Kiernan M; Goldstein D; Park S, 2020, 'Patient reported outcome scores used in chemotherapy-induced peripheral neuropathy: Defining minimal important differences', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 481 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Mekapogu A; Xu Z; Pothula S; Perera C; Pang T; Hosen Z; Janetka J; Damalanka V; Mahoney M; Klampfer L; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Inhibition of both the ligand and receptor of the hepatocyte growth factor/c-MET pathway, in combination with chemotherapy, retards progression of PanIN lesions in KPC mice', in Pancreatology, Elsevier BV, pp. S39 - S40, http://dx.doi.org/10.1016/j.pan.2020.07.049
    Conference Abstracts | 2020
    Mizrahi D; Park SB; Li T; Timmins H; Trinh T; Au K; Battaglini E; Wyld D; Henderson R; Grimison P; Ke H; Marker J; Wall B; Goldstein D, 2020, 'Haemoglobin, body mass index and age as risk-factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy', in ANNALS OF ONCOLOGY, ELSEVIER, ELECTR NETWORK, Vol. 31, pp. S1371 - S1371, presented at ESMO Asia Virtual Congress, ELECTR NETWORK, 20 November 2020 - 22 November 2020, http://dx.doi.org/10.1016/j.annonc.2020.10.328
    Conference Abstracts | 2020
    Pang TCY; Mekapogu AR; Xu Z; Pothula S; Goldstein D; Pirola RC; Wilson JS; Becker TM; Apte MV, 2020, 'Characterization of Circulating Pancreatic Stellate Cells (Pscs) in Pancreatic Cancer, by Single Cell Transcriptomic Analysis', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 49, pp. 1423 - 1423, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000614149700122&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Cohen-Hyams T; Killingsworth M; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Effects of pancreatic stellate cell- and cancer cell-derived exosomes on islet cell functions: Implications for pancreatic cancer-related diabetes', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'I. Pancreatic Stellate Cell and Cancer Cell Derived Exosomes Impair Beta Cell Function: Implications for Pancreatic Cancer Related Diabetes', in Gastroenterology, Elsevier, Chicago, USA, presented at Digestive Disease Week, Chicago, USA, 02 May 2020, http://dx.doi.org/10.1016/S0016-5085(20)31245-2
    Conference Papers | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte M, 2020, 'Pancreatic cancer-related diabetes: Do pancreatic stellate cell and cancer cell derived exosomes play a role?', in Pancreratology, presented at European Pancreatic Club
    Conference Papers | 2020
    Perera C; Xu Z; Mekapogu AR; Hosen SMZ; Pothula S; Greenfield J; Chari S; Goldstein D; Pirola R; Wilson J; Apte MV, 2020, 'PANCREATIC STELLATE CELL AND CANCER CELL DERIVED EXOSOMES IMPAIR BETA CELL FUNCTION: IMPLICATIONS FOR PANCREATIC CANCER RELATED DIABETES', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, TX, Austin, pp. S221 - S221, presented at Crohn's and Colitis Congress, TX, Austin, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000540349500565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2020
    Reni M; Riess H; O'Reilly EM; Park JO; Hatoum H; Saez BL; Salminen T; Oettle H; Lopez R; Dowden SD; Karthaus M; Tabernero J; Van Cutsem E; Philip PA; Goldstein D; Berlin J; Tempero MA, 2020, 'Phase III APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) versus gemcitabine (Gem) alone for patients with resected pancreatic cancer (PC): Outcomes by geographic region.', Vol. 38, pp. 4515 - 4515, http://dx.doi.org/10.1200/jco.2020.38.15_suppl.4515
    Preprints | 2020
    Sharbeen G; McCarroll JA; Akerman A; Kopecky C; Youkhana J; Holst J; Boyer C; Erkan M; Goldstein D; Timpson P; Cox TR; Pereira BA; Chitty JL; Fey S; Najumudeen AK; Campbell AD; Sansom OJ; Ignacio RMC; Naim S; Liu J; Russia N; Lee J; Chou A; Johns A; Gill A; Gonzales-Aloy E; Kokkinos J; Gebski V; Turner N; Apte M; Davis TP; Morton JP; Haghighi K; Phillips PA, 2020, Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma determine response to SLC7A11 inhibition, , http://dx.doi.org/10.1101/2020.07.12.199638
    Conference Papers | 2020
    Tay R; Kee D; Black M; Haurat J; Turner M; Goldstein D; Scott C, 2020, 'The Australian Rare Cancer Portal - A national framework for co-ordinating streamlined access to rare cancer clinical expertise and research', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 206 - 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000790145400327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Timmins H; Li T; Kiernan M; Harrison M; Trinh T; Battaglini E; Goldstein D; Park S, 2020, 'Dose modification: Does it affect follow-up outcomes in taxane-induced neuropathy?', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, ELECTR NETWORK, Vol. 25, pp. 480 - 481, presented at Virtual Conference of Peripheral-Nerve-Society, ELECTR NETWORK, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596008100111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Best M; Butow P; Bartley N; Jacobs C; Juraskova I; Newson A; Goldstein D; Savard J; Meiser B; Ballinger M; Biesecker B; Thomas D, 2019, 'Advanced cancer patient perspectives on consenting to molecular tumour profiling', in EUROPEAN JOURNAL OF HUMAN GENETICS, NATURE PUBLISHING GROUP, SWEDEN, Gothenburg, pp. 1172 - 1173, presented at 52nd Conference of the European-Society-of-Human-Genetics (ESHG), SWEDEN, Gothenburg, 15 June 2019 - 18 June 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000489313900239&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Goldstein D, 2019, 'International volunteering through ASCO - a Vietnam experience', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 69 - 69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400041&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Hayes SA; Martin A; Yip S; Howell VM; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Simes J; Goldstein D; Pavlakis N, 2019, 'Abstract 4531: SWATH-MS profiling identifies prognostic factors for progression-free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)', in Cancer Chemistry, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-4531
    Conference Papers | 2019
    Hayes SA; Martin A; Yip S; Howell VM; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Tebbutt NC; Simes J; Goldstein D; Pavlakis N, 2019, 'SWATH-MS profiling identifies prognostic factors for progression- free survival (PFS) In INTEGRATE - A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC) - A study by the Australasian Gastrointestinal Trials Group (AGITG)', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-4531
    Conference Posters | 2019
    Iioanni L; maharaj A; loughan J; zalcberg J; earnest A; Goldstein D; Kench J; Merrett N; christophi C; croagh D; pilgrim C; burmeister E; white K; neale R; green S; evans S, 2019, 'Prognostic models to predict survival in patients with pancreatic cancer: A systematic review', Bangkok, presented at ASM RACS, Bangkok, 06 May 2019 - 10 May 2019
    Conference Papers | 2019
    Lee B; Shapiro J; Thomson B; Ananda S; Lipton L; McLachlan S-A; Wong R; Cooray P; Burge M; Clarke K; Pattison S; Nikfarjam M; Tebbutt N; Harris M; Croagh D; Goldstein D; Nagrial A; Zielinski R; Roy A; Chee CE; Putoczki T; Hollande F; Hofmann O; Vissers J; Grimmond S; Gibbs P, 2019, 'How can digital health be used to improve outcomes in pancreatic ductal adenocarcinoma (PDAC)? Examining the potential of the PURPLE translational pancreatic cancer platform', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 73 - 74, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400052&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Maharaj A; Samoborec S; Evans SM; Zalcberg J; Neale RE; Goldstein D; Merrett N; White K; Croagh D; Pilgrim CHC; Evans P; Knowles BPF; Leong T; Philip J; Smith M; Ioannou L, 2019, 'Patient Reported Outcome Measures (PROMs) in pancreatic cancer: a systematic review', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. S57 - S57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000486499800130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Mizrahi D; Trinh T; Au K; Timmins HC; Li T; McCrary JM; Friedlander M; Grimison P; Park SB; Goldstein D, 2019, 'Does physical activity participation associate with the degree of chemotherapy-induced peripheral neuropathy after neurotoxic treatment?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 15, pp. 179 - 179, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000493438400288&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Pang TC; Xu Z; Mekapogu AR; Pothula S; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'A Novel Adjuvant Treatment Approach in Pancreatic Cancer Via Hepatocyte Growth Factor (HGF)/c-MET Inhibition', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1504 - 1504, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000505712800433&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Thavaneswaran S; Napier C; Goldstein D; Meiser B; Butow P; Thomas DM; Ballinger ML; Best M, 2019, 'Medical oncologists' experience with returning molecular tumor profiling to patients.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 37, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2019 - 04 June 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487345804031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2019
    Wang X; Goldstein D; Crowe P; Yang J-L, 2019, 'Synergistic effect of targeting both CDK4/6 and mTORin sarcoma cell lines', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-3907
    Conference Papers | 2019
    Xu Z; Pang T; Pothula S; Mekapogu A; Perera C; Murakami T; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'Inhibition of Hepatocyte Growth Factor (HGF) Signaling Pathway in Combination With Chemotherapy Reduces Tumour Burden in an Orthotopic Model of Advanced Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1551 - 1551, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000505712800617&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2019
    Xu Z; Pang T; Pothula S; Mekapogu A; Perera C; Murakami T; Goldstein D; Pirola R; Wilson J; Apte M, 2019, 'Inhibition of hepatocyte growth factor signaling pathway in combination with chemotherapy reduces tumor burden in an orthotopic model of advanced pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 37 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Blinman P; Martin A; Jefford M; Goldstein D; Boadle D; Morris M; Tebbutt N; Aiken C; Segelov E; Paul J; Haydon A; Iveson T; Stockler M, 2018, 'Patients' Preferences for 3 Versus 6 Months of Adjuvant Chemotherapy (ACT) for Colon Cancer in the SCOT Trial: What Survival Benefits Make Longer Chemotherapy Worthwhile?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 51 - 51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000439493100012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Gronchi A; Bonvalot S; Poveda A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp H; Goldstein D; Martin Broto J; Wardelmann E; Marreaud S; Zalcberg JR; Le Cesne A; Litiere S; Blay J; Casali PG, 2018, 'Microscopic Surgical Margins and Outcome in Localized GIST Treated within the Eortc Stbsg, Agitg, Unicancer, Fsg, Isg and Geis Randomized Trial On Adjuvant Imatinib', in ANNALS OF SURGICAL ONCOLOGY, SPRINGER, IL, Chicago, pp. S6 - S6, presented at 71st Annual Cancer Symposium of the Society-of-Surgical-Oncology, IL, Chicago, 21 March 2018 - 24 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431188600002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Kokkinos J; Sharbeen G; McCarroll J; Boyer C; Akerman A; Youkhana J; Davis TP; Goldstein D; Phillips PA, 2018, 'beta III-Tubulin is a Brake for External Cell-Death Signaling and Regulates TRAIL Sensitivity in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Miami Beach, Florida, Vol. 47, pp. 1401 - 1401, presented at 49th Annual Meeting of the American Pancreatic Association, Miami Beach, Florida, 31 October 2018 - 03 November 2018, http://dx.doi.org/10.1097/MPA.0000000000001177
    Conference Papers | 2018
    Kokkinos J; Sharbeen G; Mccarroll J; Akerman A; Youkhana J; Goldstein D; Phillips P, 2018, 'beta III-Tubulin is a brake for external cell-death signaling and chemosensitivity in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530647800030&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Kuo J; Bampton D; Lemech CR; Brown MP; Stanley A; Chojnowski G; Hammond E; Dredge K; Goldstein D, 2018, 'Preliminary results from a Phase Ib study of pixatimod (PG545) in combination with nivolumab in patients with advanced solid tumours with an expansion cohort in patients with metastatic pancreatic cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, IRELAND, Dublin, pp. E18 - E19, presented at 30th EORTC-NCI-AACR Symposium, IRELAND, Dublin, 13 November 2018 - 16 November 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461258600037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Pang T; Xu Z; Pothula S; Yang MH; Becker T; Goldstein D; Heeschen C; Pirola R; Wilson J; Apte MV, 2018, 'WORLD-FIRST IDENTIFICATION OF CIRCULATING PANCREATIC STELLATE CELLS IN METASTATIC PANCREATIC CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, DC, Washington, pp. S114 - S114, presented at Annual Meeting of the American-Society-for-Gastrointestinal-Endoscopy / Digestive Disease Week, DC, Washington, 02 June 2018 - 05 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000450011100327&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2018
    Sharbeen G; Akerman A; McCarroll J; Boyer C; Holst J; Youkhana J; Davis TP; Goldstein D; Erkan M; Phillips PA, 2018, 'Metabolically Reprograming Pancreatic Stellate Cells Using a Novel Nanomedicine for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 47, pp. 1422 - 1422, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449304600230&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Wilson J; Pang T; Xu Z; Mekapogu A; Pothula S; Goldstein D; Pirola R; Wilson J; Apte M, 2018, 'Establishment of a noval adjuvant model of orthotopic pancreatic cancer: effects of HGF-cMET inhibition on disease progression', Sydney, presented at Avner Cancer Symposium, Sydney
    Conference Papers | 2018
    Xu F; Quinn CM; Porwal M; O'Neill S; Goldstein D, 2018, 'Can health service utilisation by gastrointestinal cancer patients be assessed using data from a Biobank?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449544200120&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Xu Z; Buckley BJ; Pothula S; Pang T; Goldstein D; Pirola RC; Wilson JS; Kelso MJ; Ranson M; Apte MV, 2018, 'Amiloride Analogues as Inhibitors of Human Urokinase Plasminogen Activator and Anti-Pancreatic Cancer Agents', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1434 - 1434, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449304600277&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2018
    Xu Z; Pothula S; Pang T; Mekapogu A; Goldstein D; Pirola R; Wilson J; Apte M, 2018, 'Inhbition of hepatocyte growth factor (HGF) signalling pathway in combination with chemotherapy reduces tumour buden in an orthotopic pancreatic cancer model', Sydney, presented at Avner Cancer Symposium, Sydney
    Conference Presentations | 2018
    maharaja A; evans S; neale R; Goldstein D; Merrett N; zalcberg J, 2018, 'Patient-Reported Outcome Measures (PROMs) in Pancreatic Cancer: A Systematic Review', presented at ANZGOSA/ANZHPBA conjoint meeting, Weelington New Zealand, 08 October 2018 - 09 October 2018
    Conference Papers | 2017
    Bekaii-Saab T; Goldstein D; Li CP; Okusaka T; O'Neil B; Reni M; Tabernero J; Qin S; Van Cutsem E; Borodyansky L; Li CJ, 2017, 'CanStem111P trial: A phase III study of napabucasin plus nab-paclitaxel (nab-PTX) with gemcitabine (gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC)', in Annals of Oncology, pp. iii136, http://dx.doi.org/10.1093/annonc/mdx261.379
    Conference Papers | 2017
    Clifford B; Barry B; Simar D; Goldstein D, 2017, 'Exercise Induced Analgesia in Survivors of Cancer', in MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, LIPPINCOTT WILLIAMS & WILKINS, CO, Denver, pp. 163 - 163, presented at Annual Meeting of the American-College-of-Sports-Medicine (ACSM), CO, Denver, 30 May 2017 - 03 June 2017, http://dx.doi.org/10.1249/01.mss.0000517274.66389.d8
    Conference Papers | 2017
    McCrary JM; Goldstein D; Battaglini E; Barry B; Sandler C; Murray J; Park S, 2017, 'The Effects of Exercise Training on Neurophysiology, Symptoms, and Function in Cancer Survivors With Chemotherapy-Induced Peripheral Neuropathy', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 130 - 131, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500179&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in Immunotherapy: Molecules and Mountains, Sydney, presented at COSA's 44th Annual Scientif Meeting, Sydney, http://dx.doi.org/10.1111/ajco.12798
    Conference Abstracts | 2017
    Meiser B; Kaur R; Zilliacus E; Wong T; Woodland L; Tomkins S; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda SK; Shaw T; Tebble H; Goldstein D, 2017, 'Evaluation of an Online Communication Skills Training Programme for Oncology Health Care Professionals Working with Culturally and Linguistically Diverse Patients', in COSA's 44th Annual Scientific Meeting, Immunotherapy: Molecules and Mountains, Vol. 13, pp. 66 - 66, presented at COSA's 44th Annual Scientific Meeting, 13 November 2017 - 15 November 2017, http://dx.doi.org/10.1111/ajco.12798
    Conference Papers | 2017
    Pang T; Pothula S; Xu Z; Becker T; Goldstein D; Pirola R; Wilson J; Apte M, 2017, 'Circulating tumor and stellate cells in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 61 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100112&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Pang T; Xu Z; Pothula S; Becker T; Goldstein D; Pirola R; Wilson J; Apte M, 2017, 'Circulating Pancreatic Stellate Cells (Cpscs) and Tumor Cells (Ctcs) in Metastatic Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1425 - 1425, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414520800188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Pothula S; Xu Z; Goldstein D; Pirola R; Wilson J; Apte M, 2017, 'Stromal reprogramming offers a novel therapeutic approach in pancreatic cancer: Implications of targeting HGF/c-MET pathway', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407897100113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Tan AC; McCrary M; Park SB; Goldstein D, 2017, 'Chemotherapy-Induced Peripheral Neuropathy - Patient Reported Outcomes Compared With Clinician and Nursing Assessment', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 183 - 184, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500300&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2017
    Timmins HC; Li T; Kiernan MC; Horvath LG; Harrison M; Grimison P; Cox KM; Boyle FM; Goldstein D; Park SB, 2017, 'NEUROPHYSIOLOGICAL MEASURES CORRELATE WITH PATIENT REPORTED SYMPTOMS OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, WILEY, SPAIN, Sitges, Vol. 22, pp. 395 - 396, presented at Peripheral-Nerve-Society Meeting, SPAIN, Sitges, 08 July 2017 - 12 July 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000409243500424&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Vasista A; Martin A; Pavlakis N; Sjoquist K; Goldstein D; Jeremy S; Karapetis C; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Nott L; Stephanie S; Matthew B; Harris D; Jonker D; Chua YJ; Stockler M; Kiely B, 2017, 'How Long Have I Got? Can Time to Progression on Last Line Treatment Inform us About Post-Progression Survival Time in Advanced Gastric Cancer?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 76 - 76, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427542700065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2017
    Vasista A; Martin A; Pavlakis N; Sjoquist KM; Goldstein D; Shapiro J; Karapetis C; Gill S; Jain V; Liu G; Kannourakis G; Kim YH; Wigston (Nott) L; Snow S; Harris D; Jonker D; Chua YJ; Stockler M; Kiely B, 2017, 'Can Time to Progression on Last Line Treatment Inform us About Post-Progression Survival Time in Advanced Gastric Cancer?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 138 - 139, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000413954500197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2017
    Wang X; Crowe PC; Goldstein DG; Yang JY, 2017, 'Anti-prolifeative effect of targeting CDK4/6 and mTOR alone or in combination in sarcoma cell lines', Florence, Italy, presented at EACR-AACR-SIC: The Challenges of optimising immuno and targeted therapies: from cancer biology to the clinic, Florence, Italy, 24 June 2017 - 27 June 2017
    Conference Posters | 2017
    Wang X; crowe PC; goldstein DG; Yang JY, 2017, 'In vitro and in vivo effect of targeting CDK4/6 and mTOR singly or together in sarcoma cell lines', Adelaide, Australia, presented at 2017 Annual Sarcoma Conference, Adelaide, Australia, 13 October 2017 - 14 October 2017
    Conference Papers | 2016
    Apte M; Xu Z; Pothula S; Goldstein D; Pirola R; Wilson JS, 2016, 'Stromal remodeling in pancreatic cancer', in Pancreatology, Elsevier, Sendai, pp. S28 - S28, presented at International Association of Pancreatology, Sendai, -
    Conference Abstracts | 2016
    Battaglini E; Goldstein D; Park SB, 2016, 'ASSESSING THE IMPACT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN AUSTRALIA VIA A PATIENT SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2016
    Chan H; Roncolato F; Long A; Foroudi F; Goldstein D; Siva S; Davis I, 2016, 'CURRENT CLINICIAN PRACTICES IN UTILIZING RADIOTHERAPY AND MOLECULARLY TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: AN ANZUP SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000380004900064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Farrar MA; KAndula T; Murray J; Goldstein D; Krishnan A; PArk S, 2016, 'Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?', in Subclinical peripheral neuropathy prior to chemotherapy in colorectal cancer patients – Myth or reality?, Elsevier, Vol. 127, pp. e13, presented at ANZAN Biennial Clinical Neurophysiology Workshop, http://dx.doi.org/10.1016/j.clinph.2015.11.029
    Conference Abstracts | 2016
    McCrary JM; Park S; Goldstein D, 2016, 'A SYSTEMATIC REVIEW AND DELPHI SURVEY OF ASSESSMENT STRATEGIES FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 128 - 128, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    McCrary JM; Park S; Goldstein D, 2016, 'CLINICIAN AND NURSE REPORTING HABITS FOR CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 12, pp. 129 - 129, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387769900196&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    McNamara MG; Bridgewater JA; Lopes A; Wasan H; Malka D; Jensen HR; Okusaka T; Knox JJ; Wagner AD; Cunningham D; Shannon J; Goldstein D; Moehler MH; Bekaii-Saab TS; Valle JW, 2016, 'Systemic therapy in elderly patients with advanced biliary tract cancer: Sub-analysis of ABC-02 and 10 other prospective studies.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 34, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.382
    Conference Abstracts | 2016
    Phillips P; Sharbeen G; Youkhana J; Mawson A; McCarroll J; Akerman A; Goldstein D, 2016, 'MutY-Homolog Modulates Pancreatic Cancer Cell Survival and Chemoresistance', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 45, pp. 1534 - 1534, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000386978400183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2016
    Tempero MA; Cardin DB; Goldstein D; O'Reilly EM; Philip AP; Riess H; Macarulla T; Yung L; Li M; Lu BD; Biankin A, 2016, 'APACT: Phase III randomized trial of adjuvant treatment with nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone in patients (pts) with resected pancreatic cancer (PC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 34, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.tps473
    Conference Abstracts | 2016
    Wang X; Yeo R; Crowe P; Goldstein D; Hogg R; Dilda P; Yang JL, 2016, 'Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, GERMANY, Munich, Vol. 69, pp. S37 - S38, presented at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, GERMANY, Munich, 29 November 2016 - 02 December 2016, http://dx.doi.org/10.1016/S0959-8049(16)32693-4
    Conference Abstracts | 2016
    Yip S; Harvie R; Martin AJ; Sjoquist KM; Tsobanis E; Kang Y-K; Bang Y-J; Alcindor T; O'Callaghan CJ; Burnell MJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Strickland A; Zalcberg JR; Simes J; Goldstein D; Pavlakis N, 2016, 'Evaluation of circulating VEGF based biomarkers in INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 34, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 21 January 2016 - 23 January 2016, http://dx.doi.org/10.1200/jco.2016.34.4_suppl.64
    Conference Abstracts | 2015
    Barbour A; O'Rourke N; Chandrasegaram MD; Chua YJ; Kench J; Samra JS; Pavlakis N; Haghighi KS; Yip S; Fawcett J; Donoghoe M; Walker K; Burge ME; Gananadha S; Harris M; Aghmesheh M; Joubert WL; Gebski V; Simes J; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4115
    Conference Abstracts | 2015
    Barbour A; O'Rourke N; Samra JS; Haghighi KS; Kench J; Mitchell J; Pavlakis N; Burge ME; Fawcett J; Gananadha S; Harris M; Aghmesheh M; Chua YJ; Joubert WL; Chan MMK; Chandrasegaram MD; Yip S; Simes J; Gebski V; Goldstein D, 2015, 'A multicenter, phase II trial of preoperative gemcitabine and nab-paclitaxel for resectable pancreas cancer: The AGITG GAP study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 33, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 15 January 2015 - 17 January 2015, http://dx.doi.org/10.1200/jco.2015.33.3_suppl.387
    Conference Abstracts | 2015
    Boyer C; Teo J; Phillips P; Erlich RB; Sagnella S; Sharbeen G; Dwarte T; Duong HTT; Goldstein D; Davis TP; Kavallaris M; Mccarroll J, 2015, 'Erratum: Effective Delivery of siRNA into Cancer Cells and Tumors Using Well-Defined Biodegradable Cationic Star Polymers (Molecular Pharmaceutics (2013) 10: 6 (2435−2444) DOI: 10.1021/mp400049e)', in Molecular Pharmaceutics, Vol. 12, pp. 1004, http://dx.doi.org/10.1021/acs.molpharmaceut.5b00092
    Conference Papers | 2015
    Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2015, 'FIRST-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: AN AUSTRALIAN EXPERIENCE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 51 - 51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Brungs D; Aghmesheh M; Sjoquist K; Goldstein D, 2015, 'SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES', in Asia-Pacific Journal of Clinical Oncology, WILEY-BLACKWELL, pp. 168 - 168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000364320800296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2015
    Burmeister E; Jordan S; O'Connell D; Vanessa B; David G; Helen G; Monka J; Neil M; David W; Rachel N, 2015, 'Using a Delphi process to determine optimal care for patients with pancreatic cancer', http://dx.doi.org/10.1016/j.pan.2015.05.308
    Conference Papers | 2015
    Butow P; Sze M; Goldstein D; Jefford M, 2015, 'Having cancer in a country not your own: the Chinese immigrant story in Australia', in PSYCHO-ONCOLOGY, WILEY-BLACKWELL, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358255000039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Chan D; Goldstein D; Sjoquist KM; Pavlakis N, 2015, 'Antiangiogenic agents (AAs) in metastatic oesophago-gastric cancer (mOGC): A systematic review and meta-analysis', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15111
    Conference Abstracts | 2015
    Kunzmann V; Ramanathan RK; Goldstein D; Penenberg DN; Ferrara S; Lu BD; Von Hoff DD, 2015, 'Reduction in primary pancreatic and metastatic tumor burden in the phase III MPACT trial of nab-paclitaxel (nab-P) plus gemcitabine (Gem) versus Gem alone.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.e15299
    Conference Posters | 2015
    Lim HJ; Wang X; Goldstein ; Crowe , 2015, 'Targeting the PI3K/PTEN/AKT/mTOR pathway in sarcoma cell lines', Lorne, Victoria, Australia, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015
    Conference Presentations | 2015
    Meiser B; Zilliacus E; Wong T; Girgis A; Butow P; Hale S; Kissane D; Perry A; Aranda S; Tomkins S; Hodges J; Norris C; Shaw T; Tebble H; Woodland L; Kaur R; Goldstein D, 2015, 'Communication skills training for oncology health care professionals working with culturally and linguistically diverse patients'
    Conference Abstracts | 2015
    Pavlakis N; Sjoquist KM; Tsobanis E; Martin AJ; Kang Y-K; Bang Y-J; O'Callaghan CJ; Tebbutt NC; Rha SY; Lee J; Cho JY; Lipton LR; Burnell MJ; Alcindor T; Strickland A; Kim JW; Yip S; Simes J; Zalcberg JR; Goldstein D, 2015, 'INTEGRATE: A randomized, phase II, double-blind, placebo-controlled study of regorafenib in refractory advanced oesophagogastric cancer (AOGC): A study by the Australasian Gastrointestinal Trials Group (AGITG)-Final overall and subgroup results', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.4003
    Conference Papers | 2015
    Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', San Diego, Pancreas 44(8):1407, presented at American Pancreatic Association, San Diego, Pancreas 44(8):1407, -
    Conference Papers | 2015
    Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', Shanghai, Pancreatology, presented at International Association of Pancreatology, Shanghai, Pancreatology, -
    Conference Papers | 2015
    Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2015, 'Pancreatic cancer: stromal reprogramming offers a novel therapeutic approach', Toledo, Pancreatology 15(3):S17, presented at European Pancreatic Club, Toledo, Pancreatology 15(3):S17, -
    Conference Papers | 2015
    Price T; Pavlakis N; Karapetis C; Michael M; Singhal N; Goldstein D; Van Hazel G; Zalcberg J; Hicks R; Yeend S; Chua YJ, 2015, 'The Clinical Oncology Society of Australia (COSA) SIGNETURe Neuroendocrine Tumor (NET) Registry of Australia: First Report of Patient Characteristics and Patterns of Care', in NEUROENDOCRINOLOGY, KARGER, SPAIN, Barcelona, pp. 98 - 98, presented at 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, SPAIN, Barcelona, 11 March 2015 - 13 March 2015, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000361683500062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Ritchie GE; Fernando M; Goldstein D, 2015, 'RITUXIMAB TO TREAT GEMCITABINE INDUCED HEMOLYTIC URAEMIC SYNDROME IN THREE PATIENTS WITH PANCREATIC ADNENOCARCINOMA', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 11, pp. 63 - 63, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000357957300056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2015
    Segelov E, 2015, 'TOPS - a randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, Chicago, presented at 2015 ASCO Annual Meeting, Chicago, 29 May 2015 - 02 June 2015, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036902066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
    Conference Abstracts | 2015
    Sharbeen G; Liu J; McCarroll J; Limbri L; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta IVb-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1414, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Sharbeen G; McCarroll J; Liu J; Youkhana J; Goldstein D; Kavallaris M; Phillips P, 2015, 'beta III-Tubulin Regulates Sensitivity to Nab-Paclitaxel (Abraxane (R)) in Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, Vol. 44, pp. 1414 - 1415, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000363324000260&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2015
    Stein A; Arnold D; Bechstein WO; Bridgewater JA; Goldstein D; Jensen LH; Kasper S; Kluempen HJ; Kunzmann V; Lindig U; Lohse AW; Nashan B; Primrose JN; Markus R; Shannon JA; Sinn M; Karl-Heinz W; Wege H, 2015, 'Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1): A randomized, multidisciplinary, multinational phase III trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4140
    Conference Abstracts | 2015
    Tempero MA; Cardin DB; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip PA; Riess H; Macarulla T; Yung L; Li M; Lu B, 2015, 'nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 33, presented at Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, IL, Chicago, 29 May 2015 - 02 June 2015, http://dx.doi.org/10.1200/jco.2015.33.15_suppl.tps4153
    Conference Posters | 2015
    Wang X; Crowe PJ; Goldstein D; Yang JL, 2015, 'Overcoming resistance of targeted EGFR/panHER monotherapy by inhibition of STAT3 escape pathway in sarcoma', Lorne, Victoria, Australia, Vol. 7, pp. 21496 - 21509, presented at 27th Lorne Cancer Conference 2015, Lorne, Victoria, Australia, 12 February 2015 - 14 February 2015, http://dx.doi.org/10.18632/oncotarget.7452
    Conference Abstracts | 2015
    Wang X; Goldstein D; Crowe P; Yang JL, 2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, AUSTRIA, Vienna, http://dx.doi.org/10.1016/S0959-8049(16)31921-9
    Conference Papers | 2015
    Wang X; Yeo RX; Crowe P; Goldstein D; Hogg P; Dilda P; Yang JL, 2015, 'Synergistic effect of targeting EGFR and metabolism in sarcoma cell lines', Brisbane, Australia, presented at 2015 Annual Sarcoma Conference, Brisbane, Australia, 17 October 2015 - 18 October 2015
    Conference Abstracts | 2015
    Wege H; Arnold D; Bechstein WO; Bridgewater J; Goldstein D; Jensen LH; Kasper S; Klumpen HJ; Kunzmann V; Lindig U; Lohse AW; Nashan B; Primrose J; Rentsch M; Shannon J; Sinn M; Weiss KH; Stein A, 2015, 'ADJUVANT CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN COMPARED TO OBSERVATION AFTER CURATIVE INTENT RESECTION OF CHOLANGIOCARCINOMA AND MUSCLE INVASIVE GALLBLADDER CARCINOMA (ACTICCA-1) - A RANDOMIZED, MULTIDISCIPLINARY, MULTINATIONAL PHASE III TRIAL', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, AUSTRIA, Vienna, Vol. 62, pp. S845 - S846, presented at 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, AUSTRIA, Vienna, 22 April 2015 - 26 April 2015, http://dx.doi.org/10.1016/S0168-8278(15)31489-6
    Conference Papers | 2014
    Baylock B; Dhillon HM; Goddard EM; Turner J; Rice H; Kabourakis M; Beale P; Ackland S; Seide J; Horvath L; Spencer L; Begbie S; Coppin R; Burge M; Hanley A; Marx G; Canavan R; Ferguson T; Campbell L; Karapetis C; Nolan L; Ashgari R; Liakos R; Iddawela M; Tenance C; Della-Fiorentina S; VanDerMeer R; Price T; Atkinson M; Weng N; Saliba C; Chantrill L; Skinner L; Goldstein D; Tsar C; Walpole E; Moore M; Greenfield K; George M; Hill L; Vardy JL, 2014, 'THE COLON HEALTH AND LIFE-LONG EXERCISE CHANGE (CHALLENGE) TRIAL: PARTICIPANT ADHERENCE TO FITNESS ASSESSMENTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 200 - 200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000345350900370&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Chua YJ; Karapetis CS; Gebski V; O'Connell R; Begbie S; Nott LM; Cronk MF; Underhill C; Abdi EA; Van Hagen T; Wong N; Hall M; Ferraro DA; Sjoquist KM; Santos C; Mackey JR; Goldstein D, 2014, 'Human equilibrative nucleoside transporter 1 (hENT1) in gemcitabine and FOLFOX (oxaliplatin, 5-fluorouracil, and leucovorin)-treated patients with metastatic pancreatic cancer: The randomized phase II PAN1 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Gastrointestinal Cancers Symposium, CA, San Francisco, 16 January 2014 - 18 January 2014, http://dx.doi.org/10.1200/jco.2014.32.3_suppl.228
    Conference Papers | 2014
    Davis ID; Long A; Martin A; Espinoza D; Yip S; Kichenadasse G; Thompson JF; Harrison ML; Lowenthal RM; Pavlakis N; Azad A; Kannourakis G; Steer C; Goldstein D; Shapiro JD; Stockler MR, 2014, 'EVERSUN: A phase II trial of everolimus alternating with sunitinib as first-line therapy for advanced renal cell carcinoma (aRCC) (ANZUP trial 0901)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.438
    Conference Papers | 2014
    Long A; Roncolato F; Foroudi F; Goldstein D; Davis I; Siva S, 2014, 'CURRENT CLINICIAN PRACTICES IN UTILISING RADIOTHERAPY AND TARGETED THERAPIES IN TREATING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA - A SURVEY OF AUSTRALIAN AND NEW ZEALAND CLINICIANS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 36 - 37, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Pothula S; Patel M; Xu Z; Lee A; Goldstein D; Pirola R; Apte M; Wilson JS, 2014, 'The role of hepatocyte growth factor/c-MET pathway in pancreatic stellate cell-endothelial cell interactions: anti-angiogenic implications in pancreatic cancer', Southampton, Pancreatology 14(3):S9, presented at International Association of Pancreatology and European Pancreatic Club, Southampton, Pancreatology 14(3):S9, -
    Conference Papers | 2014
    Pothula S; Xu Z; Goldstein D; Pirola R; Wilson JS; Apte M, 2014, 'Hepatocyte Growth Factor (HGF) inhibition may be a superior therapeutic approach than gemcitabine in pancreatic cancer', Melbourne, presented at Australasian Pancreatic Club and the Australian Health and Medical Research Congress, Melbourne, -
    Conference Papers | 2014
    Shannon J; Goldstein D; Wong N; Chichen S; Sjoquist K; O'Connell R; Grimison P; McLachlan S; Tebbutt NC; Lipton L; Vasey P; Cronk M; Varma SC; Jefford M; Segelov E; Abdi E; Ng S; Karapetis C; Gebski V; Zalcberg J, 2014, 'A MULTI-CENTRE, PHASE II, OPEN-LABEL, SINGLE ARM STUDY OF PANITUMUMAB, CISPLATIN AND GEMCITABINE IN BILIARY TRACT CANCER: PRIMARY RESULTS OF THE AGITG TACTIC STUDY', in Annals of Oncology, Oxford University Press (OUP), Madrid, Spain, pp. 1 - 1, presented at 39th ESMO Congress (ESMO 2014), Madrid, Spain, 26 September 2014 - 30 September 2014, http://dx.doi.org/10.1093/annonc/mdu334.106
    Conference Papers | 2014
    Tempero MA; Cardin D; Biankin A; Goldstein D; Moore M; O'Reilly EM; Philip P; Riess H; Macarulla T; Yung L; Wei X; Lu B, 2014, 'APACT: a Phase III Trial of nab-Paclitaxel (nab-P) Plus Gemcitabine (Gem) vs Gem Alone as Adjuvant Therapy for Patients (pts) with Resected Pancreatic Cancer (PC)', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Teo J; Boyer C; Sharbeen G; Sagnella S; Liu J; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2014, 'Design and Synthesis of Novel PEGylated Star Nanoparticles as Delivery Agents for Short-Interfering RNA (siRNA) to Pancreatic Cancer Cells', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1416 - 1416, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344362600356&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2014
    Wang X; Goldstein ; Crowe ; Yang , 2014, 'Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines', San Diego, CA, PA, presented at The 105th Annual Meeting of the American Association for Cancer Research 2014, San Diego, CA, PA, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-172
    Conference Presentations | 2014
    Wang X; Goldstein D; Crowe P; Yang J-L, 2014, 'Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-1723
    Conference Papers | 2014
    Webber K; Bennett BK; Goldstein D; Lloyd AR, 2014, 'Genetic associations of fatigue and other symptom domains after breast cancer treatment: Results from a prospective cohort study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.9537
    Conference Papers | 2014
    Wong W; Haghighi KS; Goldstein D, 2014, 'Stereotactic body radiotherapy using 4D image-guidance for inoperable primary liver cancer or metastases', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S124 - S125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687118700358&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2014
    Yip S; Pavlakis N; Harvie R; Martin A; Jovanovic L; Hudson A; Thompson JF; Nelson C; Long A; Steer C; Harrison ML; Kannourakis G; Goldstein D; Kichenadasse G; Lowenthal RM; Stockler MR; Davis ID, 2014, 'Circulating biomarkers and outcomes in a single-arm phase II trial of first-line sunitinib alternating with everolimus for advanced renal cell carcinoma (aRCC): EVERSUN ANZUP trial 0901', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, presented at Genitourinary Cancers Symposium, CA, San Francisco, 30 January 2014 - 01 February 2014, http://dx.doi.org/10.1200/jco.2014.32.4_suppl.428
    Conference Papers | 2014
    Youkhana J; Mccarroll J; Sharbeen G; Erkan M; Liu J; Goldstein D; Phillips PA, 2014, 'Heat shock protein 47 is a potential therapeutic target for the depletion of cancer-promoting stromal cells in pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 7 - 7, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000343863000015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Beesley VL; Janda M; Wockner LF; O'Rourke P; Gooden H; Goldstein D; Merrett ND; Wyld DK; Neale RE, 2013, 'PANCREATIC CANCER PATIENT'S MODERATE OR HIGH UNMET SUPPORTIVE CARE NEEDS OVER TIME AND RISK FACTORS OF FUTURE UNMET NEEDS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 105 - 105, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Bennett B; Webber K; Goldstein D; Lloyd A, 2013, 'What do patients really mean when they complain of fatigue after treatment? Reliable identification of post cancer fatigue', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S283 - S283, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843602060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Butow PN; Sze M; Eisenbruch M; Bell M; Aldridge L; Vardy JL; Hui R; Boyle F; Liauw WS; Goldstein D, 2013, 'Should culture affect practice? Prognostic discussions with immigrants', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419602272&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Chiorean EG; Von Hoff DD; Ervin TJ; Arena FP; Infante JR; Bathini VG; Wood TE; Mainwaring PN; Muldoon RT; Clingan PR; Kunzmann V; Ramanathan RK; Tabernero J; Goldstein D; Ko A; Lu B, 2013, 'CA19-9 decrease at 8 weeks as a predictor of overall survival (OS) in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients with metastatic pancreatic cancer (MPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601432&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Goldstein D; Von Hoff DD; Moore M; Greeno E; Ritch P; Tortora G; Ramanathan RK; Tabernero J; Ko A; Lu B, 2013, 'Evaluation of peripheral neuropathy in a phase Ill trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S613 - S613, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843604021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Goldstein D, 2013, 'Therapeutic Potential of Angiogenesis Inhibitors for Gastric Cancer', in Annals of Oncology, pp. ix8, http://dx.doi.org/10.1093/annonc/mdt437.1
    Conference Papers | 2013
    Hammel P; Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; Andre T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335564000024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Hammel P; Huguet F; Van Laethem J-L; Goldstein D; Glimelius B; Artru P; Borbath I; Bouche O; Shannon J; Andre T; Mineur L; Chibaudel B; Bonnetain F; Louvet C, 2013, 'Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605339&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Moore MJ; Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Hon JK; Biakhov MY; Hingorani SR; Ganju V; Weekes CD; Scheithauer W; Ramanathan RK; Tabernero J; Goldstein D; Wei X; Romano A, 2013, 'Prognostic factors (PFs) of survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with metastatic pancreatic cancer (MPC).', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601433&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Pavlakis N; Goldstein D; Sjoquist KM; Martin A; Tsobanis E; Yip S; Shannon J; Burge ME; Cronk MF; Tebbutt NC; Strickland A; Lipton LR; Price TJ; Nott LM; Harris DL; Burnell MJ; Alcindor T; Bang Y-J; Kang Y-K; O'Callaghan CJ, 2013, 'INTEGRATE: A randomized phase II double-blind placebo-controlled study of regorafenib in refractory advanced esophagogastric cancer (AOGC)-A study by the Australasian Gastrointestinal Trials Group (AGITG)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419605441&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Pothula S; Xu Z; Arun S; Goldstein D; Biankin A; Pirola R; Wilson J; Apte M, 2013, 'Hepatocyte Growth Factor Inhibition: A Therapeutic Approach Superior to Gemcitabine in Pancreatic Cancer?', in Pancreas, Lippincott Williams & Wilkins, Miami, pp. 1377 - 1377, presented at American Pancreatic Association, Miami, 31 October 2013 - 02 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000330468400188&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Ramanathan RK; Von Hoff DD; Moore M; Teixeira L; Siena S; Tabernero J; Goldstein D; Wei X; Lu B, 2013, 'Positron emission tomography (PET) response from a randomized phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients (pts) with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S611 - S611, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843604015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Sandler C; Webber K; Friedlander M; Lewis C; Chin M; Venkateswaran R; Segelov E; Bastick P; Lynch J; Thomas D; Liauw W; Boyle F; Goldstein D; Lloyd A, 2013, 'BARRIERS TO RECRUITMENT FOR A POST-CANCER FATIGUE INTERVENTION STUDY - THE TOPS TRIAL', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 116 - 116, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800178&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Scheithauer W; Von Hoff DD; Ramanathan RK; Moore M; Tabernero J; Goldstein D; Hammel P; Kunzmann V; Ko A; Romano A, 2013, 'Dose delivery in a phase III trial (MPACT) of weekly nab-paclitaxel (nab-P) plus gemcitabine (G) vs G alone for patients with metastatic adenocarcinoma of the pancreas', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S614 - S614, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843604024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Scott A; Goldstein D; Grennan K, 2013, 'IS SECOND LINE CHEMOTHERAPY IN PANCREATIC CANCER ONE LINE TOO MANY?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 150 - 150, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800282&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Sharbeen G; Liu J; McCarroll J; Youkhana J; Teo J; McCarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-Tubulin is a Novel Therapeutic Target for the Treatment of Pancreatic Cancer', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1381 - 1381, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400204&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Sharbeen G; Liu J; Mccarroll J; Youkhana J; Teo J; Mccarthy N; Goldstein D; Kavallaris M; Phillips PA, 2013, 'beta III-tubulin is a novel therapeutic target for the treatment of pancreatic cancer', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 12 - 12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Teo J; Boyer C; Liu J; Sharbeen G; Erlich R; Youkhana J; Duong HT; Goldstein D; Davis TP; Kavallaris M; McCarroll J; Phillips PA, 2013, 'Inhibition of beta III-Tubulin Using a Novel Nanoparticle-siRNA Approach Sensitizes Pancreatic Cancer Cells to Chemotherapy', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1385 - 1385, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330468400222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Vickers MM; Tu D; Lee C; Wheatley-Price P; Parulekar W; Brundage MD; Moore MJ; Au H-J; O'Callaghan CJ; Jonker DJ; Ringash J; Goldstein D, 2013, 'Significance of baseline quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601427&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Von Hoff DD; Ervin TJ; Arena FP; Chiorean EG; Infante JR; Moore MJ; Seay TE; Tjulandin S; Ma WW; Saleh MN; Harris M; Reni M; Ramanathan RK; Tabernero J; Hidalgo M; Van Cutsem E; Goldstein D; Wei X; Iglesias JL; Renschler MF, 2013, 'Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419601380&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Posters | 2013
    Wang X; Goldstein D; Crowe P; Yang J, 2013, 'Mechanisms of gefitinib alone and in combination therapy in soft tissue sarcoma cell lines', Boston, MA, US, presented at Molecular Targets and Cancer Therapeutics 2013, Boston, MA, US, 19 October 2013 - 23 October 2013
    Conference Posters | 2013
    Wang X; Goldstein D; Crowe P; Yang J, 2013, 'STAT3 inhibitor S3I-201 suppresses human osteosarcoma cell growth', Lorne, Victoria, Australia, presented at 25th Lorne Cancer Conference 2013, Lorne, Victoria, Australia, 14 February 2013 - 16 February 2013
    Conference Abstracts | 2013
    Webber K; Girgis A; Kaye B; Bonaventura BA; Boyle FM; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2013, 'The unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners (GPs)', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, Vol. 31, presented at 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 31 May 2013 - 04 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335419603085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2013
    Zilliacus E; Meiser B; Taouk M; Watts K; Kissane D; Girgis A; Butow P; Hale S; Perry A; Aranda S; Goldstein D, 2013, 'WORKING WITH PATIENTS FROM CULTURALLY AND LINGUISTICALLY DIVERSE BACKGROUNDS: PERSPECTIVES OF ONCOLOGY HEALTH PROFESSIONALS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 9, pp. 130 - 130, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325868800222&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Bennett BK; Lloyd AR; Webber K; Friedlander M; Goldstein D, 2012, 'Predictors of resilience in women treated for breast cancer: A prospective study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802389&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Butow PN; Aldridge L; Bell M; Sze M; Eisenbruch M; King M; Jefford M; Schofield P; Duggal-Beri P; Goldstein D, 2012, 'Cancer survivorship outcomes in immigrants.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009801015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Chua YJ; Karapetis CS; Underhill C; Nott LM; Goldstein D; Cronk MF; Gebski V; Wong N; Sjoquist KM; Biankin AV, 2012, 'PAN1: A randomized phase II study evaluating potential predictive biomarkers in the treatment of metastatic pancreatic cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803706&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Fawcett J; Sjoquist KM; Padbury R; Christophi C; Tebbutt NC; Pilgrim CHC; Gebski V; Wong N; Aiken C; Goldstein D, 2012, 'ATTACHE: A phase III, multicenter, randomized comparison of chemotherapy given prior to and post surgical resection versus chemotherapy given post surgical resection for hepatic metastases from colorectal cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803692&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Presentations | 2012
    Girgis A; Webber K; Bennetts BH; Bonaventura A; Boyle F; Koh E; Friedlander M; Segelov E; Goldstein D, 2012, '"This follow-up care would meet my needs, but I would still worry that problems with my health would not be found": A cross-sectional survey of adult cancer survivors', pp. 8 (Suppl 3), 117, presented at COSA 39th Annual Scientific Meeting
    Conference Papers | 2012
    Goddard EM; Dhillon HM; Turner J; Kabourakis M; Beale PJ; Goodwin A; Goldstein D; Clarke SJ; Ouriques M; Ackland SP; Abell F; Bonaventura A; Mallesara G; Fischer C; Kreiger L; Lashbrook M; Vardy JL, 2012, 'THE IMPACT OF PHYSICAL ACTIVITY ON DISEASE-FREE SURVIVAL IN PATIENTS WITH HIGH-RISK STAGE II OR III COLON CANCER: ONE MONTH SCREENING RESULTS', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 345 - 345, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400386&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2012
    Goldstein D; Sze M; Bell M; King M; Jefford M; Eisenbruch M; Girgis A; Vaccaro L; Butow PN, 2012, 'Disparities in quality-of-life outcomes in immigrant cancer patients.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, Vol. 30, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009802650&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Kiely BE; Martin AJ; Tattersall MHN; Nowak AK; Goldstein D; Wilcken N; Wyld D; Beale PJ; Jefford M; Glasgow AL; Abdi EA; Glare PA; Stockler MR, 2012, 'Usefulness of medical oncologists' estimates of survival time in people with advanced cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, IL, Chicago, presented at 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 01 June 2012 - 06 June 2012, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000318009803861&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2012
    Racadot S; Hammel P; Chibaudel B; Goldstein D; Spry N; Van Laethem J; Van Houtte P; Glimelius B; Gubanski M; Huguet F, 2012, 'Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning', in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ELSEVIER SCIENCE INC, MA, Boston, pp. S322 - S322, presented at 54th Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), MA, Boston, 28 October 2012 - 31 October 2012, http://dx.doi.org/10.1016/j.ijrobp.2012.07.845
    Conference Posters | 2012
    Wang X; Goldstein D; Crowe P; Yang J, 2012, 'STAT3-targeted therapy on human soft tissue sarcomas', Lorne, Victoria, Australia, presented at 24th Lorne Cancer Conference 2012, Lorne, Victoria, Australia, 09 February 2012 - 11 February 2012
    Conference Posters | 2012
    Wang X; Goldstein D; Crowe P; Yang J, 2012, 'Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors', presented at The 103rd Annual Meeting of AACR 2012, 31 March 2012 - 04 April 2012
    Conference Abstracts | 2012
    Webber K; Girgis A; Bennett BK; Bonaventura T; Boyle F; Koh E-S; Friedlander M; Segelov E; Goldstein D, 2012, 'CURRENT CARE AND NEEDS OF ADULT CANCER SURVIVORS - A CROSS-SECTIONAL SURVEY', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, Vol. 8, pp. 356 - 357, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310544400419&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Arun SJ; Xu Z; Fiala-Beer E; Yang L; Phillips P; Goldstein D; Biankin A; Pirola R; Wilson JS; Apte MV, 2011, 'Hepatocyte growth factor: a potential therapeutic target in pancreatic cancer', in Journal of Gastroenterology and Hepatology, Wiley, pp. 20 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295157300051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Bennett BK; Goldstein D; Friedlander M; Park SB; Kiernan MG, 2011, 'Oxaliplatin-induced Neurotoxicity - Comparing Four Methods of Assessment', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S234 - S234, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, SWEDEN, Stockholm, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71114-5
    Conference Papers | 2011
    Davis MP; Goldstein D; George S; Casali PG; Li S; Perkins J; Demetri GD, 2011, 'Asthenia and Fatigue as Predictors of Sunitinib Efficacy In Gastrointestinal Stromal Tumour (GIST)', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S135 - S136, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, SWEDEN, Stockholm, 23 September 2011 - 27 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295752800477&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Goldstein D; Lee C; Tracey E; Cook-Yarborough C; Lord S, 2011, 'Validating innovation: A population-based study of gastrointestinal stromal tumors (GIST) to estimate the survival benefit of imatinib.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2011.29.15_suppl.10060
    Conference Papers | 2011
    Park SB; Lin CSY; Krishnan AV; Goldstein D; Friedlander ML; Kiernan MC, 2011, 'A Novel Approach to the Emerging and Frequent Problem of Sustained Long-term Oxaliplatin-induced Neurotoxicity', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SWEDEN, Stockholm, pp. S436 - S436, presented at European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, SWEDEN, Stockholm, 23 September 2011 - 27 September 2011, http://dx.doi.org/10.1016/S0959-8049(11)71792-0
    Conference Abstracts | 2011
    Sze M; Butow PN; King M; Goldstein D; Jefford M; Girgis A; Eisenbruch M; Bell M; Vaccaro L; Dong R; Asghari M; Tattersall MH; Hui R, 2011, 'Cancer in a country not your own: Illness perceptions and distress in immigrant versus native-born cancer patients', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 81 - 81
    Conference Papers | 2011
    Youkhana J; Liu J; Kiriella N; Yang L; Xu Z; Biankin A; Goldstein D; Pirola R; Wilson J; Apte MV; Phillips PA, 2011, 'Heat Shock Proteins 27 and 47 Inhibit Platelet-Derived Growth Factor (PDGF)-Induced Pancreatic Stellate Cell Proliferation: Implication in Pancreatic Cancer Progression', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1365 - 1366, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000296398000273&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2011
    Youkhana J; Liu J; Kiriella N; Yang S; Xu Z; Biankin AV; Goldstein D; Wilson JS; Apte MV; Phillips P, 2011, 'Heat shock proteins 27 and 47 inhibit platelet-derived growth factor (PDGF)-induced pancreatic stellate cell proliferation: implication in pancreatic cancer progression', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. 19 - 19, presented at Australian Gastroenterology Week, Brisbane Australia
    Conference Papers | 2010
    Aldridge L; McGrane J; Butow PN; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Yates P; Connell S; Duggal-beri P; Sze M; Lobb E; Goldstein D, 2010, 'Unmet needs in Chinese (Mandarin and Cantonese), Greek, and Arabic-speaking cancer survivors in Australia', in Psycho-oncology, John Wiley & Sons, New York, pp. 1810 - 1813
    Conference Papers | 2010
    Bennett BK; Goldstein D; De Souza PL; Wilken N; Friedlander M; Hickie IB; Scott E; Rogers N; Lloyd AR, 2010, 'What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study', in Journal of Clinical Oncology, American Society of Clinical Oncology, United States, pp. 93s
    Conference Papers | 2010
    Fiala-Beer E; Xu Z; Phillips P; Yang L; Goldstein D; Pirola R; Wilson J; Apte M, 2010, 'Role of Pancreatic Stellate Cells in Pancreatic Cancer: The Urokinase Plasminogen Activator System', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1320 - 1320, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Fiala-Beer E; Xu Z; Phillips PA; Yang L; Goldstein D; Pirola R; Wilson JS; Apte MV, 2010, 'Role of pancreatic stellate cells in pancreatic cancer: the urokinase plasminogen system', in Journal of Gastroenterology and Hepatology, Wiley, pp. A75 - A75, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000283321200202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2010
    Goldstein D; Lee C; Hui Y; Shah B; Yip D; McArthur GA, 2010, 'Development of a nomogram to predict overall survival in patients with locally advanced or metastatic gastrointestinal stromal tumor receiving first-line treatment with imatinib', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2010.28.15_suppl.10054
    Conference Papers | 2010
    Webber K; Goldstein D; Bennett BK; Boyle F; De Souza PL; Wilken N; Friedlander M; Lloyd AR, 2010, 'Late fatigue after adjuvant therapy for early breast cancer is largely unrelated to cancer or its treatment: 5 year follow-up of a prospective cohort study', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia Pty Ltd, Australia, pp. 53 - 60, presented at ., -
    Conference Papers | 2010
    Yang JL; Zahorowska B; Kasim Y; Goldstein D; Crowe P, 2010, 'Abstract 1655: Mechanism of the synergistic antiproliferative effect of gefitinib and interferon-alpha in sarcoma cell lines', in Cancer Research, American Association for Cancer Research (AACR), pp. 1655 - 1655, http://dx.doi.org/10.1158/1538-7445.am10-1655
    Conference Abstracts | 2009
    Aldridge L; Butow PN; Goldstein D; Eisenbruch M; Girgis A; Jefford M; Schofield PR; King M; Duggal-beri P; Sze M; Lobb E; Grayson NM; Faraji S, 2009, 'Unmet needs in Chinese, Greek, Arabic, and English-speaking cancer patients in New South Wales', in Psycho-oncology, John Wiley & Sons, New York, pp. 117 - 117
    Conference Abstracts | 2009
    Aldridge L; McGrane J; Butow PN; Goldstein D; Girgis A; Jefford M; Schofield PR; King M; Eisenbruch M; Duggal-beri P; Sze M; Lobb E; Grayson NM; Faraji S, 2009, 'Unmet needs in Chinese, Greek, and Arabic-speaking cancer patients in New South Wales', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 221 - 221
    Conference Abstracts | 2009
    Butow PN; Lobb E; Schofield PR; Jefford M; Goldstein D; King M; Eisenbruch M; Girgis A; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse backgrounds – the interpreters’ perceptions of roles, challenges, and support needs', in Asia-Pacific Journal of Clinical Oncology, Blackwell Publishing Asia, Australia, pp. 207 - 207
    Conference Abstracts | 2009
    Butow PN; Lobb EA; Schofield PR; Goldstein D; Eisenbruch M; Girgis A; Jefford M; King M; Sze M; Aldridge L, 2009, 'Oncology consultations with patients from culturally and linguistically diverse (CALD) backgrounds: the interpreter perspective', in Psycho-oncology, John Wiley & Sons, New York, pp. 46 - 46
    Conference Papers | 2009
    Neoptolemos J; Buechler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at 45th Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 29 May 2009 - 02 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606603097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Neoptolemos J; Buechler M; Stocken DD; Ghaneh P; Smith D; Bassi C; Moore M; Cunningham D; Dervenis C; Goldstein D, 2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at 45th Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 29 May 2009 - 02 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276607000024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2009
    Phillips P; Yang L; Vonlaufen A; Xu Z; Biankin AV; Goldstein D; Pirola R; Wilson JS; Apte MV, 2009, 'Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. A277 - A277, presented at Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, IL, Chicago, 30 May 2009 - 04 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275277201376&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    <